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Organism resistance continues to develop to the currently available antimicrobial 
compounds necessitating the development of innovative new therapeutic compounds with 
different specificities and mechanisms of action that provide acceptable therapeutic indices. 
Unnatural amino acid containing antimicrobial peptides could provide a novel avenue for the 
development of therapies with improved efficacy and pharmacokinetics over natural amino acid 
containing peptides which are prone to protease degradation. 
Molecular dynamics (MD) simulations of antimicrobial peptides containing unnatural 
amino acids have been performed using explicit water and multiple model membrane types in 
all-atom simulations.  The structural properties of peptides were investigated using both the 
canonical and isothermal-isobaric ensembles to further understand the mechanism through which 
the collections of AMPs exert their in vitro activity.  
Simulations with micelle membrane models were conducted at 300 K to correlate with 
experimental circular dichroism (CD) data showing the secondary structure the peptides adopt in 
  
 
the presence of an electrostatic membrane model.  Analysis of the stabilized MD trajectory 
reflects peptide structural consistency with experimental data. 
Simulations of the peptides with bilayer model membranes were conducted at the 
physiologically relevant 310 K to correlate with experimental cellular activity data which 
demonstrated the antimicrobial activity of the peptides without providing insight into the 
mechanism through which the activity was achieved.  Long time scale simulations have noted 
distinct differences between bilayers in the presence of AMPs as compared to those without the 
peptide.  Mixed bilayers with an anionic charge modeled bacterial membranes while a confluent 
zwitterionic bilayer modeled the mammalian membrane. 
This research has demonstrated that force field parameters for unnatural amino acids can 
be derived from QM calculations.  FF parameters derived from structures identified from a DFT 
approach have also been used to expand the AMBER ff03 force field.  The FF parameters were 
able to able to model the interaction of the peptides which contain unnatural amino acids.  The 
data is consistent with NMR data and further supported with CD spectroscopy. 
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CHAPTER 1 
AN INTRODUCTION TO 
ANTIMICROBIAL PEPTIDES  
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1.1  INTRODUCTION 
Antimicrobial peptides have evolved within species as they evolved over time.  Man’s 
search for ways to inhibit bacterial proliferation date back to the late 1860’s with the work of 
Louis Pasteur, Robert Koch and their contemporaries.1  The suggestion that microbes were 
responsible for infection and food spoilage slowly became an accepted theory within science.  
The discovery of chemical compounds having anti-microbial properties emerged with the use of 
carbolic acid (phenol) as a surgical disinfectant.2  Since that time the quest for additional entities 
with antimicrobial properties has been the focus of much research.  Alexander Fleming’s 
identification of the antimicrobial enzyme lysozyme (1923) and a few years later, the 
serendipitous discovery of penicillin (1928)3, 4 set the precedent for the identification of 
organisms producing chemicals with antimicrobial properties which offer defense to would be 
environmental invaders.5  In 1975, scientists and pharmaceutical companies decided the war 
against infectious disease had been won and that further antibiotic development was 
unnecessary.6  The results of this myopic decision without considerations for microbial resistance 
development led to many pharmaceutical companies abandoning further investigation into 
antibiotic drug development.7  Some antibiotic resistance occurred shortly after the routine use of 
antibiotics began (1950’s) however the continued expansion of the rate of resistance was not 
realized until the 1990’s.7  In 2000, the World Health Organization (WHO) realized the extent of 
antibiotic resistance developing worldwide,7 and urged a more responsible utilization of 
antibiotics.  Education regarding appropriate use of antibiotics continues today and is an ongoing 
process.8  Almost since the time of penicillin’s discovery drug resistance has been a problem.5  
Microbes are able to alter their cell walls to protect themselves from the antimicrobial drugs 
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which seek to disable or kill these organisms.9  Emergence of numerous organisms with 
resistance to multiple antimicrobial therapies becomes an ever more serious problem considering 
the limited arsenal of compounds available and effective for the treatment of many infectious 
bacteria.   Over the last 24 years, only 36 new antibacterial compounds were approved by the 
United States’ Food and Drug Administration (FDA).10  The lack of effective treatments has 
precipitated the writing of legislation to meet the “10 x’20 initiative outlined by the “Bad Bugs 
No Drugs”10 campaign in 2003.  The 10 x’20 initiative seeks to develop ten new antibacterial 
treatments by 2020.  Through the establishment of a Limited Population Antibacterial Drug 
(LPAD) approval process to encourage development of compounds specifically targeting 
resistant bacteria.11 
Infections acquired in hospitals have demonstrated increased resistance to current 
therapies and are of particular interest; the organisms include Streptococcus and Enterococcus 
(especially vancomycin-resistant Enterococci (VRE)), Staphylococcus aureus (methicillin-
resistant S. Aureus (MRSA)), Klebsiella pneumonia, Acinetobacter baumanii, Pseudomonas 
aeruginosa, Mycobacterium tuberculosis, and Enterobacter species.5, 8  The economic impact and 
the cost of human life has necessitated research efforts be invested in the development of 
effective treatments where current approved therapeutic compounds have failed. 8, 11 
Since the realization that many of the existing antibiotics are no longer able to counter 
these threats, the United States has even developed an agency, National Antimicrobial Resistance 
Monitoring System (NARMS): Enteric Bacteria, for following the rate of resistance 
development.7  As is evident, there is a huge demand, despite little financial incentive, for further 
antimicrobial compound development with novel mechanisms of activity.  It seems obvious that 
with the increased demand a financial incentive would coincide.  The relatively short amount of 
4 
 
time needed to treat a patient with a successful antimicrobial compound has limited financial 
incentive for industrial development of new compounds.  The need for the development of new 
antimicrobial agents cannot be understated. 
1.2  MAGAININ 
Magainins are a collection of naturally occurring cationic AMPs which were originally 
derived from the African tree frog, Xenopus laevis.12-15  Magainin 2 is a peptide which has the 
following amino acid sequence: GIGKFLHSAKKFGKAFVGEIMNS. 12-15  Figure 1.1 shows the 
NMR derived alpha helical secondary structure as published in the protein data bank (PDB) with 
ID:2MAG, the structure of Magainin 2.  Magainin has demonstrated broad antimicrobial activity 
making it of therapeutic interest.  Magainin 2 was the electrostatic model upon which the 
unnatural amino acid containing peptides were modeled.16, 17  The unnatural amino acid 
containing AMPs which resulted from the models included the unnatural amino acids beta 
alanine (β-Ala), gamma amino butyric acid (GABA), 6-amino hexanoic acid (6-AHX),  ornithine 
(ORN), diamionbutanoic acid (DAB), diamionpropanoic acid (DPR), octahydroindole carboxylic 
acid (OIC), and tetrahydroisoquinoline carboxylic acid (TIC) (Figure 1.2).16, 17  
Figure 1.1 Amphipathic structure of magainin 2 PDBID: 2MAG.  Hydrophilic residues have red 
carbon atoms.  Hydrophobic residues have blue carbon atoms.   
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The skeleton of AMPs incorporating the unnatural amino acids is shown in Figure 1.3.  Sterically 
hindered Tic-Oic dipeptides are separated by varying distances with spacer 1 which increases the 
number of carbon atoms in the peptide backbone.  Gly, the smallest naturally occurring amino 
acid was used as reference for extension of the number of carbon atoms in the protein backbone.  
Extension to include a beta carbon in the backbone was accomplished by incorporating beta 
Figure 1.2 Amino acids incorporated into the AMP sequence   
para-Chlorophenylalanine para-Fluorophenylalanine 
Octahydroindole 
carboxylic acid 
Tetrahydroisoquinoline 
carboxylic acid 
6-amino 
hexanoic acid 
Beta alanine  
Gamma amino butyric 
acid 
Glycine 
    
Lysine 
Diamionpropanoic 
acid 
Diamionbut
-anoic acid 
Ornithine 
Arginine 
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alanine.  Gamma amino butyric acid incorporated into the peptide sequence increased the 
flexibility of the backbone by adding gamma carbons into the backbone.  The delta carbon was 
not synthesized but the epsilon carbon was generated by the inclusion of 6-Ahx. 
1.3  ANTIMICROBIAL PEPTIDES 
Antimicrobial peptides (AMPs) have evolved with species through the ages.  According 
to Tomas Ganz, antimicrobial peptides are “polypeptides of fewer than 100 amino acids, found 
in host defense settings, and exhibiting antimicrobial activity at physiologic ambient conditions 
and peptide concentrations.”18  The presence of antimicrobial peptides appears to be ubiquitous 
in the biologic environment and wherever they have been sought, unique innate immune 
protection in the form of AMPs has been detected.  
It wasn’t until the early 1960’s when H.I. Zeya and John K. Spitznagel characterized a 
cationic peptide found in rabbit and guinea pig neutrophil granules that the identification of 
polymorphonuclear leukocytes (PMN) (antimicrobial peptides was noted, though not fully 
understood) were isolated and proposed to have therapeutic potential.19   
Concurrently, the identification of antimicrobial substances in insect hemolymph was 
made by Hans Boman and his confrere.20  Francisco Garcia Olmedo and his colleagues were 
investigating antimicrobial peptides present in plants.21  The discovery of human neutrophil 
antimicrobial peptides was not made until 1984 by Robert Lehrer, Michael Selsted, and Tomas 
Ganz.22  They named their family of antimicrobial peptides “defensins” for the role they were 
assumed to play in protecting from microbial invaders.  Robert Lehrer was responsible for 
initiating a search for the mechanism of action of the defensins.  He identified the disruption of 
the cell membrane as a requirement for microbial death.23  It was not until the early 1990’s when 
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scientists became conversant amongst those who studied phagocytes, insects and plants and the 
potential for therapeutic development was realized.18 
Due to their broad endemic nature, AMPs are good candidates as therapeutic agents.  
AMPs have numerous advantages over the traditional, small molecule, antimicrobial compounds.  
Attractive features of AMPs include reasonable host cell toxicity (relatively non-toxic), reduced 
resistance development from microbial invaders, and broad spectrum of activity. AMPs have 
demonstrated membrane disrupting capability beyond that of bacterial cells.  Anticancer activity 
has also been identified for some of these peptides.24  The membrane differences between normal 
and malignant cells make anticancer peptides (ACPs) a potential therapeutic option.24 
The specificity of AMPs is a desirable therapeutic property.  Avoiding damage to host 
cells while destroying alien cells decreases side effects resulting from offsite interactions which 
are associated with toxicity.  Given the need for new, selective antimicrobial compounds with 
excellent toxicity profiles AMPs, and specifically antifungal peptides (AFP), are a novel 
collection of peptides which target the membrane surface.  Antiviral and anti-parasitic AMPs 
have also been identified among the diverse class of peptides.25  The dynamic activity 
demonstrated by naturally occurring AMPs makes them a good starting point for structure 
optimization and improving their therapeutic potential.  
1.4  SECONDARY STRUCTURE 
Anfinsen’s theory outlining the correlation between the primary amino acid sequence, 
secondary structure, and function has led to the pursuit of secondary structure elucidation of 
many sequenced proteins.  The secondary structure associated with an AMP is thought to 
directly correlate to its function.  Presently naturally occurring AMPs are known to attain the 
8 
 
following three types of secondary structure/configuration: alpha helical, beta helix/sheet, or 
cyclic secondary structure.  AMPs are known to have a random coil structure or a lack of 
secondary structure in solution, and only develop secondary structures (such as alpha helical, 
beta helix/sheet, or cyclic) in the presence of electrostatic charge environments such as 
membranes (Figure 1.4). 26,27   
AMPs are thought to require a minimum of 20 amino acids for membrane disruption 
however; peptides with fewer amino acid residues have been shown to dimerize in order to 
disrupt the membrane lipid bilayer.24  The peptides with the adopted secondary structure are 
thought to span the thickness of the bilayer in several of the proposed mechanisms.  The theory 
of the requisite number of residues is thus dependent upon the secondary structure adopted by 
the peptide and the mechanism through which the membrane is disrupted.  
Figure 1.3 Line structure of the AMP designed with the unnatural amino acid, Tic-Oic dipeptides 
incorporated into the peptide sequence. 
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Many attempts at AMP design have focused on arginine enrichment creating areas of 
cationic charge and cysteine incorporated into the peptide sequence for further oxidation.  
Additionally, inclusion of thiols for oxidation to form disulfide bonds sometimes creates cyclic 
peptides.25  The cyclic peptides created through oxidation of cystein’s thiol often create 
hydrophobic regions within the AMP which are able to interact with the hydrophobic region of 
the aliphatic lipid tails within the membrane core.  Others attempts at AMP design focused on 
enrichment with tryptophan due to its preference for the interfacial region of lipid bilayers.28  
Movement of charged molecules across a lipid bilayer is challenging 
α-helix 
β-pleated 
sheet 
Random 
coil 
Figure 1.4 Common secondary structures associated with naturally occurring peptides
.27
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Figure 1.5 Eukaryotic membrane models A) Mammalian membrane model B) Fungal membrane 
model. 
27
 
 
11 
 
due to the hydrophobic nature of the aliphatic lipid tails which must be traversed.  Use of 
unnatural amino acids has enabled peptides to be more resistant to proteases and better tailor the 
amino acids to the target membrane. 
It should be noted there is a distinct difference between AMPs and cell-penetrating 
peptides (CPP).  While AMPs disrupt the membrane of a cell to the point of cellular death, CPPs 
are internalized by cells while avoiding the membrane destabilization and cell death.
29
  CPPs are 
presently being investigated as drug delivery options for difficult to deliver peptide derived 
drugs.
 29,30
 
1.5  TARGETS OF AMPS 
The structural and chemical characteristics associated with the membranes encapsulating 
each organism’s cells is unique; not just to that organism but, within multicellular species 
membrane composition is unique to individual tissue types.  The focus herein is on the 
components of the membrane which differentiate target cells from host cells.  The structural 
features associated with eukaryotic cells which include mammalian and fungal organisms will be 
discussed.  Additionally, the two most common membrane features, Gram negative vs. Gram 
positive, used in the differentiation of prokaryotic organisms will be discussed as well as how the 
mycobacteria differ from the bacteria which can be identified using the Gram stain technique. 
The first generation of unnatural amino acid containing antimicrobial peptides was tested 
to identify selectivity for prokaryotic over eukaryotic cells.  These two groups of cells with 
differing chemical compositions within the membrane are believed to be the result of 
electrostatic differences produced through variations in the membrane lipid composition.   
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1.6  EUKARYOTIC MEMBRANES 
The Eukarya are distinguished from the prokaryotic organisms by the membrane bound 
nature of the cell nucleus.  Both mammals and fungi are members of this taxon.  Parasites, 
insects, reptiles, and amphibians are also members of the Eurarya.  The membership of mammals 
to this group makes treating alien cells from fungi and parasites difficult to treat while 
maintaining low toxicity for the host cell due to the similarity in the chemical compositions of 
the membranes.  The generic structural features which distinguish the mammalian cells from that 
of the fungi are discussed in the context of electrostatic modulating molecules which can be 
exploited for therapeutic selection. 
1.6.1  MAMMALIAN MEMBRANES 
Mammalian cells have a membrane charge closer to neutral as a result of the abundance 
of zwitterionic phospholipids (Figures 1.5 A and B).  In addition to the zwitterionic 
phospholipids, eukaryotic cells frequently have bulky sterols incorporated into the membrane 
surface contributing polar but electrostatically neutral structure.  Glycolipids which function as 
both an energy source and cellular markers are found in all eukaryotic cell membranes.   Many of 
the in vitro toxicity tests focus on the effect the AMP has on erythrocytes or red blood cells 
Hemolysis is associated with a lack of cellular specificity for foreign organisms over that 
of the mammalian host.  AMPs with hemolytic properties would have limited utility due to 
toxicity. 
 
 
 
13 
 
1.6.2  FUNGAL MEMBRANES   
The most common fungal infections present in the U.S. involve dermal surfaces exposed 
to prolonged periods of high humidity which create a hospitable environment for fungal 
infections such as athlete’s foot, ring worm, jock itch and yeast infections.  The community of 
immune-compromised patients including those with AIDS, undergoing cancer treatment, and 
organ transplant recipients is particularly at high risk for fungal infections which are commonly 
thought of as opportunistic.  The aggrandized and diverse emergence of fungal infections has 
precipitated the need for new chemotherapeutic compounds.  The penurious therapies approved 
for treatment of the eukaryotic, fungal infections have poor membrane permeating capabilities.  
The lack of cell penetration of antimycotic compounds necessitates high doses for effective 
antimycotic activity.  The poor therapeutic profiles might be attributed to the membrane 
composition of mammalian and fungal cell walls (Figure 1.5 A and B) which share electrostatic 
similarity.  Much like their bacterial counterparts, antifungal compounds have also experienced 
the drug resistant evolution to the therapeutic arsenal further handicapping fungal infection 
treatment.   
The development of AFPs has great therapeutic potential.  The last generation of 
Figure 1.6 A) Cholesterol which is major components of eukaryotic cell membranes   and B) Cardiolipin 
where  R 1, R2, R3, and R4 represent aliphatic carbon tails 
A B 
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antifungal small molecule drugs is still fraught with many of the original compound limitations 
but AFPs administered as an adjuvant can act synergistically to improve the activity of the 
antimycotic by destabilizing the foreign cell membranes while avoiding host cells.  Once the 
membranes have been destabilized, delivery of the antimycotic will have greater target delivery 
success enabling a lower dose and reduced side-effects. 
1.7  PROKARYOTIC MEMBRANES 
Prokaryotic cells differ from the eukaryotic due to the lack of a cell nucleus and other 
membrane bound organelles.  Many species of bacteria (referring to the colloquial usage and not 
the genus) contribute and have demonstrated that they are an essential component of mammalian 
organisms and contribute to the health through a symbiotic relationship.  The challenge is 
selecting for those organisms which are robust enough to overcome the normal flora resulting in 
an infection.  In general the membrane surface of prokaryotic organisms has an anionic charge 
due to the large percentage of negatively charged phospholipids within the membrane.   
The following description of the prokaryotic bacterial membranes both Gram positive 
and Gram negative has been published elsewhere.26  The cartoons depicted in Figure 1.7 A & B 
give a simplified perspective of the membrane complexity which exists with the various 
membrane types.  Within an organism the membrane composition varies which adds to the 
complexity of accurate model development.  The membrane lipid composition varies among 
species and can even vary within a species due to the evolutionary adaptation of some enabling 
them to survive in environments the non-adapted species would not be able to survive.   
15 
  
Figure 1.7 A) Model of prokaryotic gram positive cell membrane B) Model of prokaryotic gram 
negative cell membrane 
26, 27
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1.6.1 Gram Positive Bacteria 
Since the membrane is the target of AMPs and it is the disruption of the membrane which 
leads to the antimicrobial activity it is important to understand the specific molecules which are 
responsible for distinguishing one membrane type from another.  Mammalian cell membranes 
have mostly hydrophobic cholesterol incorporated into the lipid bilayers.  The inclusion of 
cholesterol with its small polar head group produced by the hydroxyl functional group decreases 
the flexibility associated with the membrane surface, see Figure 1.6 A.  The lipid composition for 
several of the clinically relevant infectious organisms has been examined.31  Extension of the 
membrane specificity would reason that the lipids, proteins, and other cellular components and 
the ratios of each contribute to the AMP selectivity observed between different organisms. One 
example of the unique membrane lipid composition responsible for AMP selectivity occurs with 
the Gram positive bacteria Staphylococcus epidermidis, which is composed primarily of POPG 
at 90% of the lipid composition.26  The spore forming Gram positive bacteria Bacillus subtilus 
has a less anionic membrane with only 29% of the membrane comprised of POPG (Figure 1.9).26  
1.7.2 Gram Negative Bacteria 
 Gram negative bacterial strains tend to have an inner and outer membrane with 
carbohydrate rings of peptidoglycan sandwiched between the membranes (Figure 1.7), thus 
reducing the amount of stain that is retained by the membrane when Gram stains are applied.9 
Salmonella typhimurium, Pesudomonas cepacia and Escherichia coli contain only 33, 18 and 6 
percent POPG respectively reflecting the great variability even between the Gram negative 
bacteria.26 Klebsiella pneumoniae and Pseudomonas aeruginosa, which are members of the 
ESKAPE pathogens10 contain 5 and 21 percent POPG respectively.26  The zwitterionic lipid 1-
Palmitoyl-2-Oleoyl-sn-Glycero-3-Phosphoethanolamine (POPE) has been identified as a major 
17 
 
component of Gram negative bacterial membranes.26  Escherichia coli, Klebsiella pneumonia 
and Pseudomonas aeruginosa have membranes primarily composed of the anionic POPE lipid 
which contain 80, 82 and 60 percent POPE respectively.32  The dual anionic charge associated 
with cardiolipin (Figure 16 B), identified as “Lipid A” in Figure 1.7 B offers four hydrophobic, 
aliphatic tails associated with the two phosphate ester moieties of the head groups.
33
  Other 
structural features which differentiate prokaryotic and eukaryotic cell membranes include the 
sterols in the instance of fungi and cholesterol in the instance of mammals.  The complex sugar 
coats composed of lipopolysaccharide and peptidoglycan challenge the disruption of the 
membrane yet provide unique structural characteristics.
9
   
 
Figure 1.8  Model of prokaryotic mycobacteria cell membranes. 36-41 
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1.7.3  Mycobacteria 
 Mycobacteria are prokaryotic organisms despite the original suspicion that they were a 
fungal species’ (as evidenced by the “myco” root which means fungus).  They are discussed here 
separately due to the complex membrane which is the target for therapeutic AMPs.  Several 
clinically significant members of the mycobacteria include Mycobacterium tuberculosis, the 
causative agent of tuberculosis infections, Mycobacterium leprae, the causative agent of leprosy, 
and nontuberculosis mycobacterial infections caused by other mycobacterial species.34  The 
expanding population of immunocompromised patients has led to the re-emergence with 
antibiotic resistance developing within this once well controlled collection of infections.34  The 
mycobacteria are considered Gram-positive however they do not retain the requisite crystal 
violate stain on a consistent basis.  A second staining technique, acid-alcohol staining, is needed 
to correctly differentiate mycobacteria from other prokaryotic organisms 5.  The World Health 
Organization estimates that as many as 32% of the world population is infected with M. 
tuberculosis infections which provides a glimpse of the significant need for the development of 
effective treatment options.34, 35   
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Figure 1.9 1-Palmitoyl-2-Oleoyl-sn-Glycero-3-Phosphocholine (POPC), 1-Palmitoyl-2-Oleoyl-sn-
Glycero-3-[Phospho-rac-(1-glycerol)] (POPG) and sodium dodecylsulfate (SDS), the three lipid 
molecules used in the construction of the membrane models.  
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The complex membrane surrounding the mycobacterial cells has demonstrated 
immunomodulatory activities and has thus been the focus of antimicrobial compound 
development.34, 35  The complex collection of lipids and carbohydrate molecules combined with 
the unique mycolic acid and unique polysaccharides such as arabinogalactan to create the 
dynamic species.    
The cartoon depicted in Figure 1.8 shows a simplified perspective of a mycobacterium 
membrane; is an aggregation of information from several published sources sources.
36-41
 
1.8  PROPOSED MECHANISMS OF ACTION 
 There have been three mechanisms through which AMPs have been hypothesized to exert 
their membrane disrupting activity.  The first is the Barrel-stave mechanism where the peptides 
completely line a pore within the membrane.  The second is there toroidal pore mechanism 
where the AMPs intermingle with the polar head groups of the membrane to create a membrane 
disruptive pore.  The final mechanism is the carpet mechanism in which the AMPs have a 
detergent like effect creating micelles from the amphipathic membrane lipids after the bilayer 
structure has been disrupted.  While the three mechanisms have been paired with many of the 
naturally occurring AMPs less is known about the mechanism of action through which the 
unnatural amino acid containing AMPs exert their activity.  The common mechanism will be 
discussed in detail as a reference point for the ensuing investigation. 
1.8.1  Barrel-Stave Mechanism 
The variation in charge associated with bacterial membranes enables tailoring of the 
peptide charge for optimum electrostatic interaction.  There are three proposed mechanisms 
through which antimicrobial peptides are speculated to exert membrane destabilization activity.42  
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Others distinguish the mechanism as one of two classes, those which function synergistically and 
those which have functional duality.12  Identifying which mechanism or mechanisms correlate 
with individual AMP’s function has been the subject of numerous studies.12, 29, 43-52  The 
concentration of peptide relative to that of the lipids is critical in the membrane disruption 
mechanisms.12  Aggregation of the peptide before the aggregate is attracted to the bilayer surface 
is a prerequisite.  Once the critical peptide concentration has been achieved, aggregation can 
occur, however whether aggregation occurs prior to membrane attraction, i.e. in solution or at the 
surface of the membrane after the peptide has been attracted, has been debated.  Despite the 
debate of when aggregation occurs, aggregation is a prerequisite for pore formation regardless of 
Figure 1.10  Barrel-Stave Mechanism.  Hydrophilic residue regions are noted in red.  Hydrophobic 
residue regions are noted in blue.   Anionic POPG lipids are represented by magenta spheres and 
zwitterionic POPC lipids are represented with cyan colored spheres. Adapted from figures produced 
by Brogden.
34
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the AMP type causing the disruption.  Despite the diverse nature of AMP structure and 
selectivity they have been divided into three unique proposed mechanistic types: the barrel-stave, 
carpet, and toroidal pore.53, 54   
The barrel-stave model was original introduced in the 1970s and has been considered the 
model mechanism for peptide-induced trans-membrane pore formation.55 The barrel-stave model 
has been reported to be the natural mechanism of membrane disruption for several AMPs 
including alamethicin,55 ceratotoxins,56 peptaibols,57 and distinctin.56 Originally it was suggested 
that melittin and magainin function through a barrel-stave mode, although further research has 
demonstrated that they function through a toroidal pore mechanism. 42  In the barrel-stave model 
the peptide must be long enough to span the membrane.45 Dimers or multimers form after 
binding of the AMP to the bacterial membrane. The formation of this assembly is a requisite step 
for pore formation through this mechanism.58  Figure 1.10 is a cartoon depicting the mechanism 
of the barrel stave mechanism of bilayer disruption.   Figure 1. 10A) the bilayer is surrounded by 
free peptide in solution.  Figure 1. 10 B) electrostatic interactions between the peptides and 
bilayer cause aggregation.  Figure 1. 10 C) the peptides aggregate on the bilayer surface leading 
to the disruption of the electrostatic interactions which hold the lipids together.  Figure 1. 10 D) 
the peptides are fully inserted into the bilayer creating a pore lined with AMPs. 2-Oleoyl-1-
palmitoyl-sn-glycero-3-phosphocholine (POPC) (Figure 1.9) is represented by cyan head groups 
while 1-Palmitoyl-2-Oleoyl-sn-Glycero-3-[Phospho-rac-(1-glycerol)] (POPG) (Figure 1.9) is 
represented by magenta head groups. The polar amino acids are represented by the red portion of 
the alpha helix cartoon while the hydrophobic portion is represented by the blue portion of the 
alpha helix cartoon. Figure is an adaptation of a figure from Brogden.42   
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1.7.2  Toroidal Pore Mechanism 
The toroidal pore mechanism shares many common features with the barrel-stave pore 
model.  They are similar in that they both require binding of the AMP to the bacterial membrane 
followed by aggregation of the AMP within the membrane which finally leads to the formation 
of pores.58  This mechanism was originally used to describe magainin-induced pores.59  The 
toroidal model is different from the barrel-stave model, in that the peptides are always in 
association with the lipid head groups even when they are perpendicularly inserted into the lipid 
bilayer.  This association forces the bilayer to fold toward the hydrophobic center (from both the 
top and bottom of the bilayer) of the bilayer producing a pore which is lined by both the peptides 
Figure 1.11 Torroidal Pore Mechanism.  Hydrophilic is in red.  Hydrophobic residues are in blue.  
Anionic POPG lipids are represented by magenta spheres and zwitterionic POPC lipids are 
represented with cyan colored spheres. Adapted from a figure created by Brogden.
34
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and the lipid head groups (see Figure 1.11).55  Unlike the barrel-stave model, the peptides which 
act though the toroidal pore mechanism do not need to be long enough to span the entire 
thickness of the membrane.45  This enables smaller peptides to destabilize the lipid bilayer by 
stabilizing the lipid pore rather than acting as a pore lining.  The size of the pore created varies 
depending on the AMP which formed the pore and the lipid bilayer composition.  In general, 
pores on the nanometer size scale are obtained using the toroidal pore mechanism.52   
Figure 1.11 is a cartoon depicting the mechanism of the toroidal pore mechanism of 
bilayer disruption.  Figure 1.11 A) the bilayer is surrounded by free peptide in solution. Figure 
1.11 B) electrostatic interactions between the peptides and bilayer cause.  Figure 1.11 C) the 
peptides aggregate on the bilayer surface leading to the disruption of the electrostatic interactions 
which hold the lipids together.  In Figure 1.11 D) the peptides are fully inserted into the bilayer 
creating a pore lined with both AMPs and the polar head groups of the membrane.  POPC 
(Figure 1.9) is represented by cyan head groups while POPG (Figure 1.9) is represented by 
magenta head groups.  The polar amino acids are represented by the red portion of the alpha 
helix cartoon while the hydrophobic portion is represented by the blue portion of the alpha helix 
cartoon.  These figures are an adaptation of a figure from Brogden.42   
1.8.3  Carpet Mechanism 
The third mechanism is the carpet model. In this model, peptides accumulate on the 
bilayer surface.  The peptides orient parallel to the membrane surface through electrostatic 
attraction of the anionic phospholipid head groups which cover the surface of the membrane  
(Figure 1.12).42  Through the binding of the peptide to the phospholipid membrane head groups a 
layer or ‘carpet’ is formed on the bilayer surface. Alignment of the peptide monomers on the 
surface occurs with the hydrophilic surface facing the phospholipid head groups.46, 51, 54, 60  This 
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peptide binding continues until a threshold concentration is reached upon which permeation 
occurs in a detergent like manner.61  The ability of an antimicrobial peptide to permeate a 
membrane is a concentration dependent process. At high peptide concentrations the peptides on 
the surface of the bilayer, through a detergent like activity, are able to form micelles.42  When the 
critical concentration of peptide has been reached, transient, toroidal holes form in the membrane 
surface allowing small molecules to cross the bilayer prior to cellular collapse.  Thus essentially 
when the use of the toroidal pore mechanism is engaged many times this constitutes the carpet 
mechanism. 
A unique characteristic of the carpet mechanism is that the traditional requirement for the 
adoption of a specific secondary structure (such as an α-helix) upon binding to the membrane is 
not required by this mechanism.54  Computational chemistry is able to provide useful tools and 
techniques which can complement data obtained from chemical experiments or it can be used for 
the investigation of systems which either cannot be studied using synthetic techniques or have 
produced inconclusive results. 12, 16, 17, 43, 45, 51, 54, 56, 57, 59, 62-64  During the course of this techniques 
will be utilized to provide the most rational explanation of the activity of our AMPs and their 
interaction with model eukaryotic and prokaryotic membrane systems.  Energetic analysis of the 
interaction between the AMPs and the bilayers have been undertaken through MD simulation in 
which the atoms within a given system are allowed to interact over a short period of time by 
approximating the physical motion of the individual particles.  
 Understanding the mechanism through which each AMP exerts its in vitro activity can 
aid the design of the next generation of AMPs containing unnatural amino acids.  Determining 
the secondary structure of the peptides containing unnatural amino acids can aid in the 
mechanism elucidation. 
26 
 
 
 
1.9  BILAYER CURVATURE 
Naturally occurring cells, and thus the membranes which exist as part of a larger 
spherical shape are influenced by the radius of the spherical cell.  The curvature present in the 
membranes plays an important role in the membrane disruptive effects of AMPs.65  MD 
simulations with BAR domains, which constitute a type of protein which drives the formation of 
tabulated and vesiculated membrane structures has demonstrated the ability to induce bilayer 
curvature when simulated using a coarse grain (CG) model.66  The large number of atoms 
Figure 1.12 Carpet Mechanism.  Hydrophilic residues are represented in red.  Hydrophobic residues 
are shown in blue.  Anionic POPG lipids are represented by magenta spheres and zwitterionic POPC 
lipids are represented with cyan colored spheres. Adapted from a figure by Brogden.
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required for the cooperative effect between the peptides and bilayer to occur makes the 
development and simulation of accurate model bilayer systems difficult to achieve with the 
requisite time scales at which the curvature can be observed to develop.  This is a limitation of 
atomistic MD simulations present in all bilayer simulations. The main challenge any theoretical 
approach encounters is its ability to accurately replicate the system of interest.  A detail as small 
as the curvature of the membrane can affect the ability of an AMP to form an interaction with the 
head groups of the bilayer lipids.  There is evidence that the AMP concentration required for 
membrane thinning prior to pore formation can vary with the curvature of the membrane lipids.  
Differences between the curvature of the liposomes and micelles used in in vitro studies and the 
in silico studies have been another potential source of error. 
Previous MD simulations with AMPs have primarily involved use of CG-MD65, 67-70  The 
CG method minimizes the number of charge points which need to be considered at each step 
within the calculation and thus the offers a parsimonious approach for simulations with many 
atoms (100 000+ atoms).  The speed gained with fewer calculations is achieved at the expense of 
atomic detail.  Due to the loss of atomic perspective an all atom approach has been utilized in 
this research and will be discussed further in the next few chapters. 
Environmental variables considered in the MD simulation are to model in vivo conditions 
as much as possible.  Simulations have been conducted at 300 K for the micelle simulations to 
correlate with in vitro data71 which was collected at room temperature.  Bilayer simulations 
designed to model the environment of the in vitro studies have been conducted at 310 K, body 
temperature.  
Previous MD simulations with AMPs have primarily involved use of CG-MD65, 67-70  Use 
of CG-MD has been utilized because the small number of charge points, resulting from the 
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aggregation of numerous atoms into one charge point, increases the speed of the simulation.  
Having fewer charge points requires fewer calculations at each time step of the simulation. 
1.10  MEMBRANE SPECIFICITY 
The cell membrane’s lipid composition varies for each organism and even each tissue 
type within an organism.  The variation in the chemical composition between cell types can be a 
great target for therapeutic compound development.  Tailoring an AMPs structure to interact 
with the invasive cell’s membrane creates selectivity and specify.     
1.11  COMPUTATIONAL THEORY 
The goal of computational chemistry is to mathematically represent chemical reality. 
Molecules are composed of atoms which in computational models are represented as charged 
particles.  In theory, including measures of all chemical properties (descriptors) associated with 
each atom should be able to reproduce experimentally derived results.  Inclusion of such large 
numbers of descriptors is not computationally feasible with the current resources available.  The 
truncation of descriptors may seem like an over simplification of the complex inter atomic 
interactions which occur between the atoms of a molecule and its surrounding environment but, 
it has demonstrated itself sufficient to be consistent with experimental data.  The main focus is 
on the atomic charges because Coulomb interactions are the only physical force for chemical 
phenomena and van der Waals forces are responsible for handling the non-bonded interactions in 
the AMBER9 ff03 force field.72  Considering the relative energy associated with the three 
dimensional arrangement of atoms, represented by collections of charged particles, the atomic 
interactions which occur during the reaction which result in the formation of unique products are 
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able to provide insight into other physical observable properties exhibited by the molecules.72  
The ultimate goal would be an exact solution of the Schrödinger Equation72 (Equation 1.1) which 
at this time is feasible for only one and two particle systems, with the two particle system being 
separated into two pseudo one-particle problems and introducing a center of mass coordinate 
system.72   
    
   
  
          Eqn. (1.1) 
The computational approaches will be discussed in further detail in Chapters 2 and 3. 
1.12  STRUCTURE FUNCTION RELATIONSHIPS 
In the 1960’s Anfinsen proposed his “thermodynamic hypothesis” which states that a 
protein’s native structure corresponds to the state with the lowest free energy of the protein in the 
water solvent system.73  The correlation between the peptide sequence, the secondary structures 
and the resulting function suggests that determining the secondary structure can provide insight 
into the function of the peptide.74  Use of the Generalized Born/Simulated Annealing is one 
approach that will identify low energy structures of the peptide systems.  Using an implicit 
solvent specified through the use of a dielectric constant appropriate for water and a 
physiologically relevant ionic concentration the system was heated to 3000 K and cooled over 10 
000 steps.  Had an infinite number of steps been used for the cooling process, the global 
minimum energy structure, which has the lowest potential energy, would have been identified.  
Since an infinitely slow process is not feasible due to the time scale, an abbreviated cooling time 
has been used which resulted in a local minimum energy structure.   
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1.13  COMPUTATIONAL TIME SCALE AND THE 
RELATIONSHIP TO REALITY 
1.13.1  Software 
Many powerful software programs have been developed for the study of compounds at 
the molecular level yet widespread use and understanding is still limited within the chemistry 
community.  Most prevalent in the literature covering bilayer simulations are utilization of 
GROMACS (GROningen MAchine for Chemical Simulations)75, NAMD (NAnoscale Molecular 
Dynamics), and CHARMM (Chemistry at HARvard Macromolecular Mechanics)76 software 
programs for MD simulation of bilayers.  Despite the abundance of simulations with the above 
software simulations the bilayer simulations undertaken herein have been conducted with 
AMBER 9.77  AMBER 9 was selected for the available expertise available at East Carolina 
University (ECU), in the Department of Chemistry.  Additionally, the AMBER suite of programs 
offers a straight forward approach to add parameters to the force field for those molecules not 
previously included in the original force field parameter library.   
Gaussian 0378 is the 2003 release of the Gaussian series of electronic structure programs 
which utilizes the basic laws of quantum mechanics to predict energies, molecular structures, and 
vibrational frequencies of molecular systems.  Calculation of these properties enables other data 
to be extrapolated.  Understanding these components of a molecule under differing reaction 
conditions can enable accurate prediction of the most stable species of a compound when it is 
difficult or impossible to observe the structure experimentally due to short-lived intermediates 
and transition structures.  In this study we will use it to calculate the minimum energy 
structures.79 
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The same level of theory, and basis sets were used in Gaussian for the parameterization 
of the amber force field.  The high level QM calculations resulting from Gaussian were 
supported by x-ray structure data for each of the 20 standard amino acids.  The same procedures 
were followed for each of the unnatural amino acids used in this study however structural data is 
not currently available.79    
Materials Studio80 is a comprehensive materials modeling and simulation software which 
has been well used in the research and development of pharmaceuticals.  During the course of 
this research it was utilized for its graphical user environment which has allowed the 
development of starting structures for all calculations and simulations of peptide/model 
membrane systems. 
Insight II is Accelrys software for the modeling of biological systems which has 
numerous functionalities, but here it was utilized for the construction of the lipid bilayers and the 
micelles.  Manipulation of structure systems and bilayers with peptides can easily be 
accomplished using this program.  While this software has plug-ins which could accomplish 
many of the calculations in this study; limited access prevents utilizing this as the major 
software.  Discovery Studio is another Accelrys software which provides a molecular mechanics 
simulation environment for energy minimization and dynamics.  It will be used to conduct pre-
minimizations of the AMPs.   
DMol3 is a density functional theory (DFT) program which is able to solve quantum 
mechanical equations efficiently for large systems.81  DFT is based on the principle that the 
ground state electronic energy is determined completely by the electron density.  It will be used 
to calculate the minimum energy of the structures of the lipid molecules which have more atoms 
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than the unnatural amino acids which compose the AMPs.  DMol3 is able to efficiently optimize 
the larger structures.81 
Pymol is a powerful software which enables molecular visualization of systems formatted 
for display of atomic coordinates.82  Pymol has been used to visualize structures, take 
measurements, and create animations in addition to pictures.82  Manipulation of lipid molecules 
in Pymol makes it possible to create the bilayer systems and enables easy adjustment of the 
distances between the polar head groups between the leaflets of the bilayers and the lipids within 
each leaflet. 
Cygwin is a Linux-like environment for Windows which enables interface between the 
two environments.83  All of the access to the high performance computing (HPC) cluster has 
been accessed through Cygwin software.  SSH is an invaluable tool in the movement of large 
files between the HPC and personal computers by providing a secure environment for the 
transfer of files.  
AMBER9 is a collection of about 50 programs including sander, xLEaP, antechamber, 
ptraj, mm-pbsa, which are used to study the molecular movements of atoms in different 
environments.77  The different environments can include different water models, or an in vaccuo 
approach, implicit solvation or use of a nonpolar solvent.77 Antechamber is an auxiliary program 
of AMBER977, for molecular mechanic (MM) studies which amongst other things, is able to find 
missing force field (FF) parameters and supply reasonable and similar substitutes.77  This 
software has been utilized for all of the MD simulations undertaken during the course of this 
investigation. 
 While computer models are able to provide detailed representations; the model is only as 
accurate as the FF parameters ability to capture the actual physiological interactions.84  It is 
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possible to include many details of the actual system in the model but, in the absence of 
crystallographic or NMR structural data, a model is an approximate representation of the system 
with error being inevitable.     
Reaching the time scale at which AMPs interact with membranes is a challenge and 
requires large and powerful computational resources.  The data can continuously be collected for 
a system however, as the simulation is allowed to progress, the limitations of the discipline 
encroach.  Limited data storage space, time, and computer resources all limit the perspective 
which can be acquired.  While the interaction of the AMPs with the membranes occurs on the 
second time scale presently that is beyond the capabilities of all but the most powerful computer 
systems.  A few hundred nanoseconds of MD simulation have provided insight into the atomistic 
interactions of AMPs which contain unnatural amino acids and membrane models   
1.13.2  Hardware Resources 
All simulations conducted utilized East Carolina University’s (ECU) Center for Applied 
Computational Studies (CACS) which presently provides computing access to more than twelve 
scientists across four educational institutes and government agencies.  The CACS promotes the 
application of computational methods to describe and understand phenomena in the life sciences, 
geosciences, engineering and other disciplines. Computational methods provide the researcher 
and educator with a set of powerful tools to explore the vast unknowns and to expose the young 
minds to the wonders of science, mathematics and engineering.  CACS’s present high 
performance computational resources are comprised of an SGI Origin 350 with 32 processors 
and an SGI Altix 4700 with 128 processors.  The SGI Origin 350 and SGI Altix 4700 were 
funded in part by a Major Research Instrumentation Grants from the National Science 
Foundation.  While the researcher to processor ratio is reasonable for studying small molecules, 
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these systems are regulated mostly for 8 processor jobs.  Large MD simulations, such as bilayer 
simulations, require larger computers with more powerful processors with excellent threading 
(communication between the processors) than those presently available at ECU. 
1.14  EXPERIMENTAL DATA 
Experimental data presented and discussed herein has been collected and published 
elsewhere.16, 17, 62, 85- 88  The computational studies are supported by the experimental data in the 
form of circular dichroism (CD) spectroscopy measurements, isothermal titration calorimetry 
(ITC), Nuclear Magnetic Resonance (NMR), and calcein leakage data are discussed in the 
context of consistency with the computational models. 
Chapter 2 will discuss the parameterization of the FF which is responsible for producing 
reasonable molecular geometries and interaction energies for the set of atoms, molecules, or 
peptides being modeled.84  Chapter 3 is intended to assist in the development of an understanding 
of the structural and chemical contribution of each nonstandard and unnatural amino acid within 
the medicinal chemists’ “amino acid tool box” to help take the guess work out of the design 
process and encourages the rationalization of the in vitro activity correlating to the structural 
features.  Chapter 4 discusses MD simulations of AMPs which contain the Tic Oic dipeptide 
with SDS micelles.  Chapter 5 discusses MD simulations of the same AMPs as were discussed in 
Chapter 4 in the presence of bilayers modeling the electrostatic properties of mammalian and 
prokaryotic membranes.  Chapter 6 is a discussion of the observed evolution of a peptide 
containing the Tic Oic dipeptide when inserted into the bilayer surfaces of model mammalian 
and prokaryotic membranes.
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FORCE FIELD DEVELOPMENT 
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ABSTRACT 
 Molecular dynamics (MD) simulations rely upon the force field parameters specified for 
each atom of a molecule within a given system.  The force field (FF) parameters for the AMBER 
FF have been optimized for modeling the behavior of peptides including the 20 standard amino 
acids.  The FF charge parameters for each of the nonstandard amino acids used in this study have 
been developed using high level quantum mechanical (QM) calculations using the same basis 
sets, 6-31G*, and level of theory i.e.  Hartree-Fock (HF), as the standard amino acid parameters 
of the amber ff03 force field which has been applied to the other atoms in the simulation.  The 
unnatural amino acids parameterized included beta alanine (β-Ala), gamma amino butyric acid 
(GABA), 6-amino hexanoic acid (6-AHX),  ornithine (ORN), diamionbutanoic acid (DAB), 
diamionpropanoic acid (DPR), octahydroindole carboxylic acid (OIC), and 
tetrahydroisoquinoline carboxylic acid (TIC) (Figure 2.1).  FF charge parameters were also 
calculated for the lipid molecules POPC, POPG, and SDS (Figure 2.2) using QM optimization 
followed by single point energy calculations using the density functional theory of the DMol3 
program.   
2.1 FORCE FIELD BACKGROUND 
Providing a through explanation of the intricacies involved in FF development and their 
application in molecular MD is not possible in a few pages.  The following pages seek to provide 
a superficial understanding of the theory which supports the in silico, or computationally derived 
data.  The reader is directed to several extensive resources which are able to provide a more 
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complete explanation of the physical chemical and mathematical basis which supports in silico 
techniques.
1-3
 
The success or failure of any MD simulation is based upon the parameters specified in 
the FF which determines how each atom and molecule behaves within the experimental system.  
While the placement and orientation of each molecule in the system play a role in the short term 
behavior of the system, any improper placement should be overcome if the FF parameters are 
able to accurately model the behavior of the atomic behavior.  The mathematical functions 
describe the potential energy and are usually derived from experimental work, high-level 
quantum mechanical calculations, or both.
1- 3
  Due to the basis of the molecular mechanics (MM) 
of MD being based upon QM foundations the discussion will start with QM and its relationship 
to MM.  
  The potential energy of a protein system is a function of the energetic properties of the 
interatomic interactions and is expressed by the equations of motion, which is based on the 
atomic coordinates.
1- 3
  The coordinates may vary however; the parameters are an invariant 
variable during the course of the simulation.  The coordinates are an invariant variable because 
they describe the geometric and energetic properties of the interparticle interactions however the 
type of atom at each coordinate does not change even though the coordinates do change.
3
  
Numerous FFs are available and have been specialized to more accurately describe the energy 
associated with unique systems such as proteins, small molecules, and metal atoms.  All-atom 
FFs model individual atoms of a system, including hydrogen atoms while a united-atom FF 
identifies hydrogen attached to both carbon and hetero atoms as a single charge center.
1
  For 
example the CH2 groups in a united-atom force field would be treated as though there was a CH2 
atom type.
3
  During the course of a MD simulation the forces applied to each atom are calculated 
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based upon the environmental conditions such as temperature.
3
  Coarse-grained (CG) FFs can 
expedite simulations with large atom counts by merging multiple atoms together allowing longer 
time scales to be achieved through calculations.
4
  Use of a CG force field which creates so called 
CG “sites” is known as coarse graining.4  The MD simulations undertaken herein utilize an all 
atom FF.  Atoms are considered as spheres with a specific radius and charge as opposed to a 
system consisting of individual sub-atomic particles (electrons, neutrons, and protons).
3
  The 
result is that the bonding information must be explicitly provided as opposed to it being derived 
from first principles by solving the electronic Schrödinger equation, equation 2.1.
1
 
ĤΨn=EnΨn         Eqn. 2.1 
Where Ĥ is the Hamiltonian operator, which is the sum of the kinetic and potential energy, Ek 
and Ep respectively.
1
  En is the quantum states (eignevalues) which form a discrete set and 
correspond to the eigen functions,Ψn for the electrons and nuclei of a system.
1
  The Schrödinger 
equation provides the energy states for a stationary quantum system.   
The Born-Oppenheimer Approximation to the Schrödinger equation separates the 
motions of molecule movement into two levels, electrons and nuclei.
1
  Electrons are treated as 
independent variables of Ĥ assuming the nuclei are fixed which is reasonable due to the large 
discrepancy in their masses.
1
  The resulting eigenvalues represent the electronic energy levels of 
a molecule as a function of atomic coordinates which is known as Born-Oppenheimer energy 
surfaces (BOES).
1
  The second level of the Born-Oppenheimer approximation enables 
investigation of the QM behavior of the nuclei using the electronic ground state as the potential 
energy of the Hamiltonian instead of the Coulombic potential.
1
  The coupling between the nuclei 
and electronic motion is neglected.
3
  The electronic portion is solved with nuclear positions as 
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parameters enabling the resulting potential energy surface (PES) to form the basis for solving the 
nuclear motion.
3
  Solving such equations numerically requires significant computational 
resources necessitating a more efficient solution.  The assumption that one electron is moving 
independently of the dynamics of all other electrons in a system means that the interactions 
between particles can be approximated by taking all interactions into account in an average 
which is called Hartree-Fock (HF) theory.
3
  Using the HF model, electrons are described by an 
orbital, and the total wave function is given as a product of orbitals.  Solving the Slater 
determinants for the molecular orbitals results in the lowest energy (of the molecule) with the 
restriction of the wave function being a single Slater determinant.
3
  HF only accounts for the 
average electron-electron interactions neglecting the correlation between those electrons.
1, 3
  
Inclusion of correlation functions requires multi-determinant wave functions, since HF is the best 
single determinant wave function; they become computationally expensive but can improve the 
solutions of the Schrödinger equation.
3
  The difference between the HF calculated energy and the 
lowest possible energy (global minima) are referred to as the Electron Correlation (EC) energy.
3
   
Gaussian is a computational software which was originally developed by John Pople and 
initially released in 1970, it has evolved since.
5
  It utilizes Gaussian orbitals to expedite 
calculations rather than using Slater-type orbitals.
5
  The quantum chemical approach uses the 
Hartree-Fock (HF) method which approximates the ground state wave function for a multi-
bodied system.  Approximating solutions to the multi-bodied Hamiltonian approximates the true 
many-body wave function which is accomplished by solving a single Slater determinant of N 
spin-orbitals for each atom in a system.
1, 3
     
QM should be the most reliable description of chemical processes due to its lack of 
experimental values involved in the calculation.  Limitations arise from the approximations 
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required for small molecules since the Schrödinger equation can only be solved for hydrogen.  
Most molecules require the use of standard approximations further limiting the accuracy while 
requiring large computational resources.
1
  The HF method was used in the optimization of the 
starting structure of the unnatural amino acids.  Calculations used the 6-31G* basis set.  The two 
types of basis functions, Slater Type Orbitals (STO) and Gaussian Type Orbitals (GTO) are used 
to improve the accuracy of the ab initio derived solution to the Schrödinger equation.  The 6-
31G* basis set is a STO, with a split valence basis where the core orbitals are a contraction of six 
primitive Gaussian Type Orbitals (PGTOs).
3
  Split valence basis sets describe valence electrons 
using twice as many functions with exception of the core orbitals which are expected to vary 
minimally.
2
  The 6-31G* basis set is not the most exhaustive set of functions but, it balances 
accuracy and computational expense.  While larger basis sets, and more polarization functions 
are possible they do not always result in model improvement.  It was selected to be consistent 
with the QM calculations done for the original development of force field parameters in the ff03 
force field employed in the MD simulation.
6
  The * denotes the use of polarization basis 
functions.
5
    
Using a self-consistent field (SCF) calculation refines the wavefunction until self-
consistency is reached.
1- 3
  SCF criterion for convergence was set at ‘tight,’ meaning full 
convergence was requested for each structure.  A SCF uses an initial set of orbitals to generate a 
new set of orbitals and the procedure is repeated until the convergence criteria has been met.  In 
this study the RMS convergence criteria has been set at 1.00 x 10
-8
.  Convergence criteria are a 
measure of the root mean square deviation (RMSD) from the starting structure.  When the 
RMSD is no longer changing it is expected that a minimum energy structure has been identified.  
The electrostatic-potential derived atomic charges came from the Merz-Singh-Kollman (MK) 
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scheme in which atomic charges are fitted to reproduce the molecular electrostatic potential 
(MEP) at various points around the molecule.
2
  MK fits the charges so the sum of all atomic 
charges equals the overall charge of the system.
7
 
Structures were constructed using Cerius 2
7
to create the starting structures.  Capping 
residues ACE, an acetyl group and NME, an N-methyl group were added to neutralize the 
backbone charges at the terminals.  Gaussian 03
8
 input files were created using the 
“antechamber” program.5  Files were checked for atomic accuracy, appropriate charge, and the 
correct spin multiplicity.  Spin multiplicity is given by 2S + 1, where S is the total electron spin 
for the molecule.
9
  Paired electrons have a net zero spin and do not contribute.
5
  One unpaired 
electron (of spin ½) results in a spin multiplicity of 2, the species is a doublet.
5
  The amber 
program antechamber
5
 calculated RESP charges based on the optimized, minimum energy 
structure identified by Gaussian03.  Use of a “MAINCHAIN.txt” file, which specifies the head 
atom name, the amine nitrogen, the main chain atom, the alpha carbon, and the tail atom which is 
the carbonyl carbon.   
The AMBER9
9
 program was used to create the .prepin files which specifies the atomic 
coordinates, molecular charge, atomic charges as well as improper angles.  Improper angles are 
“virtual” torsion angles which are specified in order to keep an atom and its neighbors in a 
specific configuration; this is the out of the plane bending which occurs.  The .frcmod files, 
which defines any missing or undefined parameters including the atomic mass, bond distances, 
angles and dihedrals in addition to improper and non-bonded interactions if necessary.  These 
parameter files were added to the FF parameter library of tLeap or xLeap, enabling peptide 
construction including the unnatural amino acids.  tLeap and xLeap are both programs within the 
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AMBER 9 suite of programs.
9
 
 
 
Figure 2.1 Amino acids for which force field parameters were developed. 
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2.2  DENSITY FUNCTIONAL THEORY 
Density functional theory (DFT) is a QM modeling method which is used to understand 
the ground state electronic structure of many-body systems by calculating variational self-
consistent solutions to DFT equations, expressed in numerical atomic orbital basis sets for many-
body systems.
9
  DFT is based on the proof by Hohenberg and Kohn which shows the ground 
state electronic energy can be determined completely by the electron density, ρ.3, 10  DFT is an ab 
initio method.  In principal DFT offers an exact energy value however, in practice, the 
approximation of the exchange correlation functional creates an inexact solution.
3
  The wave 
function of the Schrödinger equation is represented by a single ground-state wave function where 
the electron density is represented as the sum of squares of orbital densities.
1
  Using a DFT 
approach provides a good combination of accuracy and necessary computational resources 
enabling large systems to be studied more quickly than using traditional ab initio methods.
1
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Figure 2.2 Lipid molecules parameterized using DFT. The R group in the top lipid is either a choline 
head group (POPC) or a glycerol head group (POPG).  SDS is the lipid molecule used in the micelles. 
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Energy is minimized with respect to changes in ρ, subject to the constraints of charge and 
van der Waals interactions.
1
  ρ is the electron density with respect to a specific point in space.  In 
general it is easier to deal with electron density than the wave functions, however DFT is an 
iterative process (like HF) which makes it a better quantitative approach.  When compared to the 
QM calculations it is still computationally expensive.  An iterative process repeats itself until the 
desired target, in this instance a low energy structure with specified convergence criteria, has 
been achieved.  There are no approximations which necessitate measurement of the exchange 
correlation energy (which is a function of ρ).2  The equations are solved through approximations 
until convergence is achieved.  When comparing HF and DFT, DFT will produce better result 
with comparable computational expense.
3
  The lipid molecules used as component parts of the 
model membranes are shown in Figure 2.2.   
2.3  PEPTIDE CONSTRUCTION 
tLeAP and xLeAP from the AMBER9
3
 suite of programs were utilized in the 
construction of the peptide sequences after successful library formation adding parameters for 
the non-parameterized residues.  The peptide sequences listed in Table 2.1 were constructed 
using the sequence command in tLeap.  The MD simulations were conducted on the generic 
peptide sequence:  
Ac-FX-Tic-Oic-XK-Tic-Oic-XF-Tic-Oic-XK-Tic-KKKK-CONH2 
where X is either the natural amino acid glycine, or the nonstandard amino acid β-alanine.  After 
the peptides were constructed they had multiple bad contacts which necessitated a pre-
minimization step using 10 000 steps of steepest descent optimization with Discovery Studio.
9
  
POPG 
SDS 
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After the pre-minimization step the atomic coordinates were appropriately spaced, and any 
overlap which was initially present had been removed.     
 
Table 2.1:  Representative Amino acid sequences for the AMP developed by Hicks and co-workers
11
 
 
Peptide #     amino acid sequence        
23 Ac-GF-Tic-Oic-GK-Tic-Oic-GF-Tic-Oic-GK-Tic-KKKK-CONH2 
29 Ac-Gaba-F-Tic-Oic-Gaba-K-Tic-Oic-Gaba-F-Tic-Oic-Gaba-K-Tic-KKKK-CONH2 
35 Ac-GF-F-Oic-GK-F-Oic-GF-F-Oic-GK-F-KKKK-CONH2 
36 Ac-βAla-F-Tic-Oic-βAla-K-Tic-Oic-βAla-F-Tic-Oic-βAla-K-Tic-KKKK-CONH2 
37 Ac-Ahx-F-Tic-Oic-Ahx-K-Tic-Oic-Ahx-F-Tic-Oic-Ahx-K-Tic-KKKK-CONH2 
38 Ac-F-Tic-Oic-K-Tic-Oic-F-Tic-Oic-K-Tic-KKKKKK-CONH2 
40 Ac-Gaba-F-Tic-Oic-Gaba-K-Tic-Oic-Gaba-F-Tic-Oic-Gaba-K-Tic-KKKKK-CONH2 
41 Ac-GF-Tic-Oic-GK-Tic-Oic-GF-Tic-Oic-GK-Tic-Orn-Orn-Orn-Orn-CONH2 
42 Ac-G-Fpa-Tic-Oic-GK-Tic-Oic-G-Fpa-Tic-Oic-GK-Tic-KKKK-CONH2 
43 Ac-GF-Tic-Oic-G-Orn-Tic-Oic-GF-Tic-Oic-G-Orn-Tic-Orn-Orn-Orn-Orn-CONH2 
45 Ac-GF-Tic-Oic-G-Dpr-Tic-Oic-GF-Tic-Oic-G-Dpr-Tic-Dpr-DprDpr-Dpr-CONH2 
46 Ac-βAla-Fpa-Tic-Oic-βAla-Dpr-Tic-Oic-βAla-Fpa-Tic-Oic-βAla-Dpr-Tic-Dpr-Dpr-Dpr-
Dpr-CONH2 
50 Ac-GF-Tic-Oic-GK-Tic-Oic-GF-Tic-Oic-GK-Tic-βAla-KKKK-CONH2 
52 Ac-GF-Tic-Oic-GK-Tic-Oic-GF-Tic-Oic-GK-Tic-Ahx-KKKK-CONH2 
53 Ac-GF-Tic-Oic-G-Dab-Tic-Oic-GF-Tic-Oic-G-Dab-Tic-Dab-Dab-Dab-Dab-CONH2 
56 Ac-GF-Tic-Oic-GR-Tic-Oic-GF-Tic-Oic-GR-Tic-RRRR-CONH2 
61 Ac-KKKK-GF-Tic-Oic-GK-Tic-Oic-GF-Tic-Oic-GK-Tic-CONH2 
62 Ac-GF-Oic-Oic-GK-Oic-Oic-GF-Oic-Oic-GK-Tic-KKKK-CONH2 
64 Ac-GF-Tic-Oic-GK-Tic-Oic-GF-Tic-Oic-GK-Tic-KKK-CONH2 
 
Anfinsen’s theory proposes a correlation of the secondary structure to the lowest free energy 
state of the primary protein sequence.
12, 13
  Predicting the secondary structure of a peptide using 
in silico techniques has been of great interest due to the theorized correlation between the shape 
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and the function.  Despite the recent success of structure prediction of peptides and proteins, 
which are restricted to the 20 standard amino acids, inclusion of nonstandard and unnatural 
amino acids in the peptide sequence adds several degrees of difficulty.  Since the unnatural 
amino acids require synthetic means for their creation relatively less is known about their 
secondary structure and how that may correlate to observed antimicrobial activity.  Given the 
importance associated with secondary structure, developing a technique which identifies low 
energy peptide conformations is expected to provide insight into the mechanism through which 
they act.  Simulated annealing (SA) had been employed to further understand low energy 
secondary structures associated with peptides 23, 29, 36, and 37.   
2.4  SIMULATED ANNEALING  
MD utilizes temperature as a guide for the structural evolution of the molecules being 
simulated.  Proteins with a well-defined secondary structure are known to lose structure at high 
temperatures.  Simulated annealing uses the increase in molecule flexibility at high temperatures 
to determine the lowest energy structure.  Simulated annealing uses temperatures as high as 
Figure 2.3 A) Exemplary plot reflecting the temperature and energy correlation to simulation step 
number and time if an infinitely slow cooling method is employed. B) Plot reflecting the temperature 
and energy correlation for actual simulated annealing where hundreds of thousands of steps can be 
employed in the cooling process 
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2000-3000 K to disrupt the intramolecular interactions responsible for the secondary structure of 
a peptide or protein.  At high temperatures a wide area of the conformational space is sampled 
enabling the discovery of preferred, low energy atomic arrangements as the system is cooled to 
room temperature.  If the cooling of the system occurred at an infinitely slow rate, the global 
minima should be achieved, see Figure 2.3 A.  Due to the time restriction, SA seeks to model the 
results of an infinitely slow cooling process with a more reasonable time scale.  SA however due 
to its nature does not ensure the global minima, or lowest possible energy structure, has been 
found for a molecule.  Figure 2.3 B is a sample plot which shows the correlation of temperature 
and energy with the simulation step number and time.  While the cooling process is able to find a 
minimum energy structure such as is noted by the pink arrow sometimes it gets “stuck” and has 
an energy barrier which is too great preventing identification of the global minima, noted in 
Figure 2.3 B with the cyan arrow.  If an infinitely slow cooling process were feasible, the lowest 
energy structure would be identified.  An infinitely slow cooling process would require an 
infinite amount of time, expediting the cooling process introduces more error while making good 
approximations within timescales enabling useful data collection despite the introduced errors.   
2.5  MOLECULAR DYNAMICS 
MD simulations can provide a quantitative and or a qualitative perspective correlating 
atomic movement to macroscopic observables, which in turn correlate to biological activity.  Use 
of MD enables the potential effects of a change in the protein sequence; for example including 
nonstandard amino acids in the peptide sequence.  Determining the effect of the new residues, 
such as whether the change will result in a large effect or if the change will be silent resulting in 
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negligible change in peptide behavior, needs to be determined.  Observing the behavior of 
molecules at the atomic level can be correlated to the observable effects.   
The trajectory resulting from this calculation specifies how a molecule moves over time 
based on the starting position and the velocity 
14
 based on Newton’s equations of motion and is 
representative of what is observed in a physiologically relevant system.  Newton formulated 
three laws pertaining to motion: 1. An object continues to move in a straight line at constant 
velocity unless acted upon by force, 2. Force is equal to the rate of change of the momentum of 
the object, and 3.  Every action has an equal and opposite reaction.
2
  MD is based on statistical 
mechanics and Newton’s second law of motion which describes the relationship between force 
and momentum. 
                           F = 
  
  
   = 
     
  
 =ma                          Eqn. (2.2) 
mv is the canonical momentum.  The net force exerted on a particle is thus equal to the rate at 
which the momentum of the particle changes over time.  Acceleration is a = 
  
  
  
  
 the second 
law can be simplified as above (Equation 2.2).   
The force field parameters can be applied to collections of atoms using various ensembles 
to model the experimental, in vitro, or in vivo conditions using constant-temperature and 
constant-pressure ensembles can be simulated.  Starting with the acceleration, the calculation of 
the velocity and positioning by using integrals at any time.  Newton’s equation of motions is 
numerically solved using the finite difference methods to obtain a trajectory of the system.  The 
trajectory is a set of configurations saved during a simulation, once the equation determining the 
59 
 
energy is solved the value can be compared with the starting energy value.  The Assisted Model 
Building and Energy Refinement (AMBER) force field has been optimized for use with proteins 
and DNA.
2
  The ff03 FF has charges derived from QM calculations that use a continuum 
dielectric to model the solvent polarization, and the ϕ and Ψ backbone torsions for proteins have 
been modified decreasing the preference for helical configurations for proteins.  The gradient of 
the potential energy, U, function is determined by summing solving the potential energy equation 
with respect to time and the position of the atoms in the system.  The potential energy is 
described by the following equation: 
                                                              
Eqn. (2.3) 
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 ∑
    
        
     
  
                                              
Eqn. (2.4) 
The parameters the FF is based upon are composed of the functional expression of the potential 
energy function of the molecular system (equations 2.3 and 2.4).
6
  The potential energy is 
calculated where R is the function of positions of N particles, in this instance N is an atom.
1
  r 
and req are actual and ideal bond lengths, Kr, Kθ and Vn are force constants.
6
 n is the torsional 
multiplicity and ϕ is a torsion and γ, a phase angle (Figure 2.4).15  A and B are van der Waals 
coefficients, ϵ a dielectric constant, Rij an interatomic distance and q are the atomic partial 
charges which are responsible for the long-range electrostatic interactions.
15
    
The particle-mesh Ewald (PME) procedure is responsible for the long-range electrostatic 
interactions while the long range van der Waals interactions are estimated by a continuum 
Figure 2.4  A. Internuclear Separation (bond Stretching) B.  Angle Bending C.  Bond rotation 
(torsion) D.  Non-bonded Interactions (van der Waals) E)  Non-bonded Interactions (electrostatic 
interactions.  Adapted from the following reference.
2
  
A B 
D C E 
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model.
15
  The Lennard-Jones potential is a simple model which describes the interaction between 
a pair of neutral atoms or molecules. 
V(r)  = 4   [(
 
 
)
  
  (
 
 
)
 
]    Eqn. (2.5) 
Where    is the depth of the potential well,    is the distance at which the inter-particle potential 
is zero, and r is the distance between the particles.
6
   
The MD simulation with AMBER9 enables the user to tailor many of the experimental 
parameters using a system of “flags” which specify the techniques applied to the simulations.  
The AMBER9 program has hundreds of thousands of setting variables specifying the parameters 
of each experimental simulation.  A discussion of each variable is present in the AMBER9 user’s 
manual.
2
  Input files noting the parameters for the bilayer simulations have been included in 
Appendix B.  Several of the parameters most frequently varied during the course of these 
experiments follow. 
 Periodic imaging geometries are a part of any simulation using periodic boundary 
conditions.  AMBER 9 offers two box geometries, which the sub-programs LEaP and ptraj are 
able to support: rectangular parallelepiped and truncated octahedron.
6
  Both have been explored 
during the course of this study.  The repeating units are coupled to external pressures, velocities 
and temperatures which will each be specified as used.   
Implicit solvation has been utilized in the preparation of minimum energy structures of 
peptide sequences which uses the generalized Born/surface area (GBSA) model which adds the 
following two terms to the “vacuum” potential function.6  charge in a cavity with a specific 
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radius and the difference in energy between a vacuum and whatever the surrounding 
environment is as specified by the dielectric constant.
6
    
2.6  ENERGY MINIMIZATION 
Using the sequence command in tleap or xleap generates a peptide sequence which has 
all the appropriate atomic connections; however it may also include fictitious connections 
between atoms due to the software’s limited experience with the peptides.  Atoms are connected 
if there are within a reasonable bond distance and appear to have unsatisfied octets.  Hydrogen 
atoms with their diverse naming conventions depending upon the software utilized can be 
problematic when loaded into tLeap or xLeap.  For this reason, hydrogen atoms are removed 
from the peptide prior to loading it into the Leap program.  Since the force field parameters for 
each of the amino acids of the peptide sequence are known to the program, the appropriate 
missing hydrogen atoms can be added to the structure.  If the starting structure is too far removed 
from a reasonable minimum energy structure, such as having a sp3 hybridized carbon in close 
proximity to several other atoms which appears to be lacking a full octet, the software may not 
be able to recognize the true structure.   
2.6.1  CONJUGANT GRADIENT VS STEEPEST DESCENT 
 Generally structures are optimized through the use of “minimization” steps prior to 
simulation.  There are three classes of optimization methods which have commonly been 
employed and provide ways through which a minimum energy structure can be acquired. 
3
  The 
three methods of minimization are steepest descent, conjugate gradient, and Newton-Raphson 
methods have demonstrated utility in the identification of minimum energy structures.   
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Steepest descent is an iterative minimization method which attempts to improve the 
previous structure, based on the minimum energy calculated.  The functions describing the 
molecule are calculated in a step wise fashion and at each step steepest descent moves the vector 
points down the energy scale rejecting any step which results in a higher energy value than the 
preceding step.  Figure 2.5 A provides a depiction of the descent path which a molecule may 
follow relative to the energy.  Steepest descent prevents movement up the gradient forcing a 
lower value ensuring a lower energy structure will be attained relative to the starting structure.  
The gradient and the direction of sequential energy sequential structures are orthogonal to one 
another.
3
 
 
 Conjugate Gradient (CG) tries to find a lower energy structure along a different gradient 
and is devoid of the oscillatory behavior of steepest descent.
2
  CG moves orthogonally to the 
previous energy associated with a structure however the direction is conjugate.  The search for 
  
Figure 2.5  A) Steepest Descent minimization  vs  B) Conjugant Gradient  Adapted from figures in 
in Frank Jensen’s Introduction to Computational Chemistry.3 
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lower energy structures is not guaranteed to converge given the lack of direction associated with 
each step.  Use of CG approach makes the starting structure very important because low energy 
structures are heavily dependent upon the structure which the minimization started. 
CG will to converge to a minimum energy structure with the specified gradient; it just 
may not do so quickly.  The only way to get efficient convergence is starting near the minimum 
(with a reasonable starting structure).  Herein a combination of steepest descent and conjugate 
gradient has been used to improve the minimum energy structures.  Use of steepest descent 
followed by conjugate gradient minimization will identify the best minimum energy structure 
with the smallest amount of CPU time.
2
 
2.7  ENSEMBLES 
2.7.1  ISOTHERMAL 
Simulation using the isothermal ensemble creates a closed system which is simulated at 
constant temperature and volume.
2
  Use of this ensemble is often referred to as NVT.  The 
energy of the system is coupled to an external temperature bath.  In this type of system the lower 
energy conformation is expected to be more prevalent than higher energy arrangements.
6
   
2.7.2  ISOTHERMAL-ISOBARIC 
Simulation using the isothermal-isobaric ensemble also creates a closed system which is 
connected to a pressure control in addition to an external temperature bath. 
1, 3
  Use of this 
ensemble is often referred to as NPT.  The volume is correlated with the bath at a given 
pressure.
6
  This correlates to states with low energy and volume is able to fluctuate. 
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2.7.3  GRAND CANONICAL ENSEMBLE 
Use of the grand canonical ensemble occurs in a rigid cube which exchanges particles 
with an external reserve container which is correlated with a heat bath.
6
  The energy is 
exchanged with an external temperature.  The grand canonical ensemble is referred to as NμT.  
The number of molecules can vary by exchange with the reservoir at a specified chemical 
potential.
6
  
2.7.4  ISOENERGETIC  
Isoenergetic ensemble is a closed system contained in a rigid and insulated container 
commonly referred to as NVE.
3, 6
  In this system energy is held constant and all states are equally 
likely thus limiting is relevance and correlation to experimental data.   
2.8  MODEL OF WATER 
 All explicitly solvated simulations performed were solvated with the TIP3P
6
 water 
model.  Modeling the water dimer accurately has been a challenge for decades.
16
  The TIP3P 
model, which is commonly used in CHARMM and Amber force fields) provides three sites (one 
Figure 2.6  TIP3P Water model used for solvated simulations.  Bond distances, angle 
and atomic charges. 
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water two hydrogen) to model the properties of liquid water.
16
  The TIP3P model used with the 
CHARMM force field is slightly different because it includes well depth and radius for the 
hydrogen of the water molecules.
17
  TIP3P is one of several simple models, and is considered to 
be rigid with fixed atom positions, which utilize pairwise potentials without use of three body 
terms or polarization effects   and relies upon the Coulombic and Lennard-Jones expressions.
18
  
The TIP3P model of water has unique, slightly different geometries associated with each water 
molecule in the hydrogen charges of the Lennard-Jones parameters.
2
  Figure 2.6 illustrates the 
geometry of a sample water molecule extracted from one of the solvated MD simulations.  The 
TIP3P model was parameterized for simulations at 298 K and 1 atm; which models water at 
room temperature (~300 K) more accurately than physiologically relevant temperatures (310 K).  
Three point solvation models are very popular with molecular dynamics simulations due to the 
computational efficiency resulting from the mathematical simplicity of the parameter functions.
2
  
The selection of a water model can be influenced by many factors depending upon experimental 
constraints.  Given the computational expense of larger models and the relatively smaller TIP3P 
water molecule offers a parsimonious approach.  Considering the electrostatic interaction 
between two water molecules necessitates consideration of 9 site-site distances.
17
  TIP3P water 
model includes the interaction calculated between oxygen and hydrogen of differing water 
molecules.
2
  Point charges are assigned for each atom in addition to assignment of the Lennard-
Jones parameter.
2
  While this water model does not reproduce all of water’s properties with good 
accuracy it provides an appropriate solvent environment for conducting simulations 
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2.9  PERIODIC BOUNDARY CONDITIONS 
Periodic boundary conditions enable simulations to be performed using a relatively small 
sample of what may be a much larger system.
2
  An example would be a bilayer simulation which 
is modeling a cell’s membrane, which would be infinitely large.  Through mirror images of the 
simulation being placed (Figure 2.7 & 2.8) on all sides of the original simulation setup a periodic 
array is created for the system.
2
  Use of periodic boundary conditions enables fewer atoms to be 
simulated because the effects of the atoms in the surrounding images will be reflected in the 
original simulation box.  An example is depicted in Figure 2.7 B.  The central box represents the 
original simulation.  If a particle moves out of the central box and into a surrounding box a 
corresponding particle moves in from the opposite side as is denoted with the black and red 
arrows.  Depending upon the ensemble used during the course of the simulation, the number of 
particles in the simulation box remains constant through the constant replacement of particles 
Figure 2.7  Periodic boundary conditions. A) The red cube in the center of the nonet of cubes 
represents the original simulation with the periodic  images on all sides.  B)  The arrows reflect 
the effect of the movement of one atom out of the periodic box.   Inspired by 
http://www.ccl.net/cca/documents/molecular-modeling/node9.html.  Accessed 22 July 2010. 
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which move to surrounding boxes.  The surrounding periodic boxes are considered to extend 
infinite distance from the original periodic box. 
 Multiple shapes of periodic systems exist besides a cubic shape including hexagonal, 
rhombic dodecahedron and an octahedral shape (a box with the corners cut off).
2
  The diversion 
from the sharp corners of a cube is intended to decrease simulation time by decreasing the 
number of solvent molecules necessary to fill the periodic space.  A smaller solvent box may be 
a more economic choice for simulations of small molecules or similarly solvent surrounded 
systems.    
Use of a cubic box is especially useful when dealing with bilayer simulations which can 
be prepared in one of two ways for simulation.  The first is to arrange the bilayer in a “sandwich” 
arrangement as outlined in Figure 2.7A.  The central dark shaded box shows the polar head 
groups of the bilayer separated (by water solvent and appropriate ions) which is a variable 
enabling easy adjustment to accommodate peptides, small molecules, or complex systems  
simply by adjusting the distance between the polar head groups.  Additionally, determining an 
appropriate size for the solvent box is relatively easy simply taking a few angstroms off the 
distance between the polar head groups to allow for equilibration of the system.  Simulation box 
size is also straightforward in simply measuring the distance between the most terminal atoms of 
the hydrophobic region of the lipids and subtracting a few angstroms to encourage the 
hydrophobic tails to intermingle.    
The second arrangement for a bilayer is the expected cross-section, Figure 2.7 B, with the 
hydrophobic tails of the lipids facing one another with the polar head groups at the surface.  At 
first glance this appears to be the best starting point for a bilayer simulation but when 
considering the use of periodic boundaries the challenge of placing the solvent box (or two 
  
 
 
6
9
 
 
 
Figure 2.8 A) Sandwich configuration of membrane simulation B) bilayer membrane configuration 
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solvent boxes, one above the bilayer and one below, as the case may be) can present a challenge 
ensuring proper centering relative to the bilayer and then determining the final boundaries for the 
periodic system.  Both of these approaches to periodic boundary simulations are technically 
correct however determining the appropriate placement of solvent the solvent box relative to the 
bilayer position is challenging and ensuring proper distribution of solvent around the bilayer is 
difficult to determine.  For this reason use of the sandwich method will be utilized in the ensuing 
investigations.     
2.10  THERMOSTATS 
The velocities calculated for each atom at each step in an MD simulation depend upon 
the temperature.  Due to the important role temperature plays in MD simulation and the type of 
simulation and the various ensembles  make it is necessary to provide an external “water bath” 
coupling to maintain the desired temperature.   
2.10.1  BERENDSEN 
Use of the Berendsen temperature coupling system couples the simulation to an external 
heat bath with a specified temperature.
2
  The external heat bath adds or removes energy as 
necessary enabling the velocity to be scaled proportionally to the external heat bath as the 
simulation progresses with respect to time.
19
 The Berendsen thermostat is considered to be a 
weak coupling algorithm and does not generate a correct canonical ensemble.  It may function 
better for large systems, hundreds to thousands of atoms.  Use of the Nosé-Hoover thermostat is 
usually coupled to the Berendsen thermostat after equilibration to produce trajectories when 
using the canonical ensemble.
2
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2.10.2  ANDERSEN 
Use of imaginary “collisions” which make the velocities random selection from the 
Maxwell-Boltzmann distribution,
2
 and correspond to the specified temperature, at a given 
number of steps is known as Andersen temperature coupling.
2
  The dynamics resulting from use 
of the Andersen temperature coupling are Newtonian which means the correlation functions are 
compounded and averaged over the trajectory.
6
  The rate at which the collisions are allowed to 
occur is important is producing a simulation which models reality while not being too 
computationally expensive.
6
 
2.10.3  LANGEVIN  
“Langevin dynamics specify collision frequency which provides constant total energy 
classical dynamics.”20  This approach utilizes a Leapfrong integrator for the continued 
calculation the dynamics, and the kinetic energy is adjusted so it correlates with the harmonic 
oscillator case.
6
  Langevin is only to be used with explicit solvent systems and models the 
viscous properties in a solvated system.
6
 
2.11  SHAKE 
SHAKE is a form of restraint applied during a MD simulation.  Relative to the heavy 
atoms involved in a MD simulation the movement of hydrogen atoms is unlikely to affect the 
motion of the overall system.  Here the motion associated with hydrogen atoms is removed 
enabling slightly longer time steps to be employed without introducing significant amounts of 
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error into the system.
6
  The shake algorithm evolves as the coordinates change with respect to the 
original position of the hydrogen atoms.
21
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ABSTRACT 
Rational design has been applied to the development of small molecules for several 
decades and has provided a more succinct approach to identifying active molecules.  Using a 
similar in silico approach to the development of synthetic antimicrobial peptides (AMPs) would 
optimize selectivity for the desired membrane type while minimizing the side effects by tailoring 
the peptide sequence to bind to the membrane of the targeted cell.  The physical and structural 
properties associated with the unnatural amino acids used in the development of the first 
generation of magainin derived AMPs have been investigated and correlated with the observed 
in vitro activity.  The electrostatic surface potential (ESP) was derived from the charges 
calculated for each of the unnatural and nonstandard amino acids.  The ESP calculations were 
able to show the electron charge density varies with the number of carbon atoms separating the 
protonated amine of the side chain.  The closer the charge is to the backbone the more diffused it 
becomes relative to the residues with the charge further from the backbone.  The preferred 
regions of the Ramachandran plots of the 20 standard amino acids are consistent with other’s 
experimental data in addition to the preferred torsion angles identified through spectroscopic 
means.
1
  By extension of the reasonable angles produced for the standard amino acids, torsion 
angle calculations were also measured for the unnatural amino acids which varied the side chain 
and not the linker length within the peptide backbone.  Additionally, the solvent accessible 
surface areas and volumes were calculated.  For each residue the distances between polar atoms 
have been noted when relevant.    
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3.1  INTRODUCTION 
 The 20 standard amino acids encoded by the universal genetic code are the basis for 
most proteins, enzymes, and genetic material found in nature.  Designing peptides composed 
entirely of the standard amino acids has some limitations including susceptibility to host 
enzymatic degradation.  Inclusion of nonstandard and unnatural amino acids in the peptide 
sequence enhances their proteosomal degradation profiles and improves their therapeutic 
potential.  The challenge associated with the inclusion of the nonstandard and unnatural amino 
acids is the difficulty of synthesizing them and the relatively small amount of data regarding the 
secondary structure associated with peptides containing such amino acids.  While the 20 standard 
amino acid residues have been well characterized, the nonstandard and unnatural amino acids are 
not as well known.  Nonstandard amino acids are not part of most protein sequences however 
they may be involved as intermediate structures in the metabolic pathways of the standard amino 
acids and include Gaba, β-Alanine, and ornithine.  Amino acids which are not naturally encoded 
within the genetic code, the unnatural amino acids, require synthetic approaches for creation.  
The synthetically derived residues will be referred to as unnatural amino acids and include 
tetrahydroisoquinolinecarboxylic acid, octahydroindolecarboxylic acid, 6-aminohexanoic acid, 
diaminobutanoic acid, diamino propanoic acid, amino cyclohexane carboxylic acid, amino 
cyclopentane carboxylic acid, p-Cl phenylalanine, and p-F phenylalanine.  Small molecules are 
continually optimized by manipulation of key structural motifs associated with improved 
potency, DMPK profiles, and efficacy.  Each drug target has compounds which have been 
structurally sculpted for reasonable fit while using chemical intuition to minimize side effects 
resulting from activity against potential off-targets, metabolic by products etc.  Developing an 
understanding of the structural and chemical contribution of each nonstandard and unnatural 
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amino acid within the medicinal chemists’ “amino acid tool box” helps take the guess work out 
of the design process and encourages the rationalization of the in vitro activity correlating to the 
structural features.    
3.2  FORCE FIELD PARAMETER DEVELOPMENT 
The coordinates for the amino acids which did not have parameters included in the 
AMBER force field 03 were created using Materials Studio.
2
  These included (a) β alanine 
(βAla), (b) GABA, (c) 6-Amino hexanoic acid (6-Ahx), (d)tetrahydroisoquinoline carboxylic 
Acid (Tic), with the carbonyl carbon in the axial position (e) octahydroindole carboxylic Acid 
(Oic), (f) ornithine (Orn), (g) diaminobutanoic acid (Dab), (h) diaminopropanoic acid (Dap),  (i) 
aminocyclohexanoic acid (Ach), (j) aminocyclopentanoic acid (Acp), (k) p-Cl phenylalanine 
(pClPhe), and (l) p-F phenylalanine (pFPhe).  Tripeptides, Ace-Ala-X-Ala-Nme, where Ace is 
the acetyl group used to neutralize the N-terminus and Nme is the N-methyl group used to cap 
and neutralize the C-terminus.  These tripeptides were minimized using 5000 steps of steepest 
descent using Cerius 2
3
  prior to ab initio calculations.   
Antechamber was used to generate input files for GAUSSIAN03
4
 which was utilized to 
calculate the minimum energy conformation of each amino acid structure.  Hartree-Fock (HF) 
calculations using the 6-31G* basis set were used to optimize the structures and generate the 
electrostatic potential derived charges for numerous points around each molecule according to 
the Merz-Singh-Kollman scheme which fits the ESP to the point partial charges of the atoms 
within the molecule.
5
 
This level of theory is consistent with that utilized for development of parameters of the 
standard amino acids which have been validated using experimental data.
6
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Force field parameters were developed for the following unnatural amino acids: (a) β-
Ala, (b) Gaba, (c) 6-Ahx, (d) Tic, (e) Oic, (f) Orn, (g) Dab, (h) Dap,  (i) Ach, (j) Acp, (k) pClPhe, 
and (l) pFPhe.  Gaussian 03
4
 was utilized to predict energies, molecular structures, and 
vibrational frequencies of the unnatural amino acid molecule systems.  The resulting values were 
the basis for calculation of minimum energy structures upon which the force field parameters 
were derived.   
Tripeptides were constructed from a library of residues, using tleap, which has been 
expanded to include the additional amino acids for which custom force field parameters were 
developed.  Tripeptides were generated using the sequence command within the tleap program.  
Peptides were placed at the center of a solvent box which used the TIP3P model for water 
extending 10 angstroms from the peptide surface enabling the use of cubic periodic boundary 
conditions.  The ionic concentration was adjusted using random replacement of water molecules, 
with sodium and chlorine ions, using the multi-scale modeling tools for structural biology 
(MMTSB) toolset.
7
  The ionic strength of 150 mM NaCl was selected for its physiological 
relevance.
8
  The peptides were minimized using a two-step process, first constraining the peptide 
atoms using a force constant of 15.0 kcal/(mol*angstrom) allowing the water to settle around the 
tripeptide followed by a second unrestrained minimization.  Each minimization used 5000 steps 
of steepest descent with constant volume, no pressure scaling, and the Andersen temperature 
coupling.
9
  Long-range electrostatic interactions were calculated using the particle mesh Ewald 
(PME) method with a non-bonded cutoff truncated at 10.0 angstroms.  Energy values were 
recorded every 25 steps.  A second minimization was performed using 2500 steps of steepest 
descent followed by 500 steps of conjugant gradient which converged to a RMS of 7.3793 x 10
-1
.  
Following minimization, the system was warmed to 310 K over a time period of 2.1 ns.  310 K 
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was the selected temperature due its physiological relevance.  The non-bonded cutoff was set to 
10 angstroms.  A 1 fs time step was used while constraining hydrogen atom bond lengths using 
the SHAKE algorithm.
10-12
  Anderson temperature scaling
9
 was used to adjust the temperature of 
the system updating the temperature every 1 ps.   
Peptides were subjected to constant pressure dynamics until density stabilization had 
been attained.  The production run using constant volume dynamics continued until a 5 ns 
trajectory had been acquired with structure stabilization based upon a less than 2 angstrom 
deviation from the starting structure.  Long-range electrostatic interactions were calculated using 
the PME method with a non-bonded cutoff set to 10 angstroms.  A 1.5 fs time step was used 
while constraining the hydrogen atom bond lengths using the SHAKE algorithm.
10-12
 
 Simulation structures were recorded every 1.0 ps.  The parameters selected for the 
simulation were designed to model physiological conditions as much as possible.  All 
simulations were conducted at 310 K.  Anderson temperature scaling was used to maintain the 
temperature of the system throughout the course of the production run. 
3.3  CALCULATION OF THE ELECTROSTATIC SURFACE 
POTENTIAL 
Electrostatic surface potential grid generation and analyses were performed with the 
Adaptive Poisson-Boltzman Solver (ABPS).
13
  ABPS was written by Nathan Baker with J. 
Andrew McCammon and Michael Holst; and is supported by the National Biomedical 
Computation Resource, National Institutes of Health, National Partnership for Advanced 
Computational Infrastructure, and Washington University in St. Louis.
13
  ABPS takes the 
charges generated either by a software such as PDB2PQR which are derived from a database of 
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values, primarily tailored to the standard amino acids or the .pqr file, which includes the atomic 
charge values can be derived from other means.  The .pqr file, which included the atomic 
charges, was created from the minimized gas phase structure of the tripeptides prior to being 
imported into the ABPS
13
 using a software plugin within PyMol.
14
  The charge values from the 
.pqr file are distributed across the molecule based upon a two part grid shape with numerous 
customization options.  Both the course and fine mesh length was -1, -1, -1.  The grid center was 
at 0, 0, 0 with grid points every -1, -1, -1 units on the grid.  The Linearized Poisson-Boltzmann 
Equation was used for the calculations.  The dielectric constant for the protein was set at 2.0 
while the surrounding solvent dielectric was set at 78.0.  A dielectric constant value of 78.0 was 
selected to model the polarizability of a water solvated environment.  The solvent radius was set 
to 1.4 angstroms.  The temperature of the system was 310.0 K with a vacuum sphere density of 
10 angstrom cube, which is the number of grid points per angstrom cubed square.  The ionic 
concentration was set at 0.15 mM with a cation (+1) radius of 2.0 angstrom and an anion (-1) 
radius of 1.8 angstrom.  No ions with +/- 2 charges were included in the model.  The surface 
calculation method used harmonic average smoothing.   
Electrostatic surface potential maps were created using the Solvent Accessible Surface 
Area (SASA) which gives an idea regarding a molecule’s surface accessible to the surrounding 
solvent.  The calculation is usually derived using a rolling ball technique in which a sphere with 
a specified radius is able to determine the surface area in square angstroms (Å
2
).  This can help 
predict the potential for the molecule to interact with the surrounding environment whether it is 
solvent or a bilayer.  The SASA is also useful when performing implicit solvent simulations 
which are used to improve the prediction of protein secondary structure.  Considering the volume 
of specific amino acids and the distribution of charge for each individual residue can help in the 
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rational design of therapeutic peptides.  Tailoring the charge distribution of peptides can 
optimize for specific membrane charges (especially when targeting multiple drug resistant 
organisms).  
Calculation of the SASA and volume calculations were performed with the UCSF 
Chimera package.
15
  Chimera is developed by the Resource for Biocomputing, Visualization, and 
Informatics at the University of California, San Francisco, with support from the National 
Institutes of Health (National Center for Research Resources grant 2P41RR001081, National 
Institute of General Medical Sciences grant 9P41GM103311).
15
 
3.4  BACKBONE CONFORMATION 
The favored backbone conformations of standard amino acids have been well 
established.
1
  However less is known about the nonstandard amino acids.  To further investigate 
the preferred angles adopted by the nonstandard amino acids, capped tripeptides with 
nonstandard amino acids have been designed and are as shown below and utilized for modeling 
studies:  
 
In the above generalized sequence representation the X represents either the standard or 
nonstandard amino acid.  Standard amino acids containing tripeptides with a similar generalized 
sequence were also constructed and simulated as validation of the investigative approach.  
Tripeptides were minimized using 5000 steps of steepest descent with constant volume, no 
pressure scaling, and Andersen temperature coupling.  Energy values were printed every 25 
Ace-Ala-X-Ala-Nme 
Capping Acetyl Capping Methylamine 
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steps.  A second minimization was performed using 2500 steps of steepest descent followed by 
500 steps of conjugant gradient.     
Intramolecular hydrogen bonds have been observed to form experimentally between the 
backbone and side chain heteroatoms.
16
  Over the short time our simulations were conducted, 
formation of intramolecular hydrogen bonds were observed to form intermittently during the 
course of the solvated MD simulations.  Prolonged warming steps were also associated with an 
increase in intramolecular hydrogen bond formation with the atoms of the peptide backbone. 
3.5  LOG P  
The Log P was calculated for both the standard and unnatural amino acids to give an idea 
of the solubility of the peptides when administered as a therapeutic compound and the potential 
for the residue to partition into the hydrophobic environment of the hydrophobic, aliphatic tail 
region of the lipid bilayers.   The partition coefficient (P) is a measure of the concentration of a 
given compound which is dissolved in two immiscible phases at equilibrium.  Log P is for 
neutral species only. The measurement is accomplished through the addition of buffers to the 
aqueous phase to maintain a particular pH at which the compound would be non-charged. Log D, 
which is able to take charged species into account through a pH dependent measure may be a 
more appropriate selection however the software for such measurements is not presently 
available. 
Octanol and water are commonly used for such calculations and offer a measure of 
solubility in hydrophobic and highly polar solvents.  Using the logarithm of the ratio of the 
concentrations of the compound dissolved in each of the solvents produces the log P value 
(equation 3.1).   
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           Eqn 3.1 
The values listed in Table 3.1 were derived from the Advanced Chemistry Development 
program in which Log P calculations calculate the octanol-water partition coefficient for neutral 
compounds under standard conditions at 25°C.
17
  Calculations are provided with 95% confidence 
intervals or reliability index (RI) based upon a training set of >25 000 compounds in the training 
set and >18 000 log P values in the reference database.
17
  While the training set is not specific for 
our compounds the fragments from which they are composed enable reasonable estimates for log 
P.
18
  The Log P value is associated with the solvent type in which a molecule is expected to be 
soluble.  Octanol and water, which are hydrophobic and highly polar solvents respectively, are 
commonly utilized for these measurements.   
National Biomedical Computational Resource (NBCR) software Adaptive Poisson-
Boltzmann Solver (APBS)
13
 plugin within the PyMOL
14
 software was used for the calculation of 
charges.  The input files were derived from the previously calculated charges for each 
nonstandard amino acid (See Chapter 2 and Appendix A).   
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Peptide 
Sequence 
Solvent 
Accessible  
Surface 
Area Å
3
 
Volume 
Å
3
 
Distance from 
Central Carbonyl 
Carbon to Ace 
Carbonyl Carbon 
Distance from 
Central Carbonyl 
Carbon to Nme 
Carbonyl Carbon 
Log P 
Ala-Lys-Ala 324.1 302.4 3.7 3.3 -2.09 ±0.62 
Ala-Dab-Ala 302.0 275.6 3.7 3.7 -2.09 ±0.64 
Ala-Orn-Ala 308.6 291.0 3.3 3.8 -2.02 ±0.63 
Ala-Dpr-Ala 281.9 262.2 3.8 3.7 -1.99 ±0.66 
Ala-Arg-Ala 345.9 322.9 3.7 3.5 -2.84 ±0.68 
Ala-His-Ala 307.7 292.1 3.7 3.7 -2.27 ±0.69 
Ala-Hip-Ala 308.0 292.6 3.7 3.2 -2.27 ±0.69 
Ala-Tyr-Ala 323.0 312.5 3.5 3.7 -0.63 ±0.67 
Ala-Leu-Ala 304.7 291.0 3.6 3.8 -0.32 ±0.62 
Ala-Gly-Ala 260.5 229.9 3.5 3.8 -2.08 ±0.61 
Ala-βAla-Ala 275.2 244.0 4.6 3.7 -2.30 ±0.57 
Ala-GABA-Ala 292.2 258.8 5.8 3.7 -2.08 ±0.57 
Ala-6Ahx-Ala 308.4 273.4 7.1 3.7 -1.55 ±0.56 
Ala-Acp-Ala 296.0 286.2 3.9 3.8 -1.16 ±0.61 
Ala-Ach-Ala 310.6 305.5 3.8 3.3 -0.59 ±0.62 
Ala-Tic-Ala 338.2 329.3 3.0 3.7 0.38 ±0.72 
Ala-Oic-Ala 316.3 322.5 3.3 3.7 0.74 ±0.70 
Ala-Phe-Ala 352.5 323.2 3.7 3.7 0.11 ±0.67 
Ala-Pro-Ala 283.5 267.2 3.2 3.7 -1.37 ±0.70 
Ala-pClPhe-Ala 356.3 248.9 3.3 3.8 0.70 ±0.67 
Ala-pFPhe-Ala 336.3 326.4 3.2 3.7 0.16 ±0.71 
Ala-Trp-Ala 324.4 324.9 3.7 3.7 0.03 ±0.67 
Ala-Gln-Ala 312.7 292.3 3.7 3.6 -2.66 ±0.65 
Ala-Glu-Ala 309.3 287.2  3.6 3.7 -2.26 ±0.78 
Ala-Ala-Ala 271.6 245.3 3.7 3.7 -1.73 ±0.62 
Ala-Val-Ala 277.7 296.5 3.1 3.6 -0.85 ±0.62 
Ala-Ile-Ala 312.2 311.0 3.3 3.3 -0.32 ±0.62 
Ala-Ser-Ala 284.9 264.7 3.4 3.6 -2.31±0.64 
Ala-Thr-Ala 288.5 291.8 3.2 3.1 -1.96 ±0.64 
Ala-Cys-Ala 295.6 276.4 3.3 3.1 -0.84 ±0.68 
Ala-Met-Ala 304.0 315.3 3.3 3.3 -1.10 ±0.72 
Ala-Asn-Ala 282.1 295.1 3.3 3.0 -2.57 ±0.71 
Ala-Asp-Ala 281.0 286.0 3.0 3.4 -1.61 ±0.66 
 
Table 3.1 Peptide sequences and the structural properties measured for each amino acid. 
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3.6  PHI/PSI ANGLE CALCULATIONS 
The angles were calculated using the Cartesian coordinates (X,Y,Z) of each atom 
composing the relevant angle and using the vector between each atomic point to create vectors 
from which the angles were calculated.  The torsion angle is the angle can be calculated by 
calculating the cross product of the vectors composing the angle.  The sign of the torsion angle is 
determined by the relative orientation of the dot product of the same two vectors with reference 
to the middle vector.  A python script was prepared for the calculation of the torsion angles.  The 
scripts have been included in Appendix C.  Protein databank (.PDB) files were created every 
step, 1 ps , for the 5 ns of the simulations.  The first 2 ns was discarded as an equilibrating step 
and the coordinates for the central residue of the tripeptide were extracted.  The second python 
script calculates the torsion angles first the phi angle followed by the psi angle and the two 
omega angles on either side of the central residue.  The angles which were calculated were 
imported into Microsoft Excel 2010 enabling creation of the Ramachandran plots. 
3.7  RAMACHANDRAN PLOTS
 
Ramachandran plots note the distribution of the phi and psi angles of an amino acid.  
Specifically the phi angle looks at the plane formed by the vectors resulting from the coordinates 
of the carbonyl carbon of the preceding residue, amino nitrogen, alpha carbon, and the carbonyl 
Figure 3.1 Atoms involved in the Omega 1 angle, outlined in blue.  The Omega 2 angle is outlined in 
green.  Phi angle, outlined in magenta and psi angle, outlined in yellow. 
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carbon of the residue (Figure 3.1).  The psi angle is formed from the plane formed by the vectors 
resulting from the coordinates of the amino nitrogen, the alpha carbon, the carbonyl carbon and 
the alpha carbon, the carbonyl carbon and the amino nitrogen of the following residue, The three 
points are used to define the plane between the atoms.   
3.8  SPACER # 1 LINKERS 
The outline of the AMP (Figure 1.15) includes four variable amino acid linkers which 
increase the number of carbon atoms in the backbone of the peptide.  The inclusion of glycine (1 
carbon), β-alanine (2 carbons), Gaba (4 carbons), and 6-Aminohexanoic acid (5 carbons) 
increases the flexibility of the peptide.  The electrostatic properties of each peptide will be 
discussed in addition to the Ramachandran plots derived from averaging the final 2 ns of the 5 ns 
MD simulation. 
3.8.1  GLYCINE 
Glycine (Gly), is unique amongst the 20 standard amino acids because it lacks a chiral 
alpha carbon.  This small nonpolar amino acid has relatively little charge due to the 
neutralization of the backbone associated charge (Figure 3.2 A).  Gly is more flexible than the 
other amino acids due to the lack of steric hindrance because there are no side chains, only 
hydrogen atoms.  The flexible nature of Gly is supported by the wide angle distribution observed 
in the Ramachandran plot (Figure 3.2 B).  The normally disallowed regions of the Ramachandran 
plot are inhabited by the Gly residue, which has also been observed by others studying this small 
molecule.1  
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3.8.2  Β-ALANINE 
Beta-alanine, β-Ala, is a nonstandard, naturally occurring amino acid derived from the 
degradation of dihydrouracil and carnosine and is metabolized to acetic acid.  This small 
nonpolar amino acid has relatively little charge due to the aliphatic nature of the alpha and beta 
carbon atoms incorporated into the backbone (Figure 3.3).  The distance between the carbonyl 
oxygen atoms have increased from 3.5 angstrom observed in the Gly residue to 4.6 angstrom 
reflecting the inclusion of the beta carbon in the backbone.  Addition of the beta carbon increases 
the backbone flexibility more so than what was observed in Gly.  Due to the inclusion of the 
extra carbon in the backbone phi and psi angle calculations are not possible in the traditional 
sense and have been omitted.   
Figure 3.2 A.  Electrostatic surface potential distribution for the tripeptide Ace-Ala- Gly-Ala-Nme  B.  
Ramachandran Plot of the phi/psi angle distribution for the central glycine residue of the tripeptide.  The 
electro negative residues are shown with a darker red color and electro positive regions are shown with a 
blue surface. 
A B 
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3.8.3  GAMMA AMINO BUTYRIC ACID 
Gama aminobutyric acid (Gaba), is a nonstandard, naturally occurring amino acid which 
plays an important role as a neurotransmitter in the mammalian central nervous system.  The 
charge distribution along the backbone is separated even farther than in the glycine or β-alanine.  
The white gap depicted in Figure 3.4 shows the spacing effect of the inclusion of four carbon 
atoms in the backbone. The distance between the carbonyl oxygen atoms has increased from 3.5 
angstrom observed in the Gly, and 4.6 angstrom in β-Ala, to 5.8 angstrom in the Gaba residue.  
Addition of the beta, gamma, and delta carbon atoms increases the backbone flexibility more so 
than what was observed in either Gly or β-Ala.  Due to the inclusion of the extra carbon atoms in 
the backbone phi and psi angle calculations are not possible in the traditional sense and have 
been omitted.   
Figure  3.3  Electrostatic surface potential distribution in the tripeptide Ace-Ala-βAla-Ala-Nme     
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3.8.4  6-AMINOHEXANOIC ACID 
6-aminohexanoic acid (6-Ahx), is a nonstandard amino acid which can be synthesized 
from lysine. 6-Ahx has been used as a therapy for the treatment of bleeding disorders due to its 
ability to inhibit the proteolytic activity of plasmin.   6-Ahx is also a synthetic intermediate in the 
synthesis of nylon-6.  The charge distribution along the backbone is separated even farther than 
in the glycine, β-alanine, or Gaba.  The white gap depicted in Figure 3.5 shows the spacing effect 
of the inclusion of five carbon atoms in the backbone. The distance between the carbonyl oxygen 
atoms has increased from 3.5 angstrom observed in the Gly, to 4.6 angstrom in β-Ala, 5.8 
angstrom in Gaba to 7.1 angstrom in the 6-Ahx residue.  Addition of the beta, gamma, delta, and 
episilon carbon atoms increases the backbone flexibility more so than what was observed in 
either Gly, β-Ala, or Gaba.  Due to the inclusion of the extra carbon atoms in the backbone phi 
and psi angle calculations are not possible in the traditional sense and have been omitted.   
Figure  3.4 Electrostatic surface potential distribution for the tripeptide  Ace-Ala-Gaba-Ala-Nme     
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3.9  SPACER # 2 LINKERS 
The outline of the AMP (Figure 1.15) includes five variable amino acid linkers which 
increase the number of carbon atoms between the alpha carbon and the cationic charge of the 
side chain.  The inclusion of diaminopropionic acid (1 carbon), diaminobutanoic acid (2 
carbons), ornithine(3 carbons), arginine (3 carbons) and Lysine (4 carbons) into the peptide 
sequence changes the electronic charge distribution relative to the peptide backbone enabling the 
tailoring of the charge distribution relative to the desired target membrane charge type.  The 
electrostatic properties of each tripeptide will be discussed in addition to the Ramachandran plots 
derived from averaging the final 2 ns of the 5 ns MD simulation. 
3.9.1  DIAMINOPROPIONIC ACID 
2,3-Diaminopropionic acid, Dpr, is an unnatural amino acid which is a synthetic amino 
acid. The charge distribution relative to the backbone was measured at the conclusion of the MD 
simulation.  Dpr was found to have a distance of 2.6 Å between the alpha carbon and the 
Figure 3.5  Electrostatic surface potential distribution  for the tripeptide Ace-Ala-6-Ahx-Ala-Nme 
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nitrogen atom of the side chain.  The presence of the cationic charge close to the backbone 
creates a charge distribution along the backbone as evidenced by the blue shaded region in  
Figure 3.6 A.  The figure shows the effect of the shorter carbon chain between the backbone and 
the side chain charge.  
 
Dpr is less flexible than residues which are able to locate the charge farther away from 
the charged atoms in the peptide backbone.  The lack of flexibility results from the steric 
hindrance of the cationic protonated amine.  The lack of flexibility of the Dpr residue is 
supported by the limited range of the phi and psi angle distribution observed in the 
Ramachandran plot (Figure 3.6 B).  Another attribute to the observed distribution is the polar 
interactions between the cation and the carbonyl oxygen.  The regions of the Ramachandran plot 
preferentially populated by Dpr suggest a right handed alpha helical shape or a β-sheet/turn 
secondary structure may be associated with the Dpr residue.   
 
 
Figure  3.6 A.  Electrostatic surface potential distribution for the tripeptide Ace-Ala-Dpr-Ala-Nme  B.  
Ramachandran Plot phi/psi angle distribution for Dap 
A B 
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3.9.2  DIAMINOBUTANOIC ACID 
2,3-Diaminobutanoic acid (Dab), is an unnatural amino acid which is a synthetic amino 
acid. The charge distribution relative to the backbone was measured at the conclusion of the MD 
simulation.  Dab was found to have a distance of 3.4 angstrom between the alpha carbon and the 
nitrogen atom of the side chain.  The presence of the cationic charge so close to the backbone 
creates a lack of electron density toward the backbone as evidenced by the blue shaded region in 
Figure 3.7 A which shows the effect of the shorter carbon chain between the backbone and the 
side chain charge.  
Dab is less flexible than residues which are able to locate the charge farther away from 
the charged atoms in the peptide backbone.    The charged atoms of the side chain have the 
charge distributed toward the backbone creating a slightly more diffuse charge region relative to 
the Dpr residue however; the charge is still more closely positioned relative to the other residues 
including Orn, Arg, and Lys.   The lack of flexibility results from the steric hindrance of the 
cationic protonated amine.  The lack of flexibility of the Dab residue is supported by the limited 
Figure 3.7  A.  Electrostatic surface potential distribution of the tripeptide Ace-Ala-Dab-Ala-Nme B.  
Ramachandran Plot phi/psi angle distribution for Dab 
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range of the phi and psi angle distribution observed in the Ramachandran plot (Figure 3.7 B).  
The regions of the Ramachandran plot preferentially populated suggest a right handed alpha 
helical shape or a β-sheet/turn secondary structure may be associated with the Dab residue.  The 
alpha helical preferred region is generally found in the lower left quadrant of the Ramachandran 
plot.  
3.9.3  ARGININE
 
Arginine (Arg), is one of the 20 standard amino acids.  The charge distribution relative to 
the backbone was measured at the conclusion of the MD simulation.  Arg was found to have a 
distance of 4.8 angstrom between the alpha carbon and the carbon of the guanidinium group of 
the side chain.  The presence of the cationic charge at such a distance from the backbone allows 
dispersion of the cationic charge to the backbone as evidenced by the blue shaded region in 
Figure 3.8 A which shows the dispersive effect of the guanidinium group, with its delocalized 
cation.  Distribution of the charge across three carbon atoms back toward the backbone is 
reflective of the significant impact the cation has on the electron density of the Arg residue.  
Figure 3.8 A.  Electrostatic surface potential distribution for the tripeptide Ace-Ala-Arg-Ala-Nme  B.  
Ramachandran Plot phi/psi angle distribution for Arg 
A B 
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The three nitrogen atoms of the guanidinium group enable delocalization of the charge 
over a larger area which, based on the electrostatic surface potential map, shows the cationic 
charge extends toward the peptide backbone and creates a larger area of cationic charge. Arg is 
able to locate the charge of the guanidinium group farther away from the charged atoms in the 
peptide backbone than the Dpr and Dab residues.    The length of the carbon linker between the 
alpha carbon and the side chain charge is sufficient to allow the side chain to fold back upon 
itself allowing the potential for intramolecular hydrogen bonding to occur.   The flexibility of the 
Arg residue is supported by the broad range of the phi and psi angle distribution observed in the 
Ramachandran plot (Figure 3.8 B).  The region of the Ramachandran plot preferentially 
populated by the Arg tripeptide suggest a right handed alpha helical shape or a β-sheet/turn 
secondary structure may be associated with the Arg residue.  The regions populated on the 
Ramachandran plot are consistent with other groups findings.
1
 
3.9.4  ORNATHINE 
Figure 3.9 A.  Electrostatic surface potential distribution of the tripeptide Ace-Ala-Orb-Ala-Nme  B.  
Ramachandran Plot phi/psi angle distribution for Orn 
A B 
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Despite the similarity in carbon length between the alpha carbon and the charge centered 
atom between Arg and ornithine, Orn, the preferred secondary structure appears to be quite 
different.  The distance between the alpha carbon and the protonated mamine of the Orn residue 
is 5.0 angstrom, similar to the 4.8 angstrom measurement associated with Arg.  Both these 
residues have three carbon atoms linking the polar atom to the backbone.  The charge 
distribution relative to the backbone was measured at the conclusion of the MD simulation.  
Much like the Arg residue the presence of the cationic charge three carbon atoms away from the 
backbone allows dispersion of the cationic charge to the backbone through intramolecular 
hydrogen bonding which is shown in Figure 3.9 A.   The greater distance between the charge and 
the backbone increases the flexibility of the side chain, but not necessarily the backbone of the 
residue.  The flexibility of the Orn residue side chain is not measured in the torsion angle 
calculations.  The lack of flexibility in the backbone of this residue is supported by the narrow 
range of the phi and psi angle distribution observed in the Ramachandran plot (Figure 3.9 B).  
The region of the Ramachandran plot preferentially populated by the Orn tripeptide suggest a 
right handed alpha helical secondary structure may be associated with the Orn residue.  
Structural observations suggest hydrogen bonding could be a contributing factor. 
3.9.5  LYSINE 
Lysine, Lys, is a naturally occurring, standard amino acid.  Here it is used as a reference 
reflecting the structural changes associated with the variation of the number of side chain carbon 
atoms separating the backbone from the cationic charge of the side chain.  The distance between 
the alpha carbon and the protonated amine of the Lys residue is 6.4 Å.  The charge distribution 
relative to the backbone was measured at the conclusion of the MD simulation.  The shorter 
distances between the charge and the backbone allowed for the dispersion of the charge over a 
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greater area however lysine, with the large distance between the backbone and the hard charge of 
the protonated amine creates a separation which is not able to be distributed over a large area, see 
Figure 3.10 A.   The presence of the cationic charge more than three carbon atoms away from the 
backbone allows flexibility in the side chain making intramolecular hydrogen bonding  possible 
however it was not observed during the short simulation time scale studied.  The preference of 
the Lys residue to adopt a right handed alpha helical secondary structure has been determined 
through crystallographic studies in addition to structure prediction using MD simulation.1  The 
narrow range of the phi and psi angle distribution observed in the Ramachandran plot (Figure 
3.10 B) is consistent with previous MD simulations and crystallographic data.1   The large 
distance between the backbone and the protonated amine of the Lys residue make the formation 
of intramolecular hydrogen bonds possible and participation in cyclic five or six membered 
hydrogen bonds are expected.19 
 
 
Figure 3.10 A.  Electrostatic surface potential distribution for the tripeptide Ace-Ala-Tic-Ala-
Nme  B.  Ramachandran Plot phi/psi angle distribution for Tic 
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3.10  BICYCLIC UNNATURAL AMINO ACIDS 
The outline of the AMP (Figure 1.15) includes three bicyclic amino acids placed in 
sequence together, Tic and Oic.  A terminal single Tic residue is found just before the terminal 
four lysine residues.   Inclusion of these sterically hindered residues in sequence is designed to 
force the secondary structure toward that of a β-sheet or turn.  The structural properties of these 
bicyclic, unnatural amino acids have been studied using tripeptide MD simulations to examine 
the preferred angular arrangement of the backbone atoms.  Similarities to naturally occurring 
amino acids phenylalanine and proline will be discussed as well.  The electrostatic properties of 
each tripeptide will be discussed in addition to the Ramachandran plots derived from averaging 
the final 2 ns of the 5 ns MD simulation. 
3.10.1  TIC 
Tetrahydroisoquinolinecarboxylic acid (Tic) is a bicyclic, unnatural amino acid which 
has the side chain cyclizing via the amide nitrogen in an orientation similar to proline.  The 
bicyclic nature of this residue creates a sterically bulky, hydrophobic side chain.  This large 
nonpolar amino acid has relatively little charge due to aromatic ring fused to a nonaromatic ring 
in closest contact with the backbone.  The lack of charge disassociation of the backbone atoms to 
those of the bicyclic rings is reflected in Figure 3.11 A.  The side chain looping to the backbone 
severely limits the possible orientations possible.  The lack of reflected in the observed in the 
Ramachandran plot (Figure 3.11 B).  The preference, based on angle population appears to fall in 
both the right handed alpha helical region and the β-sheet/turn regions of the Ramachandran plot.    
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3.10.2  PHENYLALANINE 
Phenylalanine (Phe) was the model for the design of unnatural amino acid Tic.  The bulk 
of the hydrophobic aromatic ring was optimized while the addition of a carbon atom allowed the 
creation of the six membered ring hindering the peptide backbone.  The nonpolar Phe is reflected 
in Figure 3.12 A.  The charge is localized on the backbone atoms and the lack of charge density 
around the aromatic ring results in a bulky hydrophobic residue.  The preferred torsion angles 
adopted by the Phe residue suggest a preference for a right handed alpha helical secondary 
structure, Figure 3.12 B.  Comparison of the Phe residue to the unnatural Tic shows how the 
preferred secondary structure has been influenced.   Despite the increased steric hindrance of Tic, 
the potential secondary structure expands beyond that observed for the monocyclic Phe.  The 
MD simulation derived phi and psi angles are consistent with experimentally derived preferences 
for the Phe residue.  1 
 
Figure 3.11 A.  Electrostatic surface potential distribution for the tripeptide Ace-Ala-Tic-Ala-
Nme  B.  Ramachandran Plot phi/psi angle distribution for Tic 
A B 
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3.10.3  OIC 
Octahydroindolecarboxylic acid (Oic), is also a bicyclic, unnatural amino acid which has 
the side chain looping back to the amide nitrogen in an orientation similar to proline. The lack of 
aromaticity enables more flexibility in the side chain of the residue.   The large nonpolar amino 
acid has no charge due to the aliphatic rings with the pyrrolidine ring providing the amido 
Figure 3.13 A.  Electrostatic surface potential distribution for the tripeptide Ace-Ala-Oic-Ala-Nme  B.  
Ramachandran plot phi/psi angle distribution for Oic 
A 
B 
Figure 3.12 A.  Electrostatic surface potential distribution for the tripeptide Ace-Ala-Phe-Ala-Nme   B.  
Ramachandran plot phi/psi angle distribution  for Phe 
 
A B 
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nitrogen and the alpha carbon of the backbone.  The lack of charge disassociation of the 
backbone charge to the atoms of the bicyclic rings is reflected in Figure 3.13 A.  The side chain 
cyclizing to the backbone severely limits the possible orientations possible.  The lack of 
flexibility is reflected in the observed Ramachandran plot (Figure 3.13 B).  The preference, 
based on angle population appears to fall the β-sheet/turn regions of the Ramachandran plot.  The 
three chiral centers of the Oic residue warrant further investigation to elucidate the preferred 
structural combination for this residue.  
3.10.4  PROLINE 
Proline (Pro) is a naturally occurring amino acid which is commonly associated with β-
sheets and turns within peptides and proteins.  The nature of the pyrrolidine ring of Oic residue is 
structurally derived from Pro.  The addition of the unsaturated six membered ring to the 
pyrrolidine ring of Oic residue is responsible for increasing the hydrophobic bulk of the residue 
relative to the smaller Pro residue.  Despite the hydrophobic nature of the Pro residue, the close 
proximity of the side chain carbon atoms limit the hydrophobic nature of this residue, which was 
exaggerated in the Oic residue, see Figure 3.14 A.  The effect observed of the addition of the 
unsaturated six membered ring to the pyrrolidine ring seems to be limiting the psi angle 
preference.  Pro has two regions of preferred angular orientation, Figure 3.14 B relative to the 
single preferred region observed in Oic, Figure 3.13 B.  The conclusion is that the addition of the 
unsaturated six membered ring to the pyrrolidine ring of Pro decreases the backbone flexibility 
forcing the conformation into a β-sheet/turn secondary structure.   
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3.10.5  1-AMINOCYCLOPENTANECARBOXYLIC ACID 
1-aminocyclopentanecarboxylic acid (Acp) is a non-aromatic, sterically hindered 
unnatural amino acid.  The electrostatic surface potential distribution shown in Figure 3.15 A 
shows the hydrophobic, electrically neutral nature of the Acp residue.  The phi and psi angle 
measurements, shown in the Ramachandran plot in Figure 3.15 B, suggest this residue prefers a 
right handed alpha-helical secondary structure and thus could be a useful tool in influencing the 
peptide structure.  
Figure  3.14  A.  Electrostatic surface potential distribution for the tripeptide Ace-Ala-Pro-Ala-Nme   
B.  Ramachandran Plot  phi/psi angle distribution  for Pro 
 
A B 
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3.10.6  1-AMINOCYCLOHEXANECARBOXYLIC ACID 
1-aminocyclohexanecarboxylic acid (Ach) is a non-aromatic, sterically hindered 
unnatural amino acid. The electrostatic surface potential distribution has shown in Figure 3.16 A 
the hydrophobic, electrically neutral nature of the Ach residue.  The phi and psi angle 
measurements suggest the Ach residue prefers a right handed alpha-helical secondary structure 
A B 
Figure  3.15 A.  Electrostatic surface potential distribution B.  Ramachandran plot  phi/psi angle 
distribution  for Acp 
A B 
Figure  3.16 A.  Electrostatic surface potential distribution B.  Ramachandran plot  phi/psi angle 
distribution  for Ach 
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but, also has the flexibility to adopt beta-sheet/turn torsion angles.  Due to the flexibility in the 
torsion angles adopted by the Ach residue it could be a useful tool in influencing the peptide 
structure and should be considered as a residue in the design of future unnatural amino acid 
containing AMPs.   
 3.10.7  P-FLUOROPHENYLALANINE  
Substitution of the phenylalanine at the 4 position created para-fluorophenylalanine 
(pFPhe).  The electron withdrawing effects of the highly electronegative fluorine are not well 
reflected in the electrostatic surface potential shown in Figure 3.17 A.  The Ramachandran plot 
suggests a preferred left handed alpha helical secondary structure (Figure 3.18 B), dramatically 
different than the substituted phenylalanine, Figure 3.12 B.  The unusual secondary structure of 
Figure 3.17 A.  Electrostatic surface potential distribution for the tripeptide Ace-Ala-p-FPhe-Ala-Nme   
B.  Ramachandran Plot phi/psi angle distribution for p-F Phe 
A B 
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pFPhe is supported by an equally unusual CD spectrum.20  
3.10.8  P-CHLOROPHENYLALANINE  
Substitution of the phenylalanine at the 4 position created para-chlorophenylalanine 
(pClPhe).  The electron withdrawing effects of the highly electronegative chlorine are not well 
reflected in the electrostatic surface potential shown in Figure 3.18 A.  The Ramachandran plot 
for pClPhe suggests a preferred left handed alpha helical secondary structure (Figure 3.18 B), 
dramatically different than the substituted phenylalanine, Figure 3.12 B.  The pClPhe  
Ramachandran plot is consistent with the pFPhe plot (Figure 3.17 B) The unusual secondary 
structure of pClPhe is supported by an equally unusual CD spectrum.20 The presence of angles 
populating the lower right hand quadrant of the Ramachandran plot is suspected of being 
transitional angles through which the preferred structure transitions.  The lower right hand 
quadrant is usually considered a “forbidden” region however the standard amino acids have 
Figure  3.18 A.  Electrostatic surface potential distribution for the tripeptide Ace-Ala-p Cl Phe-Ala-Nme 
B.  Ramachandran Plot  phi/psi angle distribution  for p-Cl Phe 
A B 
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demonstrated small populations which have populated the area.1 
3.11  STANDARD AMINO ACIDS 
Tripeptide simulations were also undertaken for all 20 of the standard amino acids to 
strengthen the validity of the experimental approach.  The standard amino acids which were not 
part of the linkers or spacers are included. 
3.11.1  VALINE 
 
 
 
Figure 3.19 A.  Electrostatic surface potential distribution of the tripeptide Ace-Ala-Val-Ala-Nme B.  
Ramachandran Plot  phi/psi angle distribution  for Val 
A B 
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3.11.2 LEUCINE
 
 
 
3.11.3  ISOLEUCINE 
 
 
 
Figure 3.20 A.  Electrostatic surface potential distribution for the tripeptide Ace-Ala-Leu-Ala-
Nme  B.  Ramachandran Plot phi/psi angle distribution for Leu 
A B 
Figure 3.21 A.  Electrostatic surface potential distribution for the tripeptide Ace-Ala-Ile-Ala-Nme  B.  
Ramachandran plot phi/psi angle distribution for Ile 
A B 
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3.11.4  TYROSINE 
 
 
3.11.5  TRYPTOPHAN 
 
 
 
Figure 3.22 A.  Electrostatic surface potential distribution for the tripeptide Ace-Ala-Tyr-Ala-Nme  B.  
Ramachandran plot phi/psi angle distribution for Tyr 
A B 
Figure 3.23 A.  Electrostatic surface potential distribution for the tripeptide Ace-Ala-Trp-Ala-Nme  B.  
Ramachandran plot phi/psi angle distribution for Trp 
A B 
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3.11.6  ALANINE 
 
 
3.11.7  SERINE 
 
 
Figure 3.24  A.  Electrostatic surface potential distribution for the tripeptide Ace-Ala-Ala-Ala-Nme  B.  
Ramachandran Plot phi/psi angle distribution for alanine 
A B 
Figure 3.25 A.  Electrostatic surface potential distribution for the tripeptide Ace-Ala-Ser-Ala-Nme  B.  
Ramachandran Plot phi/psi angle distribution for Ser 
A B 
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3.11.8  THREONINE 
 
 
 
3.11.9  CYSTEINE 
 
Figure 3.26 A.  Electrostatic surface potential distribution for the tripeptide Ace-Ala-Thr-Ala-Nme   B.  
Ramachandran plot phi/psi angle distribution for Thr 
A B 
Figure 3.27 A.  Electrostatic surface potential distribution for the tripeptide Ace-Ala-Cys-Ala-Nme  B.  
Ramachandran plot phi/psi angle distribution for Cys 
A B 
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3.11.10  METHIONINE 
 
 
 
3.11.11  ASPARAGINE 
 
 
Figure 3.28 A.  Electrostatic surface potential distribution for the tripeptide Ace-Ala-Met-Ala-Nme  B.  
Ramachandran plot phi/psi angle distribution for Met 
Figure 3.29 A.  Electrostatic surface potential distribution for the tripeptide Ace-Ala-Asn-Ala-Nme  B.  
Ramachandran plot phi/psi angle distribution for Asn 
A B 
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3.11.12  GLUTAMINE 
Figure 3.30 A.  Electrostatic surface potential distribution for the tripeptide Ace-Ala-Gln-Ala-Nme  B.  
Ramachandran plot phi/psi angle distribution for Gln 
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3.11.13  HISTIDINE
 
Within the AMBER program there are two neutral forms of histidine HisE and HisD in 
addition to one protonated for, HisP.  The protonated and unprotonated forms have been 
simulated in the tripeptide arrangement.  Figure 3.31 A shows the unprotonated form of histidine 
while Figure 3.31 B shows the protonated form.  The effect of the additional proton is evident in 
the electrostatic surface potential map which reflects the anionic nature of the unprotonated form 
Figure  3.31 A.  Electrostatic surface potential distribution for the tripeptide Ace-Ala-His-Ala-Nme, the 
unprotonated form of His  B.  Electrostatic surface potential distribution for the tripeptide Ace-Ala-Hid-
Ala-Nme, the protonated form of His C.  Ramachandran plot  phi/psi angle distribution  for His 
 
A B 
C 
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of the His and the cationic charge associated with the protonated His residue.  The angular phi 
and psi distribution for the two forms of this residue were not significantly different and the 
average structure is shown in Figure 3.31 C.  The Ramachandran plot for His shows the 
preference for a right handed alpha helical secondary structure however also shows a less dense 
population present in the beta-sheet/turn region of the plot.   
3.11.14  ASPARTIC ACID 
 
 
3.11.15  GLUTAMIC ACID 
Electrostatic surface potential maps were created using the Solvent Accessible Surface 
Area (SASA) gives an idea regarding a molecule’s surface accessible to the surrounding solvent.  
The calculation is usually derived using a rolling ball technique in which a sphere with a 
specified radius is able to determine the surface area in square angstroms (Å
2
).  This can help 
predict the potential for the molecule to interact with the surrounding environment whether it is 
solvent or a bilayer, the SASA is also useful when performing implicit solvent simulations which 
Figure 3.32 A.  Electrostatic surface potential distribution for the tripeptide Ace-Ala-Asp-Ala-Nme  B.  
Ramachandran plot phi/psi angle distribution for Asp 
A B 
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is used to improve the prediction of protein secondary structure.  Considering the volume of 
specific amino acids and the distribution of charge for each individual residue can help in the 
rational design of therapeutic peptides.  Tailoring the charge distribution of peptides can 
optimize for specific membrane charges (especially when targeting multiple drug resistant 
organisms).  
 The tripeptide MD simulations for each of the 20 standard and unnatural amino acids have 
enabled a small sampling, 5 ns, of the conformational configurations of each system.   
Calculations of the torsion angles associated with each of the standard amino acids have been 
consistent with previously reported in silico experiments performed by other investigators.1  
Angle measurements derived from the experimentally derived structures and reported in the 
protein data bank (PDB) are also consistent with the calculated Ramachandran distributions for 
each of the standard amino acids.  The Ramachandran plots are consistent with the experimental 
data for the 20 standard amino acids The consistency of the Ramachandran plots with literature 
values1 validate the force field parameters because they were able to replicate the experimentally 
Figure 3.33 A.  Electrostatic surface potential distribution for the tripeptide Ace-Ala-Glu-Ala-Nme  B.  
Ramachandran plot phi/psi angle distribution for Glu 
A B 
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derived angles and by extension the expanded force field has been applied to the unnatural amino 
acid enabling a sampling of the backbone torsion angles and comparison of the resulting 
Ramachandran plots with the known regions associated with the various secondary structures.1   
Calculation of the solvent accessible surface area and volume calculations were 
performed with the UCSF Chimera package.15  Chimera is developed by the Resource for 
Biocomputing, Visualization, and Informatics at the University of California, San Francisco, 
with support from the National Institutes of Health (National Center for Research Resources 
grant 2P41RR001081, National Institute of General Medical Sciences grant 9P41GM103311).15   
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ABSTRACT 
Antimicrobial peptides are known to adopt specific secondary structure upon interaction 
with microbial cell surfaces and this unique phenomenon is dependent on the electrostatic charge 
distribution of the membrane surface.1,2  SDS Micelles have been utilized as electrostatic models 
for membranes in numerous molecular modeling studies.2- 8  Experimental data is abundant for 
SDS micelles and their structures have been well established in numerous environments.8  
Molecular dynamics (MD) simulations were undertaken examining the effect of two different 
peptides, peptide 23 with a glycine linker and peptide 36 with the β-Alanine linker, on the SDS 
micelle.  The exact mechanism of action of the AMPs has been elusive; making MD simulation 
of the system a good tool in understanding peptide-micelle interactions which contribute to the 
mechanism of action (MOA).  The simulation data is consistent with DOSY NMR and circular 
dicroism (CD) structural data.  Analysis of the Ramachandran plots for both peptide 23 and 
peptide 36 reflect the alpha helical and beta turn/sheet structural character associated with both 
peptides and corroborated by the CD and 2D NMR experiments.  The orientation of the peptides 
relative to the micelle surface has offered insight into the orientations of the peptide, relative to 
the micelle surface, and provides a basis for further studies in various membrane environments.   
4.1  MICELLE CONSTRUCTION 
The SDS molecule previously parameterized (See Chapter 2 and Appendix A) was used 
to construct micelles with 50, 62, and 80 SDS units using a custom script9 which evenly 
distributes the terminal carbon of the SDS molecules evenly around a sphere with a radius of 9 
angstroms, with polar atoms pointing away from the center (Figure 4.1).  The three sizes were 
selected to reflect the estimated experimental variability in the micelles used to conduct CD 
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studies examining the secondary structure of AMPs.10  Although three different aggregate 
micelles were constructed a parsimonious approach necessitated the selection of the most 
reasonable micelle for simulation.  Micelles consisting of 62 individual SDS molecules were 
within the aggregation range associated with SDS micelles in the literature.7, 11-13   
Water molecules were added to the micelle system in a two-step process.  Each SDS 
molecule has a charge of -1.  The micelle was neutralized by first randomly selecting 62 water 
molecules which were within 5 angstroms of each sulfur atom.  The water molecules which fell 
into the previously specified criteria were randomly replaced using the MMTSB software to add 
62 Na
+
 ions to the system.14  Following addition of sodium ions to neutralize the micelle a 
TIP3P, cubic water box extending 14 angstroms from the micelle surface was added.15  Water 
molecules were randomly replaced using MMTSB software to bring the ionic strength to 0.15 M 
NaCl.14  The ionic strength was selected due to its physiological relevance.  The micelle was 
simulated using constant pressure dynamics for 300 ps prior to addition of any peptide.  During 
this time density stabilization was observed however, the system did not stabilized based upon 
Figure 4.1 A) Starting 62 SDS micelle structure, sulfur is noted with yellow spheres and oxygen is 
noted with red spheres.  B)  The surface of the starting 62 SDS micelle structure 
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the RMSD of the molecules relative to the starting minimized structure.  This system was used in 
a preliminary equilibration simulation of the solvated, neutralized micelle alone (Figure 4.2).   
The equilibration simulation was conducted in five steps: pre-minimization, 
minimization, heating, constant pressure dynamics (equilibration phase), and constant volume 
dynamics (production phase).  The micelle was minimized using a two-step process first 
constraining the micelle atoms allowing the water to settle around the surface of the micelle, 
followed by a second unrestrained minimization.  Each minimization used 5000 steps of steepest 
descent with constant volume, no pressure scaling, and Andersen temperature coupling.  
Electrostatic interactions were truncated at 10.0 angstroms and were divided.  Energy values 
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were printed every 25 steps.  A second minimization was performed without restraints using 
2500 steps of steepest descent followed by 500 steps of conjugant gradient.   
Following minimization the system was warmed to 300K over 2.1 ns.  The non-bonded 
cutoff was set to 10 angstroms.  A 1 fs time step was used while constraining hydrogen atom 
bond lengths using the SHAKE algorithm.16  Anderson temperature scaling was used to adjust 
the temperature of the system at each step.  The step size was reduced to prevent SHAKE and 
other problems from developing.17 
The micelle was subjected to constant pressure dynamics until density stabilization had 
been attained.  The production run using constant volume dynamics continued until a 500 ps 
trajectory had been acquired.  Micelle stabilization, based upon the RMSD plot was not attained 
during this short simulation period.  Long-range electrostatic interactions were calculated using 
the particle mesh Ewald (PME) method with a non-bonded cutoff set to 12 angstroms.  A 1.5 fs 
time step was used while constraining the hydrogen atom bond lengths using the SHAKE 
algorithm.  Simulation structures were saved every 500 steps.  The parameters selected for the 
simulation environment were designed to model in vivo conditions as much as possible.  All 
simulations were conducted at 300 K.  Anderson temperature scaling was used to maintain the 
temperature of the system throughout the course of the production run.  A structural transition is 
observed for SDS molecules as the temperature is elevated making the temperature at which the 
simulation is conducted very important.  Temperatures below 300 K are associated with a 
crystalline aggregate at temperatures above 310 K micelles are able to form a higher 
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temperatures.5,18  The differences in temperature may be responsible for the observed 
experimental differences.  
Much of the computational expense involved with MD simulations results from the 
number of atoms involved in a simulation.  Reducing the number of atoms would increase the 
speed of the simulation.  One way to accomplish the reduction of atoms involved in a simulation 
is to use an implicit model in place of the common explicit water models (ex. SPC, TIP3P, 
TIP4P).  Due to the interest focusing on the solute of the system, in this case the micelle and 
peptides, reducing the water molecules to an implicit model seems an obvious solution to 
expedite data collection. Use of the Generalized Born simulation technique provides a 
description of solvent and counter ions as implicit model components by approximation of the 
linearized Poisson-Boltzmann equation.19  The high-dielectric of the water solvent is 
accomplished using a continuum electrostatics model.19  Solvation energies are combined with 
the total energy of the system and are included in the force terms driving the dynamics of the 
simulation.19  Use of the Generalized Born model was attempted with the micelle alone and in 
the presence of peptide 23 and 36.  The Generalized Born model utilizes an implicit solvent 
system, reducing the total number of atoms involved in the simulation.  Numerous attempts using 
the Generalized Born approach have demonstrated that with the current set of parameters, this 
technique may not be possible.  Given the dynamic nature of micelles and the multi-bodied 
construct, applying the Generalized Born approach is of limited utility for the current system of 
interest.   
Another technique for expediting md simulations is using an octahedral simulation box 
rather than the traditional cubic box.  A octahedral box has the four corners sliced off creating a 
octahedral shaped face on each of the six sides of the traditional cubic box.  Any reduction in the 
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number of atoms involved in the simulation will result in a decrease in the simulation time.  
Given the long time scale used to study the peptide micelle interaction and the large movements 
associated with the micelle, use of the octahedral box with a comparable size box was not able to 
provide computational savings and the re-imaging of the system proved problematic.  The 
necessary increased size of the octahedral box negated the savings expected from the smaller box 
and was thus abandoned.   
4.2  CONTROL SIMULATION 
 The simulation of the control micelle in the solvated and ionic concentration of the 
system was adjusted.  This system continued as a control simulation.  The simulation was re-
setup (ions and water were removed from the system) for consistency with the experimental 
Figure 4.3  RMSD plot of the control 62 SDS molecule micelle.  The final nanosecond of the simulation 
is shown. 
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simulations with peptides 23 and 36.  The production run with the canonical ensemble (NVT)  
(see Chapter 2 for a discussion of the various ensembles) was continued for 42 ns.  The resulting 
structure is depicted in Figure 4.3.  The non-spherical nature of the micelle is consistent with 
other scientists’ observations.12,13  The exposure of the aliphatic, hydrophobic tails of the 
dodecylsulfate to the solvent surface12,13 may be an unexpected occurrence but is well 
documented and consistent with other research group’s simulation data associated with SDS 
micelles.12,20 
 The control micelle simulation was considered stable when the average slope of the 
RMSD plot, relative to the minimized structure, had a slope approaching 0.  Stabilization is 
observed in this instance as opposed to equilibration, the more common measure of MD 
simulation completion, due to the dynamic nature of the micelle.  The control micelle maintained 
the aggregate throughout the course of the trajectory with the individual SDS molecules 
continuing to oscillate relative to other SDS molecules of the micelle.  The control simulation 
demonstrated the force field parameters developed for SDS were able to replicate the movement 
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Figure 4.4 62 SDS micelle after 42 ns of md simulation.  The 6 images (of each face of the PBC) are of 
the same micelle from the same time step noting the dynamic nature of the micelle and the non-spherical 
shape it adopts.  Water and ion atoms have been removed for clarity. 
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other investigators had observed using other force fields and software.12, 20 
4.3  PEPTIDE/MICELLE SIMULATIONS 
There are several well studied techniques for the simulation of peptides with micelles.  
One starting setup places the peptide to be simulated at the center of the vacant micelle and is 
simulated with the expectation that the peptide will migrate to the micelle surface in its preferred 
orientation ending at the micelle surface.4,6,7,13  The central placement of the peptide is expected 
to minimize placement bias allowing the peptide to move to its preferred orientation.  Another 
approach to the peptide/micelle simulations is placing the peptide at the surface of the micelle, a 
sufficient distance away, enabling the peptide to be able to move and change conformation while 
still being close enough to provide potential for electrostatic interaction with the micelle.3  
 
Figure 4.5 Peptide 23 reflecting the “faces” of the peptide used in preliminary simulations.   
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 The second approach was utilized in this study with the hope that the simulation time 
required (and thus the computational expense) will be minimized.  Preliminary studies of 
peptide/micelle interactions was undertaken to determine the effect of the peptide’s “facial” 
placement relative to the micelle surface.  Each of the four Y and Z axial faces of the peptide, as 
exemplified in Figure 4.5, was orientated toward the micelle surface.  The peptides were placed 
within 7 angstroms of the micelle surface and allowed to progress through the five step of the 
simulation process.  The resulting peptide orientations appear highly dependent upon the starting 
orientation, as would be expected.  The polar residues do not seem to completely determine the 
final orientation of the peptide relative to the micelle surface, see Figure 4.6.  Similar simulations 
were conducted for peptide 36 with similar results.  The conclusion from the simulation is that 
while the starting orientation of the peptide relative to the micelle surface does have an impact 
upon the final orientation, it does not prevent re-orientation of the peptide to a preferred 
conformation throughout the course of the simulation. 
A B 
B 
B 
Figure 4.6  Peptide 23 Demonstrating the effect of orientation relative to the micelle surface A 
starting orientations of peptide 23.  B.  Final orientation of peptide after molecular dynamics 
simulation. 
132 
 
4.3.1  PEPTIDE 23 WITH MICELLE 
 Peptide 23 was simulated with a 62 SDS molecule micelle for 25 ns.  The same 
micelle as was used as the starting structure in the control micelle simulation was used as 
the starting structure for the peptide/micelle simulations.  An initial box was placed 
extending 5 angstroms from the surface of the micelle.  The system was prepared as 
previously described (Figure 4.7 A).  Water molecules extended 18 angstroms from the 
micelle surface (Figure 4.7 B).  The starting position of peptide relative to the surface was 
previously investigated using simulations with each of four “faces” of the peptide orientated 
toward the micelle surface (data not shown).  While one of the cationic lysine residues was 
placed relatively close to the micelle surface (Figure 4.8) other nonpolar residues including 
Tic, Oic, and Phe were in comparable proximity with no portion of the peptide less than 6 
A) B) 
Figure 4.7 A) Starting sodium (purple) and chlorine (green) atoms.  The sulfur atoms of SDS are 
noted with yellow spheres.  Peptide 23 is shown in blue.  B) The water box used in the periodic 
boundary simulation 
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angstroms away from the micelle surface.  
 
Examining the electrostatic surface potential charge distribution of both peptide 23 and 
the 62 SDS micelle relative to one another (Figure 4.9) demonstrates the complementary 
placement of charged groups resulting in a favorable initial interaction profile.  The highly 
electronegative micelle surface offers a powerful electrostatic pull relative to the electropositive 
peptide 23.  The net charge associated with peptide 23 is +6.  The charge difference between the 
micelle and peptide 23 provides a powerful attractive force between them enabling the atomic 
interactions to be examined. The termini which would be in the ionized form at physiological pH 
has been artificially neutralized using an acetyl and methyl amine capping and neutralizing the N 
and C termini respectively.    
The conclusion of the MD simulation produced the structures in Figure 4.10.  Peptide 23 
is shown with the N terminus interacting with the micelle likely through formation of 
Figure 4.8 The sulfur atoms of SDS are noted with yellow spheres.  Peptide 23 is shown in blue 
Distances noted. 
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intermolecular backbone hydrogen bonds between the peptide and sulfate oxygen atoms of the 
micelle.  Four lysine residues at the C-terminus of peptide 23 are also interacting through a salt 
bridge interaction with the micelle.  The shape of the micelle has departed from typically 
illustrated sphere.  The polar head groups of the SDS molecules have been pushed away from the 
area of the micelle that the peptide is interacting with creating a trough in which the peptide 
resides.   
  Despite the prevalence of aliphatic carbon atoms of the SDS molecules exposed to the 
surface most of the aromatic rings of the peptide are found away from the SDS tails (Figure 4.10 
B).  The presence of the peptide on the micelle surface appears to disrupt the aggregation of the 
polar head groups (Figure 4.11).  The SDS head groups would be expected to aggregate together 
A) B) 
Figure 4.9 Electro positive surfaces of peptide 23 are shaded blue while electronegative surfaces are 
noted in red.   The oxygen and sulfur atoms of SDS are noted with teal and yellow spheres 
respectively.   
A) B) 
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with the hydrophobic tails more tightly clustered in the center of the sphere enabling the aliphatic 
tails to be protected from the surrounding solvent. 
 Determining an endpoint for a MD simulation can be challenging and is influenced by 
numerous external factors.  The most influential variable in this study has been the 
computational resources available.  MD simulations with model bilayers significantly increase 
the number of atoms involved in the experiment.  Any increase in the number of atoms will 
significantly increase the number of calculations required at each step of the simulation.  The 
increase in the number of calculations needs to be met with a corresponding increase in 
computing power in order to maintain the rate of data collection.  The lack of a large computer 
cluster with good communication (threading) between the nodes of each processor have limited 
the rate at which these experiments have progressed.   
Figure 4.10 A.  Final structure of 62 SDS molecules micelle with Peptide 23.  B.  The top down 
perspective of peptide 23 with the 62 SDS micelle. 
A) B) 
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Another consideration frequently employed in the analysis of MD simulations of peptide 
systems is the deviation which has occurred from a set point.  The Root Mean-Square deviation 
(RMSD) measures the differences between values in the predicted model, in this instance the 
unit would be angstroms.  The reference structure is the minimized system prior to the 
production run.  The RMSD plot for peptide 23 with the micelle can be found in Figure 4.12.   
  The production run consisted of  25 ns of constant volume dynamics.  Based on the 
RMSD plot (Figure 4.12) peptide 23 stabalized almost immediately.  The RMSD is measured as 
the deviation occuring from the minimized structure of the system.  The equilibrated state is 
evidenced by the average slope of the RMSD plots approaching 0, see Figure 4.12.  Stabilization 
of the system does not mean the system is static, lipids in the micelle are expected to have 
continual molecule movement.  The peptide achieves equilibration rather quickly, relative to the 
micelle.  Visualization of the trajectory shows that peptide approaching the micelle surface with 
the C terminus becoming locked into the micelle.  Hydrogen bonds are formed between the 
sulfonal oxygen and the amino groups of the lysine residues.  Formation of these interactions 
appears to prevent the peptide from undergoing large structural changes. 
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Figure 4.11 A & B End structure of 62 SDS molecules micelle with Peptide 23 
A) 
B) 
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4.3.2  PEPTIDE 36 WITH MICELLE 
Peptide 36 was simulated with a 62 SDS molecule micelle for 25 ns.  The same micelle 
as was used as the starting structure in the control micelle simulation was used as the starting 
structure for the peptide/micelle simulations.  An initial box was placed extending 5 angstroms 
from the surface of the micelle.  The box was solvated using the TIP3P water model.  Water 
molecules within 5 angstroms of a sulfur atom were selected, while remaining water molecules 
were removed.  The Multiscale Modeling Tools for Structural Biology (MMTSB)
14
 software was 
utilized to randomly replace the water molecules with 62 sodium atoms to neutralize the surface 
charge of the micelle, remaining water molecules were removed.  The coordinates were returned 
to tLeAP and a water box extending 18 angstroms from the micelle surface was added.  The 
Figure 4.12 RMSD plot for Peptide 23 with the 62 SDS molecule micelle 
R
M
S
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 ionic concentration of sodium and chlorine atoms was adjusted to 0.15 mM NaCl through 
random replacement of water molecules using MMTSB14 software (Figure 4.13).  Remaining 
water molecules were once again removed prior to adding the previous water box, extending 18 
angstroms from the micelle surface (Figure 4.13).  The starting position of peptide relative to the 
surface was previously investigated using simulations with each of four “faces” of the peptide 
orientated toward the micelle surface (data not shown).  While one of the cationic lysine residues 
was placed relatively close to the micelle surface (Figure 4.14) other nonpolar residues including 
Tic, Oic, and Phe were in comparable proximity with no portion of the peptide less than 6 
angstroms away from the micelle surface.  
Figure 4.13 Electro positive surfaces are shaded blue while electronegative surfaces are noted in red.   
The oxygen and sulfur atoms of SDS are noted with red and yellow spheres respectively.  The z 
direction is also 69 angstroms in length. 
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The electrostatic surface potential was calculated for peptide 36 and the micelle.  The 
charge of peptide 36 is +6 with Gly substituted for β-Ala (Figure 4.15).  Electronegative regions 
Figure 4.14 The sulfur atoms of SDS are noted with yellow spheres.  Peptide 36 is shown in blue 
Distances noted  
Figure 4.15  Electropositive surfaces of peptide 36 are shaded blue while electronegative surfaces are 
noted in red.   The oxygen and sulfur atoms of SDS are noted with red and yellow spheres 
respectively.   
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are shown in red and electropositive regions are shown in blue.    
The RMSD was calculated for the peptide and the micelle relative to the minimized 
structure prior to the production run (Figure 4.17).    Both the peptide and the micelle stabilize 
within the 42 ns production run.  The RMSD plot of peptide 36 in Figure 4.17 shows a slight 
deviation occurring around 30 ns into the simulation.  The structure of peptide 36 after 15 ns is 
shown if Figure 4.18.  The two termini are noted with yellow arrows.  The peptide has adopted a 
“u” shape with the two termini 8.3 angstroms apart. 
Comparing the structure of the peptide after the change at 30 ns (Figure 4.19) to the 15 ns 
structure (Figure 4.18) shows subtle movement of the termini away from one another.  Peptide 
36 was simulated with the 62 SDS molecule micelle until a 42 ns trajectory had been attained. 
The micelle is perturbed (Figure 4.19) from the starting structure (Figure 4.14).   
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Figure 4.16 RMSD plot for Peptide 36 with the 62 SDS molecule micelle    
 
Figure 4.17  Peptide 36 with the 62 SDS molecule micelle.  The N and C terminus are highlighted 
with yellow arrows.   
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Figure 4.18  Peptide 36 at the conclusion of the 42 ns production md simulation.  A.  peptide 36 is shown to be 
well embedded into the micelle surface relative to the sulfate head groups of the SDS.  B.  Peptide 36 is shown to 
have moved the polar head groups of the micelle enabling hydrophobic rings to be protected from the surrounding 
solvent.  
 A) 
B) 
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Figure 4.19  Peptide 36 at the conclusion of the 42 ns production md simulation.  A.  Peptide 36 
is shown to be well embedded into the micelle surface relative to the sulfate head groups of the 
SDS.  B.  Peptide 36 is shown to have moved the polar head groups of the micelle enabling 
hydrophobic rings to be protected from the surrounding solvent.  
A) 
B) 
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4.4  DISCUSSION 
Contrary to the idealized image expected for a micelle, with all the polar head groups 
exposed to the solvent surroundings and the hydrophobic, aliphatic tails all clustered safely 
beneath the solvent surface, a much more dynamic perspective is detected during experiments.  
The regions of exposed hydrophobic tails have been documented in the literature and supported 
with experimental data.21 
The smaller molecules forming a micelle in this case result in a smaller number of atoms 
which should correlate to a shorter simulation time.  The electrostatic model of a membrane 
formed by a micelle has limitations.  The smaller aggregation size results in a smaller radius and 
an increased curvature modeling the membrane surface.  A correlation between the spontaneous 
curvature of the electrostatic model and pore formation has been established.22  The small size 
also limits the number of peptides which can be expected to interact with a single micelle.  Due 
to the limited interaction possible between the peptide and the micelle the data does not directly 
correlate to in vitro experiments.  Formation of peptide aggregates22 which are requisite for 
bilayer disruption is not possible with such a small micelle.  The small size is reflected by the 
lack of micelle disruption observed in experimental studies.23  The micelle simulations have 
enabled the examination the surface interaction expected from the peptide suggesting appropriate 
peptide orientation for further study with larger model membrane systems. 
The Ramachandran plots in Figure 4.20 reflect the average phi and psi angles for each of 
the noted residues over the last 2 ns of the production simulation from the micelle simulations.  
Calculations were performed using the same set of computer scripts mentioned in Chapter 3 and 
included in Appendix B.  The preferred region for β-sheets is outlined in red while the allowed 
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region is outlined in green.  Here no distinction is made between parallel and antiparallel 
secondary structures; they both fall within the noted region.  The preferred region for right 
handed alpha helices is noted in magenta with the allowed region outlined in blue.  The region 
outlined in purple is associated with left handed alpha helices.  The region outlined in black has 
been noted to be a possible allowed region if a reduced radius hard sphere approach is utilized.24   
The unique conformations adopted by each of the peptides during the course of the 
production run would suggest very different secondary structures.  The averaged Ramachandran 
plots for the two peptides provide a different perspective.  Peptide 23 has 8-9 residues found in 
the β-sheet preferred region and 6 residues in the right handed α-helical preferred region.  The 
majority of the residues found outside the preferred region are glycine residues.  Glycine 
residues due to their small size and lack of chirality have been found to adopt a diverse collection 
of angles.25  The distribution of the peptides between the β-sheet and right handed α helical 
regions is consistent with the NMR data for peptide 23.26 
Ramachandran plots were also created for Peptide 36; averaging the final 2 ns of the 
production run for each of the residues.  Peptide 36 includes the unnatural amino acid β-alanine 
which prohibits the angle measurements due to the beta carbon’s presence.  Angle measurements 
for β-alanine have been excluded from the analysis.  Eight residues were found in the β-sheet 
preferred region for peptide 36 with one lysine residue slightly falling outside of the allowed 
region.  One residue was found in the right handed alpha helical allowed region with four 
B 
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A) 
Figure 4.20  Ramachandran plots of the average residue angles from the last 2ns of the production 
run with the canonical ensemble.  A) Peptide 23 B) Peptide 36 
B) 
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residues very close to the right handed alpha helical allowed region.    
The area of the micelles at the conclusion of the simulation was compared to the starting 
structure.  Area and volume calculations were performed with the UCSF Chimera package.  
Chimera is developed by the Resource for Biocomputing, Visualization, and Informatics at the 
University of California, San Francisco (supported by NIGMS 9P41GM103311).27  The starting 
micelle, at the end of the minimization, before peptides or the second solvent box and ions were 
added,  had a volume of 2.270 x 10
4 
Å
3
 and an area of 8827 Å
2
.  The control micelle had a final 
volume of 2.250 x 10
4 
Å
3
 and an area of 8585
 
Å
2
 which suggests that while the volume stays 
relatively constant the surface area changes.  Variability in the area of a micelle is easily 
understood given the dynamic nature of this system and the speed which the individual SDS 
molecules move.  The micelle simulated with peptide 23 had a final volume of 2.101x10
4 
Å
3 
and 
an area of 1.031 x 10
4 
Å
2
.  The micelle simulated with peptide 36 had an area of 9910 Å
3
.  The 
micelle simulated with peptide 36 (Figure 4.16 A) was very deformed at the conclusion of the 
simulation inhibiting identification of a shape for which the volume could be calculated.  The 
software builds surfaces using the solvent-accessible surface area.  The addition of peptide to the 
micelle has the effect of increasing the area of the micelle. 
The following discussion has been submitted for publication.26  “Despite the lack of 
stabilization, animation of the trajectory has provided evidence of attraction between the SDS 
head groups and the Lys side chains of peptide 23.  At the conclusion of the simulation the N and 
C termini of compound 23 appear to bind to the polar surface of the micelle thus, allowing the 
positively charged Lys side chains to interact with the negatively polarized oxygen atoms of the 
SDS micelle.  This data is consistent with NMR data.26  The resulting binding orientation has 
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most of the aromatic and aliphatic rings of the peptide being exposed to solvent instead of being 
inserted into the hydrophobic core of the micelle.  The micelle has adopted a less ridged 
configuration which enables some of the hydrophobic tails to be exposed to the solvent surface.  
This structure, with the larger hydrodynamic radius, is consistent with the observed decrease in 
the diffusion coefficient of the micelle after binding with peptide 23.  The polar head groups 
which are able to form hydrogen bonds with the bulk solvent water have deformed from the 
cartoon spherical shape commonly associated with a micelle.  In vitro and in silico experiments 
support the dynamic nature of SDS micelles.  Note the increased density of SDS head groups in 
the region of the micelle binding with the positively charged regions of the peptide.  The side 
chains of the Lys residues of peptide 23 are embedded within the surface of the micelle (Figure 
4.21).  From this orientation it appears that the electrostatic interactions between the positively 
charged Lys side chains and the negative charged polar head group of the SDS micelle 
predominate during the binding process.  The location of the aromatic side chains suggests that 
hydrophobic interactions between the peptide and the hydrophobic core of the SDS micelle do 
not play a major role in defining the binding process.  This observation is consistent with the 
aromatic region of the 1D 
1
H spectrum of peptide 23 bound to SDS micelles which shows 
similarity to the 1D 
1
H spectrum of peptide 23 in the presence of buffer see Figure 4.21.  Clearly, 
there are differences between the two spectra suggesting some interaction between the aromatic 
protons of peptide 23 (specifically the Phe residue located at the N-terminus and the Tic residue 
located before the Lys chain at the C-terminus) with the surface or core of the SDS micelle, 
however this interaction is not as pronounced as that observed in the presence of DPC micelles.   
The NMR spectra for peptide 36 with the SDS micelles is shown in Figure 4.22.  The 
peptide is inserted into the hydrophobic core of the micelle with the hydrophobic residues of the 
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Figure 4.21  400 MHz 
1
H spectra of peptide 23 in top) 150 mM sodium acetate buffer, pH=4.28 in 
D2O, middle) 100 mM SDS micelle in 150 mM sodium acetate buffer, pH=4.28 in D2O, bottom) 100 
mM DPC micelle in 150 mM sodium acetate buffer, pH=4.28 in D2O
26
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peptide predominately oriented toward the hydrophobic core of the micelle.  The interaction of 
the aromatic side chains of peptide 36 are clearly indicated by the changes in the 1D 
1
H spectrum 
see Figure 4.22.  
The results of the MD simulation shown in Figure 4.23 indicates that the N-terminal Phe 
residue (shown in cyan) and the Tic residue preceding the four C terminal Lys residues (shown 
in yellow) are located very close to both the polar head groups and the hydrophobic core of the 
micelle.” 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.22  400 MHz 
1
H spectra of peptide 36 in top) 100 mM SDS micelle in 150 mM sodium 
acetate buffer, pH=4.28 in D2O, bottom) 100 mM DPC micelle in 150 mM sodium acetate buffer, 
pH=4.28 in D2O
26
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4.5  CONCLUSION 
The experimentally derived CD spectroscopy suggests that the peptides adopt a 
predominately alpha helical structure resulting from binding to SDS micelles.  The differences 
observed during the course of the MD simulations reflect the differing secondary structures 
observed between peptide 23 and peptide 36.  Experimental data supports a different secondary 
structure when the same peptides are in the presence of a DPC micelle (zwitterionic) rather than 
the anionic SDS micelle.  The resulting secondary structure in the presence of the zwitterionic 
membrane model suggests a mixture of both α-helical and beta-turn or sheet like structures being 
adopted.  The Ramachandran plot derived from the average phi and psi angles, over the last 2 ns 
of the production run of peptide 23 and 36 provide support for the secondary structures with both 
Figure 4.23  The results of the MD simulation for compound 23 indicates that the N-terminal Phe 
residue (shown in cyan) and the Tic residue preceding the four C-terminal Lys residues (shown in 
yellow) are located very close to both the polar head groups and the hydrophobic core of the micelle.
26
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alpha helical and beta sheet/turn character as was suggested by the experimental NMR data.
26
  
The terminal structure resulting from the MD simulation peptide 23 adopts a structure which is a 
mixture of α-helical and β-turn/sheet characteristics.  The terminal structure from the MD 
simulation of peptide 36 reflects a more extended structure interacting with the SDS micelle. 
MD simulation data and experimental CD, DOSY NMR, and 
1
H NMR is reflective of 
very different interactions (between the two peptides) with the SDS micelle.  The electrostatic 
surface potential maps suggest this interaction is prominent in the binding mechanism of peptide 
23 with the SDS micelle.  Hydrophobic interactions provide a minor contribution to this 
interaction.  In the simulation with peptide 23 many hydrophobic residues (excluding a 
phenylalanine and a TIC residue) are exposed to the surrounding solvent. 
4.6  FURTHER RESEARCH 
The in silico investigation into the AMP/micelle interactions can be continued to further 
understand the first step in peptide-lipid binding prefacing membrane disruption.  Study of 
AMPs can be extended by including a mammalian micelle model using dodecylphosphocholine 
(DPC) as a zwitterionic mammalian membrane model (Figure 4.24).  DPC micelles with AMPs 
have demonstrated unique experimental structural differences using CD spectroscopy as well as 
DOSY NMR experiments.26  Observing the atomic level interactions and comparing AMP 
interactions with both SDS and DPC micelles can provide a more complete perspective of the 
initial steps involved in membrane disruption. 
 
Figure 4.24  Structure of zwitterionic dodecylphosphocholine, DPC. 
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ABSTRACT 
A collection of molecular dynamics (MD) simulations were undertaken to study the 
behavior of unnatural amino acid containing antimicrobial peptides (AMPs) AMBER9 was used 
to simulate two model bilayers.  The first were mixed bilayers with a 4:1 ratio of POPC:POPG 
creating an anionic membrane.  The second was a confluent bilayer comprised of the zwitterionic 
POPC lipid.  Peptide 23 which has a glycine residue linking the Tic Oic dipeptide units was 
added to each membrane environment.  Over the course of the simulations membrane thinning 
was observed in the mixed bilayer in the presence of peptide 23.  Thinning was not observed in 
the simulation of peptide 23 with the control bilayer.  Control simulations of each bilayer without 
peptides maintained the membrane thickness throughout the course of the simulation.  The 
control simulations lend support to the selective membrane disruptive capabilities of peptide 23 
in the presence of a mixed bilayer. 
5.1  INTRODUCTION 
The mechanism of membrane disruption for naturally occurring AMPs has been debated 
within the literature for over two decades.1-6  The atomic events prefacing the disruption of the 
bilayers are poorly understood.  The inclusion of unnatural amino acids increases the confusion 
with regard to how the membranes are disrupted due to the lack of accurate secondary structure 
information.   Simulation of the AMPs seeks to understand the mechanism through which 
membranes become compromised.  Other groups have used MD simulations to study the 
interaction of AMPs, which include unnatural amino acids with membranes7 
Several online portals8-10 are available to generate bilayers for use with other software 
programs, primarily the CHARMM (Chemistry at HARvard Macromolecular Mechanics)11,12 and 
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GROMACS (GROningen MAchine for Chemical Simulations).12,13  The large number of atoms 
composing bilayers requires substantial computational resources to simulate.   The computational 
expense has necessitated the development of techniques to improve the efficiency of the 
simulation.  Merging the hydrogen atoms bound to heavy atoms decreases the number of atoms 
which need to be considered and thus speeds up the simulation.  Another technique used to speed 
the dynamics of a simulation is through the use of a coarse grain (CG) model.  The CG model 
creates molecule “sites” for groups of atoms such as amino acids decreases the number of “atom 
sites” which need to be considered at each step of the simulation.14   
Many of the published bilayer studies have started with the well cited bilayer constructed 
and simulated by the Tieleman group in Canada.12,15  AMBER916 does not have the force field 
parameters for lipids which have been included in some of the later releases of the AMBER 
program such as the recently released AMBER12.17 
In order to model in vitro data, simulated membrane systems have been constructed.  A 
confluent POPC bilayer represents the eukaryotic cells while a mixed bilayer of POPC and 
POPG in a 4:1 ratio represents the electrostatic characteristics of prokaryotic cells.   
Construction of each bilayer was conducted using Insight II18 and pymol.19    Within a 10 
X 10 lipid unit membrane leaflet each lipid was placed 9.0 angstroms apart from neighboring 
lipids with a final composition of 200 lipid units (180 POPC:20 POPG).  Anionic lipids were 
distributed within the bilayer as shown in Figure 5.1 where the • represents the zwitterionic 
POPC lipids and the circle with the x represents the anionic POPG lipids.  The second leaflet was 
formed by copying the original leaflet and then rotating and translating to create a mirror image 
which completed the bilayer (considering boundary conditions). Counter ions were added to 
neutralize the overall charge from the solute and attain the desired ionic concentration using the 
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MMTSB’s20 software in the Cygwin environment.21 
 
5.2  MOLECULAR DYNAMICS SIMULATIONS OF AMPS IN 
MEMBRANE ENVIRONMENTS 
Insight into the mechanism of AMP membrane disruption has been acquired from MD 
simulation using AMBER9.16  Peptides 23 and 36 have been added to each bilayer system for 
simulation.  While the exact number of AMPs involved in pore formation is unknown; previous 
experiments have suggested that 5-9 peptides are required to aggregate prior to membrane 
insertion.22  In these simulations, a single peptide has been added to each bilayer to determine if 
simulations with peptides, which are partially composed of unnatural amino acids, are able to 
model the in vitro, in vivo, and spectroscopic activity observed in previous studies.23-31 
All systems were solvated using the TIP3P water model.  Point charges represent the 
electrostatic interactions.  Bilayers were solvated though the generation of a water box with a 
volume slightly smaller than the volume between the two leaflets.  This approach ensured water 
Figure 5.1 Lipid distribution where • represents POPC and the circle with the x represents POPG  
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molecules were only added to the hydrophilic region while maintaining the hydrophobic regions 
of the bilayers. 
Simulations utilizing the canonical ensemble with anisotropic pressure and Andersen 
temperature coupling protocols have been employed.32  The system have been minimized for 
1000 steps of steepest descent before heating to 310 K over 20 ps and being subjected to an 
additional ns of constant pressure (isothermal-isobaric) MD.  There is a critical point which 
exists for lipids between room temperature, 300 K and physiologically relevant temperature, 310 
K.  The result is that the comparison of MD simulations needs to be compared to experimental 
data collected under similar environmental conditions. 
Long-range electrostatics have been calculated using the particle mesh Ewald (PME) 
method as recommended for membrane simulations, specifically those involving charged 
lipids.33  The non-bonded cutoff has been set at 10 angstroms.  FF parameters for each molecule 
in the system are outlined in Chapter 2.  Once density stabilization had occurred the production 
run was started with the canonical ensemble.  The simulations have been continued to the longest 
trajectory feasible given the computational resources.  All MD simulations and analyses have 
been performed using AMBER9 unless otherwise noted. 16     
The formation of hydrogen bonds is an important intermolecular interaction which is 
suspected to play an important role in AMP/bilayer interactions. In Figure 5.2 a three site 
hydrogen bond system is outlined where D, represents the hydrogen bond donor and, A, 
represents the hydrogen bond acceptor. Hydrogen bonds were considered to be present when the  
Ha distance was 2.5 angstroms or less, the distance between the DA atoms was 3.5 angstroms or 
less and the D-H-A angle was 120° or greater or 90° or greater depending on the residue as 
outlined in Figure 5.2. 
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5.3  SURFACE AREA OF THE BILAYER AND LIPID DENSITY 
 
The literature values for the lipid area have a fair amount of variability, up to 25%.34  The 
average area per lipid for POPC was 63.5 ± 0.3 angstroms squared.  The average surface area per 
lipid or lipid density is often used as a measure of the force field’s ability to model a system.   
Depending on the ensemble employed during the production phase of the MD simulation the 
variability of the surface area is a good metric to judge the correlation to real world systems.  
The consensus is that the use of the MD_NPT, isothermal-isobaric ensemble is most appropriate 
because it will allow the bilayer to expand and contract as the simulation progresses.  The 
limiting factor is that the forces can become too great making the lipid density too high and the 
average surface area per lipid too low.  This has been negated by many through the use of a 
surface area restraint which forces a constant surface area throughout the course of the 
simulation. 
Figure 5.2 Criteria for hydrogen bond formation 
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5.4  MIXED BILAYER 10 X 10 LIPIDS 
A control mixed bilayer simulation was conducted as a reference for additional 
simulations.  Figure 5.3 shows the starting simulation orientations for the control mixed bilayer 
simulation.  Sodium ions are shown as purple spheres and chlorine ions are shown as the green 
spheres.  Lipids in the mixed bilayer were separated 9 angstroms from one another.  The lipid 
leaflets were placed 89.4 angstroms apart with X and Z dimensions creating a plane which 
measures 81 angstroms x 81 angstroms.  The distance between the lipid leaflets was selected to 
be far enough apart that the peptide (even if it were to be fully extended, which has a length of 
approximately 35 angstroms, would not ‘see’ the other leaflet enabling the periodic conditions to 
be effectively replicated.  Each leaflet was constructed with 10 lipids used in each dimension.  
The periodic boundary box had dimensions of 90, 136, 90 angstroms for the X, Y, and Z 
dimensions respectively.  The increased size  of the X and Z dimensions of the periodic 
boundary are to prevent overlap with the atoms in the adjoining periodic boxes.   The smaller 
distance in the Y direction was to encourage the intermingling of the aliphatic carbon tails of the 
lipid molecules.   
 RMSD was used as an indicator of simulation completion.  The RMSD is a measure of 
the deviation of the atomic coordinates relative to the minimized structure of the system.  The 
RMSD plot shown in Figure 5.4 was created 20 ns into the simulation.   
Animation of the trajectory did not identify any large changes throughout the course of 
the simulation.  The re-imaged bilayer created at 20 ns into the simulation is shown in Figure 5.5 
which shows the lipids intermingling of the aliphatic lipid tails.  The thickness of the bilayer, the 
distance from the phosphate atom of the top leaflet to the phosphate of the bottom leaflet, is 
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virtually unchanged throughout the course of the simulation. Figure 5.6 shows the anionic lipid 
distribution from the top of the bilayer looking down the y axis shown the plane created with the 
x and z axes.  The anionic lipids are shown with the purple surface and the zwitterionic lipid 
POPC is shown with a black surface.   
  
 
1
6
6
 
 
Figure 5.3 A) Water Box added to the control mixed bilayer simulations and periodic boundary box  B) Control mixed bilayer at start of 
simulation  
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Figure 5.4 RMSD plot of the control mixed 10 x 10 bilayer at the end of 20 ns of MD simulation 
relative to the minimized bilayer structure.  
Figure 5.5 Re-imaged control mixed 10 x 10 lipid bilayer at the end of 20 ns of MD simulation 
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5.5  CONTROL BILAYER 10 X 10 LIPIDS NO PEPTIDE 
A control confluent bilayer simulation was conducted as reference for additional 
simulations.  Figure 5.7 reflects the starting orientation of the control confluent bilayer 
simulation.  Sodium ions are shown as purple spheres and chlorine ions are shown as the green 
spheres.  Lipids in the mixed bilayer were separated by an average 8.7 angstroms from one 
another.  The lipid leaflets were placed 68 angstroms apart with X and Z dimensions having 78 
angstroms each.  The distance between the lipid leaflets was selected to be far enough apart that 
the peptide (even if it were to be fully extended, which has a length of approximately 35 
angstroms, would not ‘see’ the other leaflet enabling the periodic conditions to be effectively 
replicated.  10 lipids were used in each dimension.  The periodic boundary box had dimensions 
of 90, 126, 90 angstroms for the X, Y, and Z dimensions respectively.  The increased size of the 
Figure 5.6 Control mixed 10 x 10 bilayer showing the x and z plane POPG lipid surfaces are shown in 
purple and POPC lipid surfaces are shown in black  
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X and Z dimensions of the bilayer surface of the periodic boundary are to prevent overlap with 
the atoms in the adjoining periodic boxes.  The thickness of the bilayer, the distance from the 
phosphate atom of the top leaflet to the phosphate of the bottom leaflet, is virtually unchanged 
throughout the course of the simulation.  The smaller distance in the Y direction was to 
encourage the intermingling of the aliphatic carbon tails of the lipid molecules.   
 RMSD was used as an indicator of simulation completion.  The RMSD is a measure of 
the deviation of the atomic coordinates relative to the minimized structure of the system.  The 
RMSD plot shown in Figure 5.8 was created 15.8 ns into the simulation.  The slope of the line is 
approaching zero suggesting the system has stabilized relative to the minimized structure. 
Animation of the trajectory did not identify any large changes throughout the course of 
the simulation.  The re-imaged bilayer created at 15.8 ns into the simulation is shown in Figure 
5.9 which shows the intermingling of the aliphatic lipid tails.  Figure 5.9 B shows the bilayer 
surface.  Note the lack of bilayer thinning with the control bilayer.  The distance between the 
surfaces of the two leaflets was constant throughout the course of the simulation.  Zwitterionic 
lipid POPC is shown with a black surface. 
  
 
1
7
0
 
Figure 5.7 A) Water Box added to the control mixed bilayer simulations and periodic boundary box  B) Control mixed bilayer at start of 
simulation  
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MIXED BILAYER 10 X 10 LIPIDS WITH PEPTIDE 23 
 
 
The membrane thinning effects observed during the course of this simulation have also been  detected  in 
with the naturally occurring peptide, melittin with lipids using x-ray diffraction experiments.
35
 
  
Figure 5.8 RMSD of the control bilayer simulation, no peptide.   
Figure 5.9 A) Control bilayer at the end of 1.5 ns trajectory.  B) Control bilayer lipid solvent 
accessible surface at end of simulation without peptide 
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5.6  MIXED BILAYER 10 X 10 LIPIDS WITH PEPTIDE 23 
The first mixed bilayer simulation was conducted with peptide 23, which has glycine as 
the linker between the Tic Oic dipeptide units.  Figure 5.10 A and B shows the starting 
simulation orientations for the mixed bilayer simulation with peptide 23.  Sodium ions are shown 
as purple spheres and chlorine ions are shown as the green spheres.  Lipids in the mixed bilayer 
were separated 9 angstroms from one another.  Anionic POPG lipids are shown with the carbon 
atoms colored purple while the zwitterionic lipids are shown with the carbon atoms colored 
black.  The lipid leaflets were placed 78 angstroms apart with X and Z dimensions having 81 
angstroms each.  10 lipids were used in each dimension.  The water box added was slightly 
smaller to fill the space between the polar head groups of the lipids and measured 75 by 75 by 78 
angstroms cubed.  The periodic boundary box had dimensions of 90, 136, 90 angstroms for the 
X, Y, and Z dimensions respectively.  The increased size of the X and Z dimensions of the 
periodic boundary are to prevent overlap with the atoms in the adjoining periodic boxes.  The 
smaller distance in the Y direction was to encourage the intermingling of the aliphatic carbon 
tails of the lipid molecules.  Placement of peptide 23 relative to the bilayer surface is shown in 
Figure 5.10 C.  The peptide was placed in close proximity to the polar head groups of the bilayer 
yet far enough away to allow the water molecules to move in around the peptide between the 
peptide and the bilayer surface. 
 RMSD was used as an indicator of simulation completion.  The RMSD is a measure of 
the deviation of the atomic coordinates relative to the minimized structure of the system.  The 
RMSD plot shown in Figure 5.11 was created with the last 14 ns of a 241.5 ns trajectory.  The 
RMSD for peptide 23 is shown in yellow while the bilayer is shown in purple.  Peptide 23 
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Figure 5.10 A) Water Box added to mixed 
bilayer simulations and periodic boundary 
box B) Mixed Bilayer at start of Simulation 
C) Distance and orientation of peptide 23 
relative to the mixed bilayer surface 
B A 
C 
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stabilized early in the trajectory, within the first 50 ns (data not shown). The mixed bilayer has 
not stabilized during the 241.5 ns trajectory.  The large deviation observed near 234 ns mark of 
the simulation was determined to be an artifact of the re-imaging process which places a 
specified set of atoms at the center of the periodic box and adjusts the other molecules in relation 
to the specified atoms.        
Animation of the trajectory reflected a very dynamic movement in the C terminal end of 
peptide 23 while the N terminal lysine residues appear to form interactions, probably hydrogen 
bonds, with the lipid head groups.  Figure 5.12 shows the anionic lipids, POPG shown in purple 
and zwitterionic lipids POPC are shown in green.  Figure 5.12 A shows the orientation of peptide 
A 
Figure 5.11 RMSD for the mixed bilayer with peptide 23 
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Figure 5.12 A) Mixed bilayer simulation with peptide 23 at start of production run B) Orientation of 
peptide 23 relative to bilayer at end of 241.5 ns of simulation 
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23 at the beginning of the production run; the starting distance between the phosphate atoms 
averages 39.73 angstroms.  Figure 5.12 B shows the bilayer at the end of 241.5 ns of constant 
volume dynamics.   A clear thinning of the bilayer is observed while the lipids farthest from the 
peptide have moved further apart.  The thinning of the bilayer is reflects the powerful impact of 
peptide 23 on the bilayer.  The time scale achieved during the course of this simulation is less 
than that required for membrane disruption which has been calculated to fall between 
milliseconds and seconds.
36
  The other limitation of this simulation is the single peptide used.  
AMPs are known to require a critical concentration of peptide relative to the number of lipid 
molecules present.  Aggregation of the lipids is required before membrane disruption thus 
complete membrane disruption is not expected.   
Another interesting development over the course of the simulation is the lipid distribution 
with the bilayer surface.  The simulation started with the POPG lipids evenly distributed 
throughout the bilayer relative to the location of the POPC lipids. Figure 5.13 A shows the 
distribution of the lipid types by showing the location of the phosphate atoms for each lipid.  The 
POPC lipids are shown with orange spheres and the POPG lipids are shown with green spheres.  
Note the regions decreased lipid density, outlined in red.  The location of the peptide is found in 
a region of low lipid density and more specifically mostly zwitterionic lipids.  There are only two 
POPG lipids interacting with peptide 23, noted with yellow arrows in Figure 5.13 B.  The highly 
polar C terminus of peptide 23 with the 4 lysine residues in sequence seems the obvious choice 
for interaction with the anionic lipids.   
Examining the lipid distribution using the solvent accessible provides an explicit 
comparison of the starting position of the anionic lipids relative to the zwitterionic lipids at the 
C 
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Figure 5.13 A) Distribution of anionic, POPG (Green) and zwitterionic, POPC lipids (orange).  The red region highlights the area of low 
lipid density  B) Position of peptide 23 relative to the anionic lipids of the mixed bilayer.  The two POPG lipids interacting with peptide 23 
are noted with yellow arrows. 
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start of the production run, Figure 5.14  A provides a good reference point for comparison at the 
241.5 ns mark of the simulation, Figure 5.14 B.   
 The location of the peptide relative to the anionic lipids is relevant due to the mosaic 
associated with microbial membranes.  The aggregation of minority lipids, POPG within the 
membrane surface correlates to the observed variation in the membrane charge distribution.   The 
anionic lipid distribution at the conclusion of 241.5 ns is shown in Figure 5.14.   
 Figure 5.15 shows the Ramachandran plot for each residue from peptide 23 averaged 
over the last 2 ns of the production simulation.  The glycine residues fall outside of the “allowed 
region” of the plot however; the small size and lack of chirality associated with the residue have 
been observed experimentally.
37
  The residues cluster in the alpha helical region of the plot with 
Figure 5.14 A) Surface of lipids at start of production run B) Distribution of the lipid surfaces 241.5 
ns into the production simulation.  Anionic POPG lipids are shown in purple, zwitterionic POPC lipids 
are shown in green.  Peptide 23 is shown with blue carbon atoms. 
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the exception of the Tic residues which are consistently in the beta sheet region of the plot.  The 
preference for Tic has been previously observed during the course of the simulations (see 
Chapter 3).   
 The lipid distribution at the conclusion of the MD simulation relative to peptide 23 
suggests the peptide is able to influence the lipid distribution within the membrane.  The two 
POPG lipids close enough for interaction with the peptide are likely interacting through 
hydrogen bonds.  The first POPG is interacting with the side chain of a lysine residue and the 
other interaction is with a central lysine residue (see Figure 5.16).  The lipid distribution effects 
Figure 5.15  Ramachandran plot for peptide 23 in the presence of a mixed bilayer. 
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extend beyond the closest leaflet of the bilayer.  The bottom leaflet, furthest away from the 
peptide shows a similar lipid distribution relative to the peptide’s position (data now shown).   
 A closer look at peptide 23 relative to the bilayer surface is shown in Figure 5.16.  
Hydrophobic residues, Phe, Tic, and Oic are noted with grey carbon atoms while the cationic Lys 
residues are shown with yellow carbon atoms.  The portions of the peptide interacting with 
anionic POPG lipids are pointed out with cyan arrows.  The polar interactions appear to have 
held the peptide in close proximity to the bilayer surface enabling the hydrophobic rings of the 
terminal Phe, Tic, and Oic to move down into the hydrophobic region of the bilayer, see Figure 
5.17.
Figure 5.16 Surface of the mixed bilayer with peptide 23.   The two points of the peptide interacting 
with anionic lipids are pointed out with cyan arrows.  Hydrophobic residues are shown in grey while 
the polar lysine residues are shown in yellow. 
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5.7  CONTROL BILAYER 10 X 10 LIPIDS WITH PEPTIDE 23 
The control bilayer simulation conducted with peptide 23 was conducted for comparison 
to control bilayer and the experimentally derived liposome data.
38
  Figure 5.18 A and B shows 
the starting simulation orientations for the control bilayer simulation with peptide 23.  Sodium 
ions are shown as purple spheres and chlorine ions are shown as the green spheres.  Lipids in the 
control bilayer were separated 9 angstroms from one another.  Zwitterionic lipids are shown with 
the carbon atoms shaded black.  The lipid leaflets were placed 78 angstroms apart with X and Z 
dimensions having 81 angstroms each.  10 lipids were used in each dimension.  The water box 
added was slightly smaller to fill the space between the polar head groups of the lipids and 
measured 68 by 68 by 78 angstroms cubed. The periodic boundary box had dimensions of 90, 
126, 90 angstroms for the X, Y, and Z dimensions respectively.  The increased size of the X and 
Z dimensions of the periodic boundary are to prevent overlap with the atoms in the adjoining 
periodic boxes.  The smaller distance in the Y direction was to encourage the intermingling of 
Figure 5.17 Surface of the mixed bilayer with peptide 23.  Hydrophobic residues are shown in grey 
while the polar lysine residues are shown in yellow. 
 182 
 
the aliphatic carbon tails of the lipid molecules.  Placement of peptide 23 relative to the bilayer 
surface is shown in Figure 5.18 C.  The peptide was placed in close proximity to the zwitterionic 
head groups of the bilayer yet far enough away to allow the water molecules to move in around 
the peptide between the peptide and the bilayer surface. 
RMSD was used as an indicator of simulation completion.  The RMSD plot shown in 
Figure 5.19 was created with the last 20 ns of a 150 ns trajectory.  The RMSD for peptide 23 is 
shown in yellow while the bilayer is shown in purple.  The simulation was not continued due to 
the stabilization of both the peptide and the bilayer as calculated by an average slope near 0.  
Once the system has stabilized perturbation is unlikely within the timescale available. 
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Figure 5.18 A) Water Box added to control 
bilayer simulations and periodic boundary 
box B) Control bilayer at start of simulation 
C) Distance and orientation of peptide 23 
relative to the control bilayer surface 
A B 
C 
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Figure 5.20 A shows the orientation of peptide 23 at the beginning of the production run; 
the starting distance between the phosphate atoms was approximately 41 angstroms.  Figure 5.20 
B shows the bilayer at the end of 150 ns of constant volume dynamics.   The distance between 
bilayer thickness at the beginning of the simulation and the end is relatively unchanged, around 
40 angstroms, given the expected dynamic nature of the bilayer.  The control bilayer does not  
Figure 5.19 RMSD of the confluent POPC bilayer with peptide 23 
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Figure 5.20 A) Control bilayer with peptide 23 at start of the production simulation B) Control bilayer 
after 150 ns of constant volume dynamics.  POPC is shown with green carbon atoms peptide 23 is 
shown with blue carbon atoms. 
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display any evidence of membrane thinning as observed in the simulation with the mixed bilayer 
and peptide 23.  Given the peptide’s interaction with the bilayer surface this is an interesting 
development (Figure 5.20 B).  It is interesting to note the peptide’s proximity to the lipids and 
even its ability to form hydrogen bonds with the choline head groups of POPC and the phosphate 
ester oxygen atoms (Figure 5.21) and yet, the lack of membrane thinning suggests a less 
disruptive interaction.  The hydrophobic rings of the Phe, Tic, and Oic residues are shown with 
grey carbon atoms and the Lys residues are shown with yellow carbon atoms in Figure 5.21.  The 
simulation started with the POPG lipids evenly distributed throughout the bilayer relative to the 
location of the POPC lipids.  
Figure 5.22 shows the confluent POPC bilayer surface at the end of 150 ns of MD 
simulation.  All but one of the lysine residues appears to be interacting with the polar head 
groups of the zwitterionic lipids.  The peptide seems to be rather extended with regard to 
secondary structure.  Magainin which was the electrostatic model for the AMPs with unnatural 
Figure  5.21 Peptide 23 with a confluent POPC bilayer.  Hydrophobic rings are noted with grey carbon 
atoms and Lys residues are shown with yellow carbon atoms. 
C 
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amino acids incorporated into the peptide sequence.  Magainin is noted to adopt an amphipathic 
secondary structure with polar residues aligning themselves along one side of the alpha helical 
secondary structure and hydrophobic residues on the opposing side.  It is interesting to note that 
three of the four Tic residues have aligned themselves toward the bilayer surface.  The steric 
hindrance of the Tic Oic dipeptide discourages both residues from orienting toward the bilayer 
surface. 
 The speed with which the bilayer stabilized relative to time required for the bilayer with 
peptide 23 further suggests the disruptive influence of the peptide on the bilayer surface.  This is 
consistent with the experimentally derived data.  Peptide 23 has been observed to disrupt POPC 
Figure 5.22 Peptide 23 with a confluent POPC bilayer surface displayed peptide 23 is shown with 
green carbon atoms and the POPC lipids are shown with black carbon atoms. Tic residues are 
identified with cyan arrows. 
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bilayers in a concentration dependent manner.    
 The Ramachandran plot shown in Figure 5.23 reflects the average phi & psi angles for 
peptide 23 over the last 2 ns of the production simulation with the control bilayer.  Each residue 
was averaged over the trajectory.  The glycine residues once again fall outside the “allowed 
regions” as identified by Ramachandran however, there is x-ray structural data to support the 
small achiral glycine residue being able to inhabit a larger region of the plot than other 
residues.
37
  The Tic residues are positioned in the beta sheet region which is consistent with both 
the tripeptide simulations (Chapter 3) and the angles observed with peptide 23 in the presence of 
the mixed bilayer (Figure 5.15). 
Figure 5.23 Ramachandran plot for peptide 23 in the presence of a control bilayer. 
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5.8  SUMMARY 
 MD simulations of mixed bilayers composed of a 4:1 ratio of POPC to POPG have been 
conducted in the presence of peptide 23 which has a glycine residue linking the Tic Oic 
dipeptides.  Control simulations without peptides present were also conducted for reference and 
to ensure observed bilayer perturbations were a result of the peptides presence and not an artifact 
of the simulation.   
 The mixed bilayer in the presence of peptide 23 showed a membrane thinning effect after 
a 250 ns production simulation during which the RMSD of the bilayer did not stabilize but the 
peptide did relative to the start of the production simulation.  When peptide 23 was simulated 
with the control, confluent POPC bilayer there were intermolecular interactions occurring 
however no membrane thinning was observed during the 150 ns trajectory during which the 
RMSD stabilized.   
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Force field (FF) parameters have been developed for numerous unnatural amino acids 
including β-alanine, gamma aminobutyric acid, 6-aminohexanoic acid, tetrahydroisoquinoline 
carboxylic acid, with the octahydroindole carboxylic acid, ornithine , diaminobutanoic acid , 
diaminopropanoic acid ,  aminocyclohexanoic acid, aminocyclopentanoic acid, p-Cl 
phenylalanine, and p-F phenylalanine.  In addition, a density functional approach (DFT) 
approach was used to create FF parameters for three model lipid molecules: sodium dodecyl 
sulfate (SDS), 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC), and 1-palmitoyl-2-
oleoyl-sn-glycero-3-[phosphor-rac-(1-glycerol)] (sodium salt).   
The structural features of the unnatural amino acids have been investigated using capped 
tri-peptides, Ala-X-Ala, where the X is the unnatural amino acid.  The application is supported 
by the consistency with the simulation data resulting from the 20 naturally occurring amino acids 
which were also simulated.1  Ramachandran plots have provided support for the mixed 
secondary structure observed in experimental CD studies.  The electrostatic surface potential 
maps, which distribute the calculated charges from the previously determined FF parameters 
across the solvent accessible surface of each residue, shows the change in charge distribution 
(Chapter 2).  Comparison of some the unnatural amino acids to the most structurally similar 
standard residues reflects the changes which result from inclusion of the unnatural amino acids in 
a peptide sequence.  The structural information is meant to provide a “toolbox” for the medicinal 
chemist as they design AMPs with an emphasis on tailoring the peptide sequence, and charge 
distribution to the desired target membrane.  
AMPs which include the unnatural amino acids have been simulated in three model 
membrane environments.  The first was the smaller anionic SDS micelle which was able to 
electrostatically model microbial membrane surfaces.  The second model membrane was created 
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using only the zwitterionic lipid POPC.  The neutral overall charge resulting from a bilayer 
composed solely of POPC models the electrostatic charge distribution associated with 
mammalian cell surfaces.  The final model membrane was composed of a 4:1 ratio of 
POPC/POPG which represents the net anionic surface associated with many bacterial species’ 
membranes. 
AMPs electrostatically model the parent peptide, the naturally occurring AMP magainin 
2.2- 4   These peptides were developed based on structural features associated with 
pharmacological activity for select bacterial membranes.  The activity of a particular AMP can 
be tailored to specific species based upon the lipid composition of the target membrane surface.     
Two of the peptides have been studied using molecular dynamics (MD) simulations in 
model membrane environments.  The first model was comprised of 62 SDS molecules.  The 
micelle provided the necessary electrostatic charge requisite for AMP secondary structure to 
develop.  Peptide 23 was the first peptide studied as a reference for the impact of increasing the 
number of carbon atoms in the peptide backbone.  Peptide 23 links the bicyclic Tic Oic 
dipeptides with the standard amino acid glycine.  The small size associated with the Gly residue 
enables increased flexibility relative to the other chiral standard amino acids.  The mixed, alpha 
helical and beta turn/sheet character observed in CD studies is supported by the Ramachandran 
plot resulting from the average phi and psi angles over the last 3 ns of the MD simulation (Figure 
4.20 A).5 
The second peptide investigated with the micelle membrane model was peptide 36 which 
links the bicyclic Tic Oic dipeptides with the nonstandard amino acid β-alanine.  Increasing the 
number of carbon atoms in the peptide backbone increases the flexibility of the peptide enabling 
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unique secondary structures to develop.  The increase in backbone carbons caused the peptide to 
interact with micelle in a structurally unique way as compared to the interaction occurring with 
peptide 23 and the micelle.  The presence of a beta carbon in the peptide backbone prohibited the 
calculation of the Ramachandran phi/psi distribution for the beta-alanine residues however the 
remaining peptides reflect the mixed alpha helical and beta turn/sheet character which is 
consistent with the CD data (Figure 4.20 B).       
The second set of bilayer model membranes were simulated in an environment which 
was designed to be consistent with the in vitro data which demonstrated the pharmacologic 
activity of the unnatural amino acid containing AMPs.   
MD simulations of mixed bilayers composed of a 4:1 ratio of POPC to POPG have been 
conducted in the presence of peptides 23.  Control simulations without peptides present were 
also conducted for reference.   The mixed bilayer in the presence of peptide 23 showed a 
membrane thinning effect after a 250 ns production simulation during which the RMSD of the 
bilayer did not stabilize but the peptide did relative to the start of the production simulation 
(Figure 5.11).   
The presence of peptide 23 appears to have an influence on the distribution of the anionic 
lipids within the membrane.  Two lipids were observed to interact with peptide 23 during the 
course of the MD simulation.  The remainder of peptide 23 was positioned in a region of low 
lipid density (Figure 5.18).  The C terminal hydrophobic rings appear to be reaching the aliphatic 
tails of the lipid molecules. 
The final model was also simulated with peptide 23 and was intended to model the 
electrostatic properties associated with mammalian membranes. The control bilayer consisted of 
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a confluent POPC bilayer.  Despite the observed intermolecular interactions occurring between 
peptide 23 and the control bilayer, no membrane thinning was observed during the 150 ns 
trajectory during which the RMSD stabilized (Figure 5.19).  The average phi and psi angles 
depicted in Figure 5.15 and Figure 5.23 suggest peptide 23 has an alpha helical preference as 
evidenced by the large number of residues populating the alpha helical preferred region of the 
Figure 6.1  6 Peptide 23 with a mixed bilayer.  POPC lipids are shown with black carbon atoms, 
phosphate atoms are noted with orange spheres.  A racemic mixture of POPG is noted in cyan and 
purple carbon skeleton.  Sodium atoms are noted with purple spheres and chloride atoms are noted 
with green spheres. 
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Ramachandran plots.  The requisite electrostatic pull necessary for the secondary structure of the 
peptide has limited the utility of solvated peptide simulations.  The random coil associated with 
AMPs in solution was also observed in the solvated MD simulation.   
FUTURE RESEARCH 
Future research efforts will continue the MD simulation of the mixed bilayer with peptide 
23 and will also include simulation of peptide 36 in both the model bacterial and mammalian 
membranes.  Comparison of the two peptides relative to each other can help decipher the 
ambiguous secondary structure suggested by the CD spectra.  Analysis of the preferred angles 
associated with the peptide in the presence of each bilayer can help further our understanding of 
the mechanism through which membrane disruption occurs.   
Figure 6.2  6 Peptide 23 with a mixed bilayer.  POPC lipids are shown with black carbon atoms, 
phosphate atoms are noted with orange spheres.  A racemic mixture of POPG is noted in cyan and 
purple carbon skeleton.   
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Larger computational resources would enable larger simulations to be conducted.  MD 
simulations with a sufficient peptide to lipid ratio would provide valuable insight into the activity 
of this collection of AMPs.  Simulations of numerous peptides, on a larger bilayer (Figure 6.1 & 
Figure 6.2), and a larger time scale would provide insight into the mechanism through which the 
membranes are disrupted. 
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APPENDIX A  
FORCE FIELD PARAMETERS 
FOR NON-STANDARD 
AMINO ACIDS AND LIPID 
MOLECULES 
  
 
2
0
4
 
UNNATURAL & NON-STANDARD AMINO ACIDS 
Β-ALANINE 
 
.prepi file:  
    0    0    2 
Bala.prepi input 
molecule.res 
BAL   INT  0 
CORRECT     OMIT DU   BEG 
  0.0000 
   1  DUMM  DU    M    0  -1  -2     0.000      .0        
.0      .00000 
   2  DUMM  DU    M    1   0  -1     1.449      .0        .0      .00000 
   3  DUMM  DU    M    2   1   0     1.522   111.1        .0      .00000 
   4  N1    N     M    3   2   1     1.540   111.208  -180.000  -0.75806 
   5  H1    H     E    4   3   2     0.994   114.626  -155.677   0.38188 
   6  C1    CT    M    4   3   2     1.450    17.741    97.543   0.30232 
   7  H2    H1    E    6   4   3     1.082   108.840  -147.036   0.02196 
   8  H3    H1    E    6   4   3     1.080   108.254    96.088   0.02196 
   9  C2    CT    M    6   4   3     1.528   112.525   -25.145  -0.29408 
  10  H4    HC    E    9   6   4     1.086   109.491    56.840   0.08374 
  11  H5    HC    E    9   6   4     1.083   109.586   -60.944   0.08374 
  12  C3    C     M    9   6   4     1.518   111.096   175.043   0.75195 
  13  O1    O     E   12   9   6     1.203   121.588   -40.508  -0.59543 
LOOP 
IMPROPER 
   -M   C1   N1   H1 
   C2   +M   C3   O1 
DONE 
STOP 
  
 
2
0
5
 
.frcmod file: 
remark goes here 
MASS 
N  14.010        0.530               same as n   
H  1.008         0.161               same as hn  
CT 12.010        0.878               same as c3  
H1 1.008         0.135               same as hc  
HC 1.008         0.135               same as hc  
C  12.010        0.616               same as c   
O  16.000        0.434               same as o   
 
BOND 
N -H   410.20   1.009       same as hn-n  
N -CT  330.60   1.460       same as c3-n  
CT-H1  337.30   1.092       same as c3-hc 
CT-CT  303.10   1.535       same as c3-c3 
CT-HC  337.30   1.092       same as c3-hc 
CT-C   328.30   1.508       same as c -c3 
C -O   648.00   1.214       same as c -o  
 
ANGLE 
N -CT-H1   49.800     109.500   same as hc-c3-n  
N -CT-CT   65.900     112.130   same as c3-c3-n  
H -N -CT   46.000     116.780   same as c3-n -hn 
CT-CT-HC   46.400     110.050   same as c3-c3-hc 
CT-CT-C    63.800     110.530   same as c -c3-c3 
H1-CT-H1   39.400     108.350   same as hc-c3-hc 
H1-CT-CT   46.400     110.050   same as c3-c3-hc 
CT-C -O    68.000     123.110   same as c3-c -o  
HC-CT-HC   39.400     108.350   same as hc-c3-hc 
HC-CT-C    47.200     109.680   same as c -c3-hc 
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DIHE 
N -CT-CT-HC   1    0.156         0.000           3.000      same as X -c3-c3-X  
N -CT-CT-C    1    0.156         0.000           3.000      same as X -c3-c3-X  
H -N -CT-H1   1    0.000         0.000           2.000      same as X -c3-n -X  
H -N -CT-CT   1    0.000         0.000           2.000      same as X -c3-n -X  
CT-CT-C -O    1    0.000       180.000           2.000      same as X -c -c3-X  
H1-CT-CT-HC   1    0.156         0.000           3.000      same as X -c3-c3-X  
H1-CT-CT-C    1    0.156         0.000           3.000      same as X -c3-c3-X  
HC-CT-C -O    1    0.000       180.000           2.000      same as X -c -c3-X  
 
IMPROPER 
 
NONBON 
  N           1.8240  0.1700             same as n   
  H           0.6000  0.0157             same as hn  
  CT          1.9080  0.1094             same as c3  
  H1          1.4870  0.0157             same as hc  
  HC          1.4870  0.0157             same as hc  
  C           1.9080  0.0860             same as c   
  O           1.6612  0.2100             same as o   
 
 
 
 
 
 
  
  
 
2
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GABA 
 
 
.prepi file:  
    0    0    2 
 
Gaba.prepi input 
gaba.res 
GAB   INT  0 
CORRECT     OMIT DU   BEG 
  0.0000 
   1  DUMM  DU    M    0  -1  -2     0.000      .0        .0      .00000 
   2  DUMM  DU    M    1   0  -1     1.449      .0        .0      .00000 
   3  DUMM  DU    M    2   1   0     1.522   111.1        .0      .00000 
   4  N1    N     M    3   2   1     1.540   111.208  -180.000  -0.88538 
   5  H1    H     E    4   3   2     0.998    98.122    -0.406   0.40641 
   6  C1    CT    M    4   3   2     1.446    31.750  -131.165   0.41091 
   7  H2    H1    E    6   4   3     1.082   108.978  -140.286  -0.01603 
   8  H3    H1    E    6   4   3     1.086   107.764   104.877  -0.01603 
   9  C2    CT    M    6   4   3     1.529   113.470   -16.683   0.07878 
  10  H4    HC    E    9   6   4     1.083   109.841    57.387   0.00995 
  11  H5    HC    E    9   6   4     1.087   109.508   -59.206   0.00995 
  12  C3    CT    M    9   6   4     1.528   111.952   178.767  -0.42016 
  13  H6    HC    E   12   9   6     1.087   110.743    61.542   0.07882 
  14  H7    HC    E   12   9   6     1.088   109.911   -55.984   0.07882 
  15  C4    C     M   12   9   6     1.521   112.328  -174.673   0.87128 
  16  O1    O     E   15  12   9     1.201   122.132    31.524  -0.60732 
LOOP 
IMPROPER 
   -M   C1   N1   H1 
   C3   +M   C4   O1 
DONE 
STOP 
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.frcmod file: 
remark goes here 
MASS 
N  14.010        0.530               same as n   
H  1.008         0.161               same as hn  
CT 12.010        0.878               same as c3  
H1 1.008         0.135               same as hc  
HC 1.008         0.135               same as hc  
C  12.010        0.616               same as c   
O  16.000        0.434               same as o   
 
BOND 
N -H   410.20   1.009       same as hn-n  
N -CT  330.60   1.460       same as c3-n  
CT-H1  337.30   1.092       same as c3-hc 
CT-CT  303.10   1.535       same as c3-c3 
CT-HC  337.30   1.092       same as c3-hc 
CT-C   328.30   1.508       same as c -c3 
C -O   648.00   1.214       same as c -o  
 
ANGLE 
N -CT-H1   49.800     109.500   same as hc-c3-n  
N -CT-CT   65.900     112.130   same as c3-c3-n  
H -N -CT   46.000     116.780   same as c3-n -hn 
CT-CT-HC   46.400     110.050   same as c3-c3-hc 
CT-CT-CT   63.200     110.630   same as c3-c3-c3 
H1-CT-H1   39.400     108.350   same as hc-c3-hc 
H1-CT-CT   33.235     109.490   Calculated with empirical approach 
CT-CT-C    63.800     110.530   same as c -c3-c3 
HC-CT-HC   39.400     108.350   same as hc-c3-hc 
CT-C -O    68.000     123.110   same as c3-c -o  
HC-CT-C    47.200     109.680   same as c -c3-hc 
 
DIHE 
N -CT-CT-HC   1    0.156         0.000           3.000      same as X -c3-c3-X  
N -CT-CT-CT   1    0.156         0.000           3.000      same as X -c3-c3-X  
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H -N -CT-H1   1    0.000         0.000           2.000      same as X -c3-n -X  
H -N -CT-CT   1    0.000         0.000           2.000      same as X -c3-n -X  
CT-CT-CT-HC   1    0.156         0.000           3.000      same as X -c3-c3-X  
CT-CT-CT-C    1    0.156         0.000           3.000      same as X -c3-c3-X  
H1-CT-CT-HC   1    0.156         0.000           3.000      same as X -c3-c3-X  
H1-CT-CT-CT   1    0.156         0.000           3.000      same as X -c3-c3-X  
CT-CT-C -O    1    0.000       180.000           2.000      same as X -c -c3-X  
HC-CT-CT-HC   1    0.156         0.000           3.000      same as X -c3-c3-X  
HC-CT-CT-C    1    0.156         0.000           3.000      same as X -c3-c3-X  
HC-CT-C -O    1    0.000       180.000           2.000      same as X -c -c3-X  
 
IMPROPER 
 
NONBON 
  N           1.8240  0.1700             same as n   
  H           0.6000  0.0157             same as hn  
  CT          1.9080  0.1094             same as c3  
  H1          1.4870  0.0157             same as hc  
  HC          1.4870  0.0157             same as hc  
  C           1.9080  0.0860             same as c   
  O           1.6612  0.2100             same as o   
 
 
 
 
 
  
  
 
2
1
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6-AMINOHEXANOIC ACID (6AH) 
.prepi file:  
    0    0    2 
 
This is a remark line 
6ahx.rf 
6AH   INT  0 
CORRECT     OMIT DU   BEG 
  0.0000 
   1  DUMM  DU    M    0  -1  -2     0.000      .0        .0      .00000 
   2  DUMM  DU    M    1   0  -1     1.449      .0        .0      .00000 
   3  DUMM  DU    M    2   1   0     1.522   111.1        .0      .00000 
   4  N1    N     M    3   2   1     1.540   111.208   180.000  -0.66102 
   5  H1    H     E    4   3   2     0.993   111.315  -138.505   0.36465 
   6  C1    CT    M    4   3   2     1.450    22.498   108.272  -0.17774 
   7  H2    H1    E    6   4   3     1.082   107.805  -135.812   0.12694 
   8  H3    H1    E    6   4   3     1.084   107.618   108.460   0.12694 
   9  C2    CT    M    6   4   3     1.528   113.419   -13.797   0.06894 
  10  H4    HC    E    9   6   4     1.088   109.215    57.397   0.02278 
  11  H5    HC    E    9   6   4     1.086   108.415   -58.817   0.02278 
  12  C3    CT    M    9   6   4     1.529   112.090   179.213   0.19113 
  13  H6    HC    E   12   9   6     1.087   109.494    56.776  -0.02482 
  14  H7    HC    E   12   9   6     1.083   110.479   -60.333  -0.02482 
  15  C4    CT    M   12   9   6     1.529   112.375   178.209  -0.42852 
  16  H8    HC    E   15  12   9     1.088   109.770    56.833   0.08525 
  17  H9    HC    E   15  12   9     1.086   110.411   -60.580   0.08525 
  18  C5    C     M   15  12   9     1.519   112.250   175.180   0.82889 
  19  O1    O     E   18  15  12     1.203   121.997   -40.631  -0.60663 
LOOP 
IMPROPER 
   -M   C1   N1   H1 
   C4   +M   C5   O1 
 
DONE 
STOP 
  
 
2
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.frcmod file: 
remark goes here 
MASS 
N  14.010        0.530               same as n   
H  1.008         0.161               same as hn  
CT 12.010        0.878               same as c3  
H1 1.008         0.135               same as hc  
HC 1.008         0.135               same as hc  
C  12.010        0.616               same as c   
O  16.000        0.434               same as o   
 
BOND 
N -H   410.20   1.009       same as hn-n  
N -CT  330.60   1.460       same as c3-n  
CT-H1  337.30   1.092       same as c3-hc 
CT-CT  303.10   1.535       same as c3-c3 
CT-HC  337.30   1.092       same as c3-hc 
CT-C   328.30   1.508       same as c -c3 
C -O   648.00   1.214       same as c -o  
 
ANGLE 
N -CT-H1   49.800     109.500   same as hc-c3-n  
N -CT-CT   65.900     112.130   same as c3-c3-n  
H -N -CT   46.000     116.780   same as c3-n -hn 
CT-CT-HC   46.400     110.050   same as c3-c3-hc 
CT-CT-CT   63.200     110.630   same as c3-c3-c3 
H1-CT-H1   39.400     108.350   same as hc-c3-hc 
H1-CT-CT   33.235     109.490   Calculated with empirical approach 
HC-CT-HC   39.400     108.350   same as hc-c3-hc 
CT-CT-C    63.800     110.530   same as c -c3-c3 
CT-C -O    68.000     123.110   same as c3-c -o  
HC-CT-C    47.200     109.680   same as c -c3-hc 
 
DIHE 
N -CT-CT-HC   1    0.156         0.000           3.000      same as X -c3-c3-X  
N -CT-CT-CT   1    0.156         0.000           3.000      same as X -c3-c3-X  
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H -N -CT-H1   1    0.000         0.000           2.000      same as X -c3-n -X  
H -N -CT-CT   1    0.000         0.000           2.000      same as X -c3-n -X  
CT-CT-CT-HC   1    0.156         0.000           3.000      same as X -c3-c3-X  
CT-CT-CT-CT   1    0.156         0.000           3.000      same as X -c3-c3-X  
H1-CT-CT-HC   1    0.156         0.000           3.000      same as X -c3-c3-X  
H1-CT-CT-CT   1    0.156         0.000           3.000      same as X -c3-c3-X  
CT-CT-CT-C    1    0.156         0.000           3.000      same as X -c3-c3-X  
HC-CT-CT-HC   1    0.156         0.000           3.000      same as X -c3-c3-X  
CT-CT-C -O    1    0.000       180.000           2.000      same as X -c -c3-X  
HC-CT-CT-C    1    0.156         0.000           3.000      same as X -c3-c3-X  
HC-CT-C -O    1    0.000       180.000           2.000      same as X -c -c3-X  
 
IMPROPER 
 
NONBON 
  N           1.8240  0.1700             same as n   
  H           0.6000  0.0157             same as hn  
  CT          1.9080  0.1094             same as c3  
  H1          1.4870  0.0157             same as hc  
  HC          1.4870  0.0157             same as hc  
  C           1.9080  0.0860             same as c   
  O           1.6612  0.2100             same as o   
 
 
 
 
 
  
  
 
2
1
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ORNATHINE  
.prepi file:  
    0    0    2 
 
This is a remark line 
orn.res 
ORN   INT  0 
CORRECT     OMIT DU   BEG 
  0.0000 
   1  DUMM  DU    M    0  -1  -2     0.000      .0        .0      .00000 
   2  DUMM  DU    M    1   0  -1     1.449      .0        .0      .00000 
   3  DUMM  DU    M    2   1   0     1.522   111.1        .0      .00000 
   4  N1    N     M    3   2   1     1.540   111.208  -180.000  -0.72259 
   5  H4    H     E    4   3   2     0.997    98.771   -60.443   0.38709 
   6  C3    CT    M    4   3   2     1.438   134.505   152.660   0.10322 
   7  C5    CT    3    6   4   3     1.537   110.731    61.104   0.14063 
   8  N2    N3    3    7   6   4     1.501   110.900  -171.194  -0.51286 
   9  H8    H     E    8   7   6     1.023   106.863   -53.870   0.39656 
  10  H9    H     E    8   7   6     1.010   111.899    65.026   0.39656 
  11  H10   H     E    8   7   6     1.010   111.981  -174.205   0.39656 
  12  H6    HP    E    7   6   4     1.079   109.737   -52.128   0.09785 
  13  H7    HP    E    7   6   4     1.080   111.584    70.203   0.09785 
  14  H5    H1    E    6   4   3     1.084   106.529   -56.396   0.11861 
  15  C4    C     M    6   4   3     1.532   113.557  -173.482   0.65633 
  16  O2    O     E   15   6   4     1.216   118.260  -152.734  -0.55580 
 
 
LOOP 
 
IMPROPER 
   -M   C3   N1   H4 
   C3   +M   C4   O2 
 
DONE 
STOP 
  
 
2
1
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.frcmod file: 
remark goes here 
MASS 
N  14.010        0.530               same as n   
H  1.008         0.161               same as hn  
CT 12.010        0.878               same as c3  
N3 14.010        0.530               same as n4  
HP 1.008         0.135               same as hc  
H1 1.008         0.135               same as hc  
C  12.010        0.616               same as c   
O  16.000        0.434               same as o   
 
BOND 
N -H   410.20   1.009       same as hn-n  
N -CT  330.60   1.460       same as c3-n  
CT-CT  303.10   1.535       same as c3-c3 
CT-H1  337.30   1.092       same as c3-hc 
CT-C   328.30   1.508       same as c -c3 
CT-N3  293.60   1.499       same as c3-n4 
CT-HP  337.30   1.092       same as c3-hc 
N3-H   369.00   1.033       same as hn-n4 
C -O   648.00   1.214       same as c -o  
 
ANGLE 
N -CT-CT   65.900     112.130   same as c3-c3-n  
N -CT-H1   49.800     109.500   same as hc-c3-n  
N -CT-C    66.700     111.560   same as c -c3-n  
H -N -CT   46.000     116.780   same as c3-n -hn 
CT-CT-N3   66.000     108.930   same as c3-c3-n4 
CT-CT-HP   46.400     110.050   same as c3-c3-hc 
CT-C -O    68.000     123.110   same as c3-c -o  
CT-CT-H1   46.400     110.050   same as c3-c3-hc 
CT-CT-C    63.800     110.530   same as c -c3-c3 
CT-N3-H    46.200     110.110   same as c3-n4-hn 
N3-CT-HP   49.000     107.900   same as hc-c3-n4 
H -N3-H    40.500     108.110   same as hn-n4-hn 
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HP-CT-HP   39.400     108.350   same as hc-c3-hc 
H1-CT-C    47.200     109.680   same as c -c3-hc 
 
DIHE 
N -CT-CT-N3   1    0.156         0.000           3.000      same as X -c3-c3-X  
N -CT-CT-HP   1    0.156         0.000           3.000      same as X -c3-c3-X  
N -CT-C -O    1    0.000       180.000           2.000      same as X -c -c3-X  
H -N -CT-CT   1    0.000         0.000           2.000      same as X -c3-n -X  
H -N -CT-H1   1    0.000         0.000           2.000      same as X -c3-n -X  
H -N -CT-C    1    0.000         0.000           2.000      same as X -c3-n -X  
CT-CT-N3-H    1    0.156         0.000           3.000      same as X -c3-n4-X  
CT-CT-C -O    1    0.000       180.000           2.000      same as X -c -c3-X  
N3-CT-CT-H1   1    0.156         0.000           3.000      same as X -c3-c3-X  
N3-CT-CT-C    1    0.156         0.000           3.000      same as X -c3-c3-X  
H -N3-CT-HP   1    0.156         0.000           3.000      same as X -c3-n4-X  
HP-CT-CT-H1   1    0.156         0.000           3.000      same as X -c3-c3-X  
HP-CT-CT-C    1    0.156         0.000           3.000      same as X -c3-c3-X  
H1-CT-C -O    1    0.000       180.000           2.000      same as X -c -c3-X  
 
IMPROPER 
 
NONBON 
  N           1.8240  0.1700             same as n   
  H           0.6000  0.0157             same as hn  
  CT          1.9080  0.1094             same as c3  
  N3          1.8240  0.1700             same as n4  
  HP          1.4870  0.0157             same as hc  
  H1          1.4870  0.0157             same as hc  
  C           1.9080  0.0860             same as c   
  O           1.6612  0.2100             same as o   
 
 
 
 
 
 
  
 
2
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DIAMINOBUTANOIC ACID 
.prepi file:  
    0    0    2 
This is a remark line 
dab.res 
DAB   INT  0 
CORRECT     OMIT DU   BEG 
  0.0000 
   1  DUMM  DU    M    0  -1  -2     0.000      .0        .0      .00000 
   2  DUMM  DU    M    1   0  -1     1.449      .0        .0      .00000 
   3  DUMM  DU    M    2   1   0     1.522   111.1        .0      .00000 
   4  N1    N     M    3   2   1     1.540   111.208  -180.000  -0.02446 
   5  H4    H     E    4   3   2     1.012    92.662   -50.579   0.10134 
   6  C3    CT    M    4   3   2     1.457   150.805   128.660   0.13954 
   7  C5    CT    3    6   4   3     1.550   110.062    75.132  -0.10546 
   8  C6    CT    3    7   6   4     1.540   113.939  -179.437   0.30085 
   9  N2    N3    3    8   7   6     1.476   111.278   179.624   0.43497 
  10  H10   H     E    9   8   7     1.010   109.825  -179.358   0.05783 
  11  H11   H     E    9   8   7     1.010   109.967   -59.192   0.05783 
  12  H12   H     E    9   8   7     1.010   109.681    61.017   0.05783 
  13  H8    HP    E    8   7   6     1.092   110.719   -59.900  -0.05779 
  14  H9    HP    E    8   7   6     1.091   110.059    58.261  -0.05779 
  15  H6    HC    E    7   6   4     1.092   109.171   -57.294   0.05979 
  16  H7    HC    E    7   6   4     1.091   108.859    57.841   0.05979 
  17  H5    H1    E    6   4   3     1.093   108.411   -43.265   0.17641 
  18  C4    C     M    6   4   3     1.529   108.530  -160.350  -0.29603 
  19  O2    O     E   18   6   4     1.227   118.769   -82.936   0.09536 
LOOP 
IMPROPER 
   -M   C3   N1   H4 
   C3   +M   C4   O2 
 
DONE 
STOP 
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.frcmod file: 
remark goes here 
MASS 
N  14.010        0.530               same as n   
H  1.008         0.161               same as hn  
CT 12.010        0.878               same as c3  
N3 14.010        0.530               same as n4  
HP 1.008         0.135               same as hc  
HC 1.008         0.135               same as hc  
H1 1.008         0.135               same as hc  
C  12.010        0.616               same as c   
O  16.000        0.434               same as o   
 
BOND 
N -H   410.20   1.009       same as hn-n  
N -CT  330.60   1.460       same as c3-n  
CT-CT  303.10   1.535       same as c3-c3 
CT-H1  337.30   1.092       same as c3-hc 
CT-C   328.30   1.508       same as c -c3 
CT-HC  337.30   1.092       same as c3-hc 
CT-N3  293.60   1.499       same as c3-n4 
CT-HP  337.30   1.092       same as c3-hc 
N3-H   369.00   1.033       same as hn-n4 
C -O   648.00   1.214       same as c -o  
 
ANGLE 
N -CT-CT   65.900     112.130   same as c3-c3-n  
N -CT-H1   49.800     109.500   same as hc-c3-n  
N -CT-C    66.700     111.560   same as c -c3-n  
H -N -CT   46.000     116.780   same as c3-n -hn 
CT-CT-CT   63.200     110.630   same as c3-c3-c3 
CT-CT-HC   46.400     110.050   same as c3-c3-hc 
CT-C -O    68.000     123.110   same as c3-c -o  
CT-CT-H1   46.400     110.050   same as c3-c3-hc 
CT-CT-C    63.800     110.530   same as c -c3-c3 
CT-CT-N3   66.000     108.930   same as c3-c3-n4 
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CT-CT-HP   46.400     110.050   same as c3-c3-hc 
CT-N3-H    46.200     110.110   same as c3-n4-hn 
N3-CT-HP   49.000     107.900   same as hc-c3-n4 
H -N3-H    40.500     108.110   same as hn-n4-hn 
HP-CT-HP   39.400     108.350   same as hc-c3-hc 
HC-CT-HC   39.400     108.350   same as hc-c3-hc 
H1-CT-C    47.200     109.680   same as c -c3-hc 
DIHE 
N -CT-CT-CT   1    0.156         0.000           3.000      same as X -c3-c3-X  
N -CT-CT-HC   1    0.156         0.000           3.000      same as X -c3-c3-X  
N -CT-C -O    1    0.000       180.000           2.000      same as X -c -c3-X  
H -N -CT-CT   1    0.000         0.000           2.000      same as X -c3-n -X  
H -N -CT-H1   1    0.000         0.000           2.000      same as X -c3-n -X  
H -N -CT-C    1    0.000         0.000           2.000      same as X -c3-n -X  
CT-CT-CT-N3   1    0.156         0.000           3.000      same as X -c3-c3-X  
CT-CT-CT-HP   1    0.156         0.000           3.000      same as X -c3-c3-X  
CT-CT-C -O    1    0.000       180.000           2.000      same as X -c -c3-X  
CT-CT-N3-H    1    0.156         0.000           3.000      same as X -c3-n4-X  
CT-CT-CT-H1   1    0.156         0.000           3.000      same as X -c3-c3-X  
CT-CT-CT-C    1    0.156         0.000           3.000      same as X -c3-c3-X  
N3-CT-CT-HC   1    0.156         0.000           3.000      same as X -c3-c3-X  
H -N3-CT-HP   1    0.156         0.000           3.000      same as X -c3-n4-X  
HP-CT-CT-HC   1    0.156         0.000           3.000      same as X -c3-c3-X  
HC-CT-CT-H1   1    0.156         0.000           3.000      same as X -c3-c3-X  
HC-CT-CT-C    1    0.156         0.000           3.000      same as X -c3-c3-X  
H1-CT-C -O    1    0.000       180.000           2.000      same as X -c -c3-X  
IMPROPER 
NONBON 
  N           1.8240  0.1700             same as n   
  H           0.6000  0.0157             same as hn  
  CT          1.9080  0.1094             same as c3  
  N3          1.8240  0.1700             same as n4  
  HP          1.4870  0.0157             same as hc  
  HC          1.4870  0.0157             same as hc  
  H1          1.4870  0.0157             same as hc  
  C           1.9080  0.0860             same as c   
  O           1.6612  0.2100             same as o   
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DIAMINOPROPIONIC ACID 
 
 
 
.prepi file:  
    0    0    2 
This is a remark line 
dpr.res 
DPR   INT  0 
CORRECT     OMIT DU   BEG 
  0.0000 
   1  DUMM  DU    M    0  -1  -2     0.000      .0        .0      .00000 
   2  DUMM  DU    M    1   0  -1     1.449      .0        .0      .00000 
   3  DUMM  DU    M    2   1   0     1.522   111.1        .0      .00000 
   4  N1    N     M    3   2   1     1.540   111.208  -180.000  -0.72259 
   5  H4    H     E    4   3   2     0.997    98.771   -60.443   0.38709 
   6  C3    CT    M    4   3   2     1.438   134.505   152.660   0.10322 
   7  C5    CT    3    6   4   3     1.537   110.731    61.104   0.14063 
   8  N2    N3    3    7   6   4     1.501   110.900  -171.194  -0.51286 
   9  H8    H     E    8   7   6     1.023   106.863   -53.870   0.39656 
  10  H9    H     E    8   7   6     1.010   111.899    65.026   0.39656 
  11  H10   H     E    8   7   6     1.010   111.981  -174.205   0.39656 
  12  H6    HP    E    7   6   4     1.079   109.737   -52.128   0.09785 
  13  H7    HP    E    7   6   4     1.080   111.584    70.203   0.09785 
  14  H5    H1    E    6   4   3     1.084   106.529   -56.396   0.11861 
  15  C4    C     M    6   4   3     1.532   113.557  -173.482   0.65633 
  16  O2    O     E   15   6   4     1.216   118.260  -152.734  -0.55580 
LOOP 
IMPROPER 
   -M   C3   N1   H4 
   C3   +M   C4   O2 
  
 
2
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DONE 
STOP 
 
.frcmod file: 
remark goes here 
MASS 
N  14.010        0.530               same as n   
H  1.008         0.161               same as hn  
CT 12.010        0.878               same as c3  
N3 14.010        0.530               same as n4  
HP 1.008         0.135               same as hc  
H1 1.008         0.135               same as hc  
C  12.010        0.616               same as c   
O  16.000        0.434               same as o   
 
BOND 
N -H   410.20   1.009       same as hn-n  
N -CT  330.60   1.460       same as c3-n  
CT-CT  303.10   1.535       same as c3-c3 
CT-H1  337.30   1.092       same as c3-hc 
CT-C   328.30   1.508       same as c -c3 
CT-N3  293.60   1.499       same as c3-n4 
CT-HP  337.30   1.092       same as c3-hc 
N3-H   369.00   1.033       same as hn-n4 
C -O   648.00   1.214       same as c -o  
 
ANGLE 
N -CT-CT   65.900     112.130   same as c3-c3-n  
N -CT-H1   49.800     109.500   same as hc-c3-n  
N -CT-C    66.700     111.560   same as c -c3-n  
H -N -CT   46.000     116.780   same as c3-n -hn 
CT-CT-N3   66.000     108.930   same as c3-c3-n4 
CT-CT-HP   46.400     110.050   same as c3-c3-hc 
CT-C -O    68.000     123.110   same as c3-c -o  
CT-CT-H1   46.400     110.050   same as c3-c3-hc 
CT-CT-C    63.800     110.530   same as c -c3-c3 
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CT-N3-H    46.200     110.110   same as c3-n4-hn 
N3-CT-HP   49.000     107.900   same as hc-c3-n4 
H -N3-H    40.500     108.110   same as hn-n4-hn 
HP-CT-HP   39.400     108.350   same as hc-c3-hc 
H1-CT-C    47.200     109.680   same as c -c3-hc 
 
DIHE 
N -CT-CT-N3   1    0.156         0.000           3.000      same as X -c3-c3-X  
N -CT-CT-HP   1    0.156         0.000           3.000      same as X -c3-c3-X  
N -CT-C -O    1    0.000       180.000           2.000      same as X -c -c3-X  
H -N -CT-CT   1    0.000         0.000           2.000      same as X -c3-n -X  
H -N -CT-H1   1    0.000         0.000           2.000      same as X -c3-n -X  
H -N -CT-C    1    0.000         0.000           2.000      same as X -c3-n -X  
CT-CT-N3-H    1    0.156         0.000           3.000      same as X -c3-n4-X  
CT-CT-C -O    1    0.000       180.000           2.000      same as X -c -c3-X  
N3-CT-CT-H1   1    0.156         0.000           3.000      same as X -c3-c3-X  
N3-CT-CT-C    1    0.156         0.000           3.000      same as X -c3-c3-X  
H -N3-CT-HP   1    0.156         0.000           3.000      same as X -c3-n4-X  
HP-CT-CT-H1   1    0.156         0.000           3.000      same as X -c3-c3-X  
HP-CT-CT-C    1    0.156         0.000           3.000      same as X -c3-c3-X  
H1-CT-C -O    1    0.000       180.000           2.000      same as X -c -c3-X  
 
IMPROPER 
 
NONBON 
  N           1.8240  0.1700             same as n   
  H           0.6000  0.0157             same as hn  
  CT          1.9080  0.1094             same as c3  
  N3          1.8240  0.1700             same as n4  
  HP          1.4870  0.0157             same as hc  
  H1          1.4870  0.0157             same as hc  
  C           1.9080  0.0860             same as c   
  O           1.6612  0.2100             same as o   
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TIC 
.prepi file:  
    0    0    2 
TIC.prepi input file 
tic.res 
TIC   INT  0 
CORRECT     OMIT DU   BEG 
  0.0000 
   1  DUMM  DU    M    0  -1  -2     0.000      .0        .0      .00000 
   2  DUMM  DU    M    1   0  -1     1.449      .0        .0      .00000 
   3  DUMM  DU    M    2   1   0     1.522   111.1        .0      .00000 
   4  N1    N     M    3   2   1     1.540   111.208  -180.000  -0.22346 
   5  C9    CT    3    4   3   2     1.517    30.684   135.785  -0.15007 
   6  C5    CA    S    5   4   3     1.539   112.401   -20.564   0.06301 
   7  C4    CA    B    6   5   4     1.538   120.657   149.531  -0.26369 
   8  C3    CA    B    7   6   5     1.540   119.821  -178.904  -0.16552 
   9  C2    CA    B    8   7   6     1.540   120.083     0.761  -0.17165 
  10  C1    CA    B    9   8   7     1.541   119.865     0.637  -0.26564 
  11  C6    CA    S   10   9   8     1.539   119.776    -0.963   0.09029 
  12  C7    CT    B   11  10   9     1.534   121.009   176.302  -0.13781 
  13  H1    HC    E   12  11  10     1.139   109.955   104.833   0.06498 
  14  H2    HC    E   12  11  10     1.140   110.150   -16.240   0.06498 
  15  H14   HA    E   10   9   8     1.140   120.068   178.964   0.19124 
  16  H13   HA    E    9   8   7     1.140   120.106  -179.739   0.17933 
  17  H15   HA    E    8   7   6     1.141   119.899  -179.321   0.17953 
  18  H16   HA    E    7   6   5     1.141   120.046     1.253   0.20101 
  19  H4    H1    E    5   4   3     1.140   108.987   100.053   0.13156 
  20  H5    H1    E    5   4   3     1.139   108.870  -141.226   0.13156 
  21  C8    CT    M    4   3   2     1.519    93.510   -19.738   0.16362 
  22  H3    H1    E   21   4   3     1.141   108.900   -70.608   0.08010 
  23  C10   C     M   21   4   3     1.540   111.624   168.341   0.40091 
  24  O1    O     E   23  21   4     1.510   120.243   103.499  -0.56430 
LOOP 
   C6   C5 
   C8   C7 
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IMPROPER 
   -M   C8   N1   C9 
   C6   C4   C5   C9 
   C5   C3   C4  H16 
   C4   C2   C3  H15 
   C3   C1   C2  H13 
   C6   C2   C1  H14 
   C5   C1   C6   C7 
   C8   +M  C10   O1 
 
DONE 
STOP 
 
.frcmod file: 
TIC.frcmod 
MASS 
N  14.010        0.530               same as n   
CT 12.010        0.878               same as c3  
CA 12.010        0.360               same as c2  
HC 1.008         0.135               same as hc  
HA 1.008         0.135               same as hc  
H1 1.008         0.135               same as hc  
C  12.010        0.616               same as c   
O  16.000        0.434               same as o   
 
BOND 
N -CT  330.60   1.460       same as c3-n  
CT-CA  328.30   1.508       same as c2-c3 
CT-H1  337.30   1.092       same as c3-hc 
CA-CA  478.40   1.387       same as ca-ca 
CA-HA  344.30   1.087       same as c2-hc 
CT-HC  337.30   1.092       same as c3-hc 
CT-CT  303.10   1.535       same as c3-c3 
CT-C   328.30   1.508       same as c -c3 
C -O   648.00   1.214       same as c -o  
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ANGLE 
N -CT-CA   66.341     111.760   Calculated with empirical approach 
N -CT-H1   49.800     109.500   same as hc-c3-n  
N -CT-CT   65.900     112.130   same as c3-c3-n  
N -CT-C    66.700     111.560   same as c -c3-n  
CT-N -CT   64.000     112.620   same as c3-n -c3 
CT-CA-CA   64.300     123.420   same as c2-c2-c3 
CA-CT-H1   47.000     110.490   same as c2-c3-hc 
CA-CA-CA   67.200     119.970   same as ca-ca-ca 
CA-CA-HA   50.300     119.700   same as c2-c2-hc 
CA-CT-HC   47.000     110.490   same as c2-c3-hc 
CA-CT-CT   63.700     110.960   same as c2-c3-c3 
CT-CT-H1   46.400     110.050   same as c3-c3-hc 
CT-CT-C    63.800     110.530   same as c -c3-c3 
HC-CT-HC   39.400     108.350   same as hc-c3-hc 
HC-CT-CT   46.400     110.050   same as c3-c3-hc 
H1-CT-H1   39.400     108.350   same as hc-c3-hc 
CT-C -O    68.000     123.110   same as c3-c -o  
H1-CT-C    47.200     109.680   same as c -c3-hc 
 
DIHE 
N -CT-CA-CA   1    0.000         0.000           2.000      same as X -c2-c3-X  
N -CT-CT-CA   1    0.156         0.000           3.000      same as X -c3-c3-X  
N -CT-CT-HC   1    0.156         0.000           3.000      same as X -c3-c3-X  
N -CT-C -O    1    0.000       180.000           2.000      same as X -c -c3-X  
CT-N -CT-CT   1    0.000         0.000           2.000      same as X -c3-n -X  
CT-N -CT-H1   1    0.000         0.000           2.000      same as X -c3-n -X  
CT-N -CT-C    1    0.000         0.000           2.000      same as X -c3-n -X  
CT-CA-CA-CA   1    6.650       180.000           2.000      same as X -c2-c2-X  
CT-CA-CA-HA   1    6.650       180.000           2.000      same as X -c2-c2-X  
CT-CA-CA-CT   1    6.650       180.000           2.000      same as X -c2-c2-X  
CA-CT-N -CT   1    0.000         0.000           2.000      same as X -c3-n -X  
CA-CA-CA-CA   1    3.625       180.000           2.000      same as X -ca-ca-X  
CA-CA-CA-HA   1    6.650       180.000           2.000      same as X -c2-c2-X  
CA-CA-CT-HC   1    0.000         0.000           2.000      same as X -c2-c3-X  
CA-CA-CT-CT   1    0.000         0.000           2.000      same as X -c2-c3-X  
CA-CA-CT-H1   1    0.000         0.000           2.000      same as X -c2-c3-X  
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CA-CT-CT-H1   1    0.156         0.000           3.000      same as X -c3-c3-X  
CA-CT-CT-C    1    0.156         0.000           3.000      same as X -c3-c3-X  
CT-CT-C -O    1    0.000       180.000           2.000      same as X -c -c3-X  
HC-CT-CT-H1   1    0.156         0.000           3.000      same as X -c3-c3-X  
HC-CT-CT-C    1    0.156         0.000           3.000      same as X -c3-c3-X  
HA-CA-CA-HA   1    6.650       180.000           2.000      same as X -c2-c2-X  
H1-CT-C -O    1    0.000       180.000           2.000      same as X -c -c3-X  
 
IMPROPER 
CA-CA-CA-CT         1.1          180.0         2.0          Using default value 
CA-CA-CA-HA         1.1          180.0         2.0          Using default value 
 
NONBON 
  N           1.8240  0.1700             same as n   
  CT          1.9080  0.1094             same as c3  
  CA          1.9080  0.0860             same as ca  
  HC          1.4870  0.0157             same as hc  
  HA          1.4870  0.0157             same as hc  
  H1          1.4870  0.0157             same as hc  
  C           1.9080  0.0860             same as c   
  O           1.6612  0.2100             same as o   
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OIC 
 
.prepi file:  
    0    0    2 
 
This is a remark line 
oic.res 
OIC   INT  0 
CORRECT     OMIT DU   BEG 
  0.0000 
   1  DUMM  DU    M    0  -1  -2     0.000      .0        .0      .00000 
   2  DUMM  DU    M    1   0  -1     1.449      .0        .0      .00000 
   3  DUMM  DU    M    2   1   0     1.522   111.1        .0      .00000 
   4  N1    N     M    3   2   1     1.540   111.208  -180.000  -0.36092 
   5  C5    CT    B    4   3   2     1.466   169.593   -80.218   0.07272 
   6  C4    CT    3    5   4   3     1.537   101.904   139.335   0.06164 
   7  C3    CT    3    6   5   4     1.533   114.181  -165.027  -0.12236 
   8  C2    CT    3    7   6   5     1.532   113.578    45.134   0.02779 
   9  C1    CT    3    8   7   6     1.530   110.937   -52.066   0.02579 
  10  H1    HC    E    9   8   7     1.090   109.535   -62.841  -0.00620 
  11  H2    HC    E    9   8   7     1.086   110.366  -179.864  -0.00620 
  12  C6    CT    B    9   8   7     1.530   110.577    58.628  -0.08165 
  13  H9    HC    E   12   9   8     1.087   110.739   179.813   0.03860 
  14  H10   HC    E   12   9   8     1.085   109.477    62.635   0.03860 
  15  H3    HC    E    8   7   6     1.087   110.439    69.153   0.01264 
  16  H4    HC    E    8   7   6     1.087   109.305  -173.923   0.01264 
  17  H5    HC    E    7   6   5     1.087   109.410   169.060   0.02786 
  18  H6    HC    E    7   6   5     1.088   108.441   -75.479   0.02786 
  19  H7    HC    E    6   5   4     1.087   106.955    75.198   0.00614 
  20  C7    CT    B    6   5   4     1.534   102.764   -38.196   0.02406 
  21  H11   HC    E   20   6   5     1.083   111.971   154.062   0.02667 
  22  H12   HC    E   20   6   5     1.079   111.792   -84.941   0.02667 
  23  H8    H1    E    5   4   3     1.082   109.960  -103.825   0.04973 
  24  C8    CT    M    4   3   2     1.473    72.655    32.537  -0.03396 
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  25  H14   H1    E   24   4   3     1.081   108.152    61.857   0.05370 
  26  C9    C     M   24   4   3     1.540   111.283   -57.274   0.62724 
  27  O1    O     E   26  24   4     1.205   122.027   -97.747  -0.54906 
LOOP 
   C6   C5 
   C8   C7 
IMPROPER 
   -M   C8   N1   C5 
   C8   +M   C9   O1 
DONE 
STOP 
 
.frcmod file: 
remark goes here 
MASS 
N  14.010        0.530               same as n   
CT 12.010        0.878               same as c3  
HC 1.008         0.135               same as hc  
H1 1.008         0.135               same as hc  
C  12.010        0.616               same as c   
O  16.000        0.434               same as o   
 
BOND 
N -CT  330.60   1.460       same as c3-n  
CT-CT  303.10   1.535       same as c3-c3 
CT-H1  337.30   1.092       same as c3-hc 
CT-HC  337.30   1.092       same as c3-hc 
CT-C   328.30   1.508       same as c -c3 
C -O   648.00   1.214       same as c -o  
 
ANGLE 
N -CT-CT   65.900     112.130   same as c3-c3-n  
N -CT-H1   49.800     109.500   same as hc-c3-n  
N -CT-C    66.700     111.560   same as c -c3-n  
CT-N -CT   64.000     112.620   same as c3-n -c3 
CT-CT-CT   63.200     110.630   same as c3-c3-c3 
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CT-CT-HC   46.400     110.050   same as c3-c3-hc 
CT-CT-H1   46.400     110.050   same as c3-c3-hc 
HC-CT-HC   39.400     108.350   same as hc-c3-hc 
CT-CT-C    63.800     110.530   same as c -c3-c3 
CT-C -O    68.000     123.110   same as c3-c -o  
H1-CT-C    47.200     109.680   same as c -c3-hc 
 
DIHE 
N -CT-CT-CT   1    0.156         0.000           3.000      same as X -c3-c3-X  
N -CT-CT-HC   1    0.156         0.000           3.000      same as X -c3-c3-X  
N -CT-C -O    1    0.000       180.000           2.000      same as X -c -c3-X  
CT-N -CT-CT   1    0.000         0.000           2.000      same as X -c3-n -X  
CT-N -CT-H1   1    0.000         0.000           2.000      same as X -c3-n -X  
CT-N -CT-C    1    0.000         0.000           2.000      same as X -c3-n -X  
CT-CT-CT-CT   1    0.156         0.000           3.000      same as X -c3-c3-X  
CT-CT-CT-HC   1    0.156         0.000           3.000      same as X -c3-c3-X  
CT-CT-CT-H1   1    0.156         0.000           3.000      same as X -c3-c3-X  
CT-CT-CT-C    1    0.156         0.000           3.000      same as X -c3-c3-X  
HC-CT-CT-HC   1    0.156         0.000           3.000      same as X -c3-c3-X  
HC-CT-CT-H1   1    0.156         0.000           3.000      same as X -c3-c3-X  
CT-CT-C -O    1    0.000       180.000           2.000      same as X -c -c3-X  
HC-CT-CT-C    1    0.156         0.000           3.000      same as X -c3-c3-X  
H1-CT-C -O    1    0.000       180.000           2.000      same as X -c -c3-X  
 
IMPROPER 
 
 
NONBON 
  N           1.8240  0.1700             same as n   
  CT          1.9080  0.1094             same as c3  
  HC          1.4870  0.0157             same as hc  
  H1          1.4870  0.0157             same as hc  
  C           1.9080  0.0860             same as c   
  O           1.6612  0.2100             same as o   
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ACH 
.prepi file:  
    0    0    2 
 
This is a remark line 
ach.res 
ACH   INT  0 
CORRECT     OMIT DU   BEG 
  0.0000 
   1  DUMM  DU    M    0  -1  -2     0.000      .0        .0      .00000 
   2  DUMM  DU    M    1   0  -1     1.449      .0        .0      .00000 
   3  DUMM  DU    M    2   1   0     1.522   111.1        .0      .00000 
   4  N1    N     M    3   2   1     1.540   111.208  -180.000  -0.19960 
   5  H2    H     E    4   3   2     1.109    95.742   175.896   0.06071 
   6  C1    CT    M    4   3   2     1.508    24.553   -11.597  -0.35526 
   7  C3    CT    3    6   4   3     1.547   108.577  -128.014   0.13837 
   8  C5    CT    3    7   6   4     1.542   116.449  -147.120   0.00670 
   9  C6    CT    3    8   7   6     1.540   109.799    51.627   0.05288 
  10  C7    CT    3    9   8   7     1.541   109.452   -66.132   0.00670 
  11  C4    CT    B   10   9   8     1.541   111.183    55.175   0.13837 
  12  H11   HC    E   11  10   9     1.140    95.045    89.130   0.01269 
  13  H12   HC    E   11  10   9     1.140   108.659  -157.919   0.01269 
  14  H9    HC    E   10   9   8     1.139   109.318   176.720   0.00419 
  15  H10   HC    E   10   9   8     1.136   108.748   -64.837   0.00419 
  16  H7    HC    E    9   8   7     1.135   109.070    54.776   0.00145 
  17  H8    HC    E    9   8   7     1.138   109.742   174.732   0.00145 
  18  H5    HC    E    8   7   6     1.141   108.627   170.944   0.00419 
  19  H6    HC    E    8   7   6     1.138   110.257   -69.117   0.00419 
  20  H3    HC    E    7   6   4     1.140   107.182    86.273   0.01269 
  21  H4    HC    E    7   6   4     1.140   114.401   -36.027   0.01269 
  22  C2    C     M    6   4   3     1.540   108.193   -11.038   0.21708 
  23  O1    O     E   22   6   4     1.510   119.737   -13.840  -0.13636 
LOOP 
   C4   C1 
 
  
 
2
3
0
 
IMPROPER 
   -M   C1   N1   H2 
   C1   +M   C2   O1 
DONE 
STOP 
 
.frcmod file: 
remark goes here 
MASS 
N  14.010        0.530               same as n   
H  1.008         0.161               same as hn  
CT 12.010        0.878               same as c3  
HC 1.008         0.135               same as hc  
C  12.010        0.616               same as c   
O  16.000        0.434               same as o   
 
BOND 
N -H   410.20   1.009       same as hn-n  
N -CT  330.60   1.460       same as c3-n  
CT-CT  303.10   1.535       same as c3-c3 
CT-C   328.30   1.508       same as c -c3 
CT-HC  337.30   1.092       same as c3-hc 
C -O   648.00   1.214       same as c -o  
 
ANGLE 
N -CT-CT   65.900     112.130   same as c3-c3-n  
N -CT-C    66.700     111.560   same as c -c3-n  
H -N -CT   46.000     116.780   same as c3-n -hn 
CT-CT-CT   63.200     110.630   same as c3-c3-c3 
CT-CT-HC   46.400     110.050   same as c3-c3-hc 
CT-C -O    68.000     123.110   same as c3-c -o  
CT-CT-C    63.800     110.530   same as c -c3-c3 
HC-CT-HC   39.400     108.350   same as hc-c3-hc 
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DIHE 
N -CT-CT-CT   1    0.156         0.000           3.000      same as X -c3-c3-X  
N -CT-CT-HC   1    0.156         0.000           3.000      same as X -c3-c3-X  
N -CT-C -O    1    0.000       180.000           2.000      same as X -c -c3-X  
H -N -CT-CT   1    0.000         0.000           2.000      same as X -c3-n -X  
H -N -CT-C    1    0.000         0.000           2.000      same as X -c3-n -X  
CT-CT-CT-CT   1    0.156         0.000           3.000      same as X -c3-c3-X  
CT-CT-CT-HC   1    0.156         0.000           3.000      same as X -c3-c3-X  
CT-CT-C -O    1    0.000       180.000           2.000      same as X -c -c3-X  
CT-CT-CT-C    1    0.156         0.000           3.000      same as X -c3-c3-X  
HC-CT-CT-C    1    0.156         0.000           3.000      same as X -c3-c3-X  
HC-CT-CT-HC   1    0.156         0.000           3.000      same as X -c3-c3-X  
 
IMPROPER 
 
NONBON 
  N           1.8240  0.1700             same as n   
  H           0.6000  0.0157             same as hn  
  CT          1.9080  0.1094             same as c3  
  HC          1.4870  0.0157             same as hc  
  C           1.9080  0.0860             same as c   
  O           1.6612  0.2100             same as o   
  
  
 
2
3
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ACP 
.prepi file:  
    0    0    2 
This is a remark line 
acp.res 
ACP   INT  0 
CORRECT     OMIT DU   BEG 
  0.0000 
   1  DUMM  DU    M    0  -1  -2     0.000      .0        .0      .00000 
   2  DUMM  DU    M    1   0  -1     1.449      .0        .0      .00000 
   3  DUMM  DU    M    2   1   0     1.522   111.1        .0      .00000 
   4  N1    N     M    3   2   1     1.540   111.208  -180.000  -0.77633 
   5  H1    H     E    4   3   2     0.999    72.335    -8.888   0.37354 
   6  C1    CT    M    4   3   2     1.449    42.298  -178.414   0.18994 
   7  C2    CT    3    6   4   3     1.564   114.519  -121.832  -0.06626 
   8  C3    CT    3    7   6   4     1.545   107.322  -129.327  -0.06953 
   9  C4    CT    3    8   7   6     1.538   105.942   -16.899  -0.06953 
  10  C5    CT    B    9   8   7     1.531   104.413    31.246  -0.06626 
  11  H2    HC    E   10   9   8     1.082   110.067    83.446   0.04057 
  12  H3    HC    E   10   9   8     1.083   113.455  -157.204   0.04057 
  13  H4    HC    E    9   8   7     1.085   111.012   -88.035   0.02957 
  14  H5    HC    E    9   8   7     1.084   112.273   152.937   0.02957 
  15  H6    HC    E    8   7   6     1.085   112.336  -140.135   0.02957 
  16  H7    HC    E    8   7   6     1.084   109.965   101.453   0.02957 
  17  H8    HC    E    7   6   4     1.084   110.829   108.710   0.04057 
  18  H9    HC    E    7   6   4     1.080   110.066    -7.497   0.04057 
  19  C6    C     M    6   4   3     1.549   104.025     0.602   0.76234 
  20  O1    O     E   19   6   4     1.202   121.519    14.503  -0.55848 
LOOP 
   C5   C1 
IMPROPER 
   -M   C1   N1   H1 
   C1   +M   C6   O1 
DONE 
STOP 
  
 
2
3
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.frcmod file: 
remark goes here 
MASS 
N  14.010        0.530               same as n   
H  1.008         0.161               same as hn  
CT 12.010        0.878               same as c3  
HC 1.008         0.135               same as hc  
C  12.010        0.616               same as c   
O  16.000        0.434               same as o   
 
BOND 
N -H   410.20   1.009       same as hn-n  
N -CT  330.60   1.460       same as c3-n  
CT-CT  303.10   1.535       same as c3-c3 
CT-C   328.30   1.508       same as c -c3 
CT-HC  337.30   1.092       same as c3-hc 
C -O   648.00   1.214       same as c -o  
 
ANGLE 
N -CT-CT   65.900     112.130   same as c3-c3-n  
N -CT-C    66.700     111.560   same as c -c3-n  
H -N -CT   46.000     116.780   same as c3-n -hn 
CT-CT-CT   63.200     110.630   same as c3-c3-c3 
CT-CT-HC   46.400     110.050   same as c3-c3-hc 
CT-C -O    68.000     123.110   same as c3-c -o  
CT-CT-C    63.800     110.530   same as c -c3-c3 
HC-CT-HC   39.400     108.350   same as hc-c3-hc 
 
DIHE 
N -CT-CT-CT   1    0.156         0.000           3.000      same as X -c3-c3-X  
N -CT-CT-HC   1    0.156         0.000           3.000      same as X -c3-c3-X  
N -CT-C -O    1    0.000       180.000           2.000      same as X -c -c3-X  
H -N -CT-CT   1    0.000         0.000           2.000      same as X -c3-n -X  
H -N -CT-C    1    0.000         0.000           2.000      same as X -c3-n -X  
CT-CT-CT-CT   1    0.156         0.000           3.000      same as X -c3-c3-X  
CT-CT-CT-HC   1    0.156         0.000           3.000      same as X -c3-c3-X  
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CT-CT-C -O    1    0.000       180.000           2.000      same as X -c -c3-X  
CT-CT-CT-C    1    0.156         0.000           3.000      same as X -c3-c3-X  
HC-CT-CT-C    1    0.156         0.000           3.000      same as X -c3-c3-X  
HC-CT-CT-HC   1    0.156         0.000           3.000      same as X -c3-c3-X  
 
IMPROPER 
 
NONBON 
  N           1.8240  0.1700             same as n   
  H           0.6000  0.0157             same as hn  
  CT          1.9080  0.1094             same as c3  
  HC          1.4870  0.0157             same as hc  
  C           1.9080  0.0860             same as c   
  O           1.6612  0.2100             same as o   
 
 
 
 
 
  
  
 
2
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P-CL PHENYLALANINE 
.mol2 file:  
@<TRIPOS>MOLECULE 
PCL 
20   20    1 
SMALL 
USER_CHARGES 
 
@<TRIPOS>ATOM 
      1 C1         -1.4320   -0.5420    0.5430 Du        1 PCL         0.1063  
      2 C2         -2.8510   -1.1830    0.3800 C         1 PCL         0.6257  
      3 N1         -1.4270    0.8840    0.9730 N.3       1 PCL        -0.7238  
      4 O1         -3.1080   -2.2450    0.9740 O.2       1 PCL        -0.6052  
      5 C3          0.9530   -0.6060   -0.4830 Du        1 PCL         0.4134  
      6 C4          1.7220   -1.5330    0.2520 Du        1 PCL        -0.3506  
      7 C5          3.0980   -1.3470    0.4560 Du        1 PCL        -0.0284  
      8 C6          3.7220   -0.2140   -0.0870 Du        1 PCL        -0.0583  
      9 C7          2.9870    0.7270   -0.8200 Du        1 PCL        -0.0284  
     10 C8          1.6100    0.5240   -1.0110 Du        1 PCL        -0.3506  
     11 Cl1         5.4590    0.0230    0.1480 Cl        1 PCL        -0.1142  
     12 C9         -0.5370   -0.8350   -0.7070 Du        1 PCL        -0.5686  
     13 H1         -1.0100   -1.0870    1.3940 Du        1 PCL         0.0997  
     14 H2         -1.0930    1.0500    1.9160 H         1 PCL         0.3997  
     15 H4          1.2480   -2.4260    0.6640 Du        1 PCL         0.1989  
     16 H5          3.6800   -2.0760    1.0180 Du        1 PCL         0.1387  
     17 H6          3.4820    1.6000   -1.2430 Du        1 PCL         0.1387  
     18 H7          1.0440    1.2520   -1.5950 Du        1 PCL         0.1989  
     19 H8         -0.7070   -1.8900   -0.9660 Du        1 PCL         0.1842  
     20 H9         -0.8900   -0.2340   -1.5530 Du        1 PCL         0.1842  
@<TRIPOS>BOND 
     1    1    2 1     
     2    1    3 1     
     3    1   12 1     
     4    1   13 1     
     5    2    4 2     
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     6    3   14 1     
     7    5    6 1     
     8    5   10 1     
     9    5   12 1     
    10    6    7 1     
    11    6   15 1     
    12    7    8 1     
    13    7   16 1     
    14    8    9 1     
    15    8   11 1     
    16    9   10 1     
    17    9   17 1     
    18   10   18 1     
    19   12   19 1     
    20   12   20 1     
@<TRIPOS>SUBSTRUCTURE 
     1 PCL         1 GROUP             0       ****    0 ROOT     
.frcmod file: 
remark goes here 
MASS 
CT 12.010        0.878               same as c3  
C  12.010        0.616               same as c   
N  14.010        0.530               same as n   
O  16.000        0.434               same as o   
CA 12.010        0.360               same as c2  
Cl 35.450        1.910               same as cl  
H1 1.008         0.135               same as hc  
H  1.008         0.161               same as hn  
HA 1.008         0.135               same as hc  
HC 1.008         0.135               same as hc  
 
BOND 
CT-C   328.30   1.508       same as c -c3 
CT-N   330.60   1.460       same as c3-n  
CT-CT  303.10   1.535       same as c3-c3 
CT-H1  337.30   1.092       same as c3-hc 
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C -O   648.00   1.214       same as c -o  
C -N   478.20   1.345       same as c -n  
N -H   410.20   1.009       same as hn-n  
CA-CA  478.40   1.387       same as ca-ca 
CA-CT  328.30   1.508       same as c2-c3 
CA-HA  344.30   1.087       same as c2-hc 
CA-Cl  328.80   1.722       same as c2-cl 
CT-HC  337.30   1.092       same as c3-hc 
 
ANGLE 
CT-C -O    68.000     123.110   same as c3-c -o  
CT-C -N    67.900     115.150   same as c3-c -n  
CT-N -H    46.000     116.780   same as c3-n -hn 
CT-N -C    63.900     121.350   same as c -n -c3 
CT-CT-CA   63.700     110.960   same as c2-c3-c3 
CT-CT-HC   46.400     110.050   same as c3-c3-hc 
C -CT-N    66.700     111.560   same as c -c3-n  
C -CT-CT   63.800     110.530   same as c -c3-c3 
C -CT-H1   47.200     109.680   same as c -c3-hc 
C -N -H    49.200     118.460   same as c -n -hn 
N -CT-CT   65.900     112.130   same as c3-c3-n  
N -CT-H1   49.800     109.500   same as hc-c3-n  
N -C -O    75.800     122.030   same as n -c -o  
CA-CA-CA   67.200     119.970   same as ca-ca-ca 
CA-CA-HA   50.300     119.700   same as c2-c2-hc 
CA-CT-HC   47.000     110.490   same as c2-c3-hc 
CA-CA-CT   64.300     123.420   same as c2-c2-c3 
CA-CA-Cl   58.400     122.790   same as c2-c2-cl 
CT-CT-H1   46.400     110.050   same as c3-c3-hc 
HC-CT-HC   39.400     108.350   same as hc-c3-hc 
C -CT-HC   47.200     109.680   same as c -c3-hc 
H1-CT-H1   39.400     108.350   same as hc-c3-hc 
 
DIHE 
CT-C -N -H    1    2.500       180.000           2.000      same as X -c -n -X  
CT-C -N -CT   1    2.500       180.000           2.000      same as X -c -n -X  
CT-N -C -O    1    2.500       180.000           2.000      same as X -c -n -X  
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CT-CT-CA-CA   1    0.000         0.000           2.000      same as X -c2-c3-X  
C -CT-N -H    1    0.000         0.000           2.000      same as X -c3-n -X  
C -CT-N -C    1    0.000         0.000           2.000      same as X -c3-n -X  
C -CT-CT-CA   1    0.156         0.000           3.000      same as X -c3-c3-X  
C -CT-CT-HC   1    0.156         0.000           3.000      same as X -c3-c3-X  
C -N -CT-H1   1    0.000         0.000           2.000      same as X -c3-n -X  
N -CT-C -O    1    0.000       180.000           2.000      same as X -c -c3-X  
N -CT-C -N    1    0.000       180.000           2.000      same as X -c -c3-X  
N -CT-CT-CA   1    0.156         0.000           3.000      same as X -c3-c3-X  
N -CT-CT-HC   1    0.156         0.000           3.000      same as X -c3-c3-X  
N -C -CT-HC   1    0.000       180.000           2.000      same as X -c -c3-X  
O -C -CT-CT   1    0.000       180.000           2.000      same as X -c -c3-X  
O -C -CT-H1   1    0.000       180.000           2.000      same as X -c -c3-X  
O -C -N -H    1    2.500       180.000           2.000      same as X -c -n -X  
N -C -CT-CT   1    0.000       180.000           2.000      same as X -c -c3-X  
N -C -CT-H1   1    0.000       180.000           2.000      same as X -c -c3-X  
CA-CA-CA-CA   1    3.625       180.000           2.000      same as X -ca-ca-X  
CA-CA-CA-HA   1    6.650       180.000           2.000      same as X -c2-c2-X  
CA-CT-CT-H1   1    0.156         0.000           3.000      same as X -c3-c3-X  
CA-CA-CT-HC   1    0.000         0.000           2.000      same as X -c2-c3-X  
CA-CA-CA-Cl   1    6.650       180.000           2.000      same as X -c2-c2-X  
CA-CA-CA-CT   1    6.650       180.000           2.000      same as X -c2-c2-X  
Cl-CA-CA-HA   1    6.650       180.000           2.000      same as X -c2-c2-X  
CT-CT-N -H    1    0.000         0.000           2.000      same as X -c3-n -X  
CT-CT-N -C    1    0.000         0.000           2.000      same as X -c3-n -X  
CT-CA-CA-HA   1    6.650       180.000           2.000      same as X -c2-c2-X  
H1-CT-N -H    1    0.000         0.000           2.000      same as X -c3-n -X  
H1-CT-CT-HC   1    0.156         0.000           3.000      same as X -c3-c3-X  
HA-CA-CA-HA   1    6.650       180.000           2.000      same as X -c2-c2-X  
O -C -CT-HC   1    0.000       180.000           2.000      same as X -c -c3-X  
 
IMPROPER 
CT-N -C -O          1.1          180.0         2.0          Using default value 
C -CT-N -H          1.1          180.0         2.0          Using default value 
CA-CA-CA-CT         1.1          180.0         2.0          Using default value 
CA-CA-CA-HA         1.1          180.0         2.0          Using default value 
CA-CA-CA-Cl         1.1          180.0         2.0          Using default value 
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NONBON 
  CT          1.9080  0.1094             same as c3  
  C           1.9080  0.0860             same as c   
  N           1.8240  0.1700             same as n   
  O           1.6612  0.2100             same as o   
  CA          1.9080  0.0860             same as ca  
  Cl          1.9480  0.2650             same as cl  
  H1          1.4870  0.0157             same as hc  
  H           0.6000  0.0157             same as hn  
  HA          1.4870  0.0157             same as hc  
  HC          1.4870  0.0157             same as hc  
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P-F PHENYLALANINE 
.prepi file:  
    0    0    2 
 
This is a remark line 
pFPhe_4.res 
FPH   INT  0 
CORRECT     OMIT DU   BEG 
  0.0000 
   1  DUMM  DU    M    0  -1  -2     0.000      .0        .0      .00000 
   2  DUMM  DU    M    1   0  -1     1.449      .0        .0      .00000 
   3  DUMM  DU    M    2   1   0     1.522   111.1        .0      .00000 
   4  N1    N     M    3   2   1     1.540   111.208   180.000  -0.85235 
   5  H2    H     E    4   3   2     1.016   105.060    58.886   0.40591 
   6  C1    CT    M    4   3   2     1.485   127.402  -159.092   0.17490 
   7  C9    CT    3    6   4   3     1.575   114.015   120.885  -0.00981 
   8  C3    CA    S    7   6   4     1.526   113.417   119.886  -0.04914 
   9  C4    CA    B    8   7   6     1.412   120.830    81.583  -0.10138 
  10  C5    CA    B    9   8   7     1.404   121.268  -178.417  -0.33306 
  11  C6    CA    B   10   9   8     1.396   118.558     0.064   0.43104 
  12  C7    CA    B   11  10   9     1.396   122.216    -0.410  -0.33306 
  13  C8    CA    S   12  11  10     1.406   118.282     0.243  -0.10138 
  14  H7    HA    E   13  12  11     1.092   118.784  -179.360   0.14909 
  15  H6    HA    E   12  11  10     1.089   119.992  -179.202   0.20438 
  16  F1    F     E   11  10   9     1.382   118.950   179.891  -0.24201 
  17  H5    HA    E   10   9   8     1.090   121.529  -179.685   0.20438 
  18  H4    HA    E    9   8   7     1.090   119.241     1.249   0.14909 
  19  H8    HC    E    7   6   4     1.096   108.169  -117.992   0.06182 
  20  H9    HC    E    7   6   4     1.096   108.303    -2.005   0.06182 
  21  H1    H1    E    6   4   3     1.099   104.360  -121.546   0.05788 
  22  C2    C     M    6   4   3     1.566   113.591    -9.092   0.65989 
  23  O1    O     E   22   6   4     1.240   120.893   157.412  -0.53804 
LOOP 
   C8   C3 
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IMPROPER 
   -M   C1   N1   H2 
   C8   C4   C3   C9 
   C3   C5   C4   H4 
   C6   C4   C5   H5 
   C7   C5   C6   F1 
   C6   C8   C7   H6 
   C7   C3   C8   H7 
   C1   +M   C2   O1 
 
DONE 
STOP 
 
.frcmod file: 
remark goes here 
MASS 
N  14.010        0.530               same as n   
H  1.008         0.161               same as hn  
CT 12.010        0.878               same as c3  
CA 12.010        0.360               same as c2  
HA 1.008         0.135               same as hc  
F  19.000        0.320               same as f   
HC 1.008         0.135               same as hc  
H1 1.008         0.135               same as hc  
C  12.010        0.616               same as c   
O  16.000        0.434               same as o   
 
BOND 
N -H   410.20   1.009       same as hn-n  
N -CT  330.60   1.460       same as c3-n  
CT-CT  303.10   1.535       same as c3-c3 
CT-H1  337.30   1.092       same as c3-hc 
CT-C   328.30   1.508       same as c -c3 
CT-CA  328.30   1.508       same as c2-c3 
CT-HC  337.30   1.092       same as c3-hc 
CA-CA  478.40   1.387       same as ca-ca 
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CA-HA  344.30   1.087       same as c2-hc 
CA-F   368.70   1.340       same as c2-f  
C -O   648.00   1.214       same as c -o  
 
ANGLE 
N -CT-CT   65.900     112.130   same as c3-c3-n  
N -CT-H1   49.800     109.500   same as hc-c3-n  
N -CT-C    66.700     111.560   same as c -c3-n  
H -N -CT   46.000     116.780   same as c3-n -hn 
CT-CT-CA   63.700     110.960   same as c2-c3-c3 
CT-CT-HC   46.400     110.050   same as c3-c3-hc 
CT-C -O    68.000     123.110   same as c3-c -o  
CT-CT-H1   46.400     110.050   same as c3-c3-hc 
CT-CT-C    63.800     110.530   same as c -c3-c3 
CT-CA-CA   64.300     123.420   same as c2-c2-c3 
CA-CT-HC   47.000     110.490   same as c2-c3-hc 
CA-CA-CA   67.200     119.970   same as ca-ca-ca 
CA-CA-HA   50.300     119.700   same as c2-c2-hc 
CA-CA-F    67.800     124.010   same as c2-c2-f  
HC-CT-HC   39.400     108.350   same as hc-c3-hc 
H1-CT-C    47.200     109.680   same as c -c3-hc 
 
DIHE 
N -CT-CT-CA   1    0.156         0.000           3.000      same as X -c3-c3-X  
N -CT-CT-HC   1    0.156         0.000           3.000      same as X -c3-c3-X  
N -CT-C -O    1    0.000       180.000           2.000      same as X -c -c3-X  
H -N -CT-CT   1    0.000         0.000           2.000      same as X -c3-n -X  
H -N -CT-H1   1    0.000         0.000           2.000      same as X -c3-n -X  
H -N -CT-C    1    0.000         0.000           2.000      same as X -c3-n -X  
CT-CT-CA-CA   1    0.000         0.000           2.000      same as X -c2-c3-X  
CT-CT-C -O    1    0.000       180.000           2.000      same as X -c -c3-X  
CT-CA-CA-CA   1    6.650       180.000           2.000      same as X -c2-c2-X  
CT-CA-CA-HA   1    6.650       180.000           2.000      same as X -c2-c2-X  
CA-CT-CT-H1   1    0.156         0.000           3.000      same as X -c3-c3-X  
CA-CT-CT-C    1    0.156         0.000           3.000      same as X -c3-c3-X  
CA-CA-CA-CA   1    3.625       180.000           2.000      same as X -ca-ca-X  
CA-CA-CA-HA   1    6.650       180.000           2.000      same as X -c2-c2-X  
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CA-CA-CT-HC   1    0.000         0.000           2.000      same as X -c2-c3-X  
CA-CA-CA-F    1    6.650       180.000           2.000      same as X -c2-c2-X  
HA-CA-CA-HA   1    6.650       180.000           2.000      same as X -c2-c2-X  
HA-CA-CA-F    1    6.650       180.000           2.000      same as X -c2-c2-X  
HC-CT-CT-H1   1    0.156         0.000           3.000      same as X -c3-c3-X  
HC-CT-CT-C    1    0.156         0.000           3.000      same as X -c3-c3-X  
H1-CT-C -O    1    0.000       180.000           2.000      same as X -c -c3-X  
 
IMPROPER 
CA-CA-CA-CT         1.1          180.0         2.0          Using default value 
CA-CA-CA-HA         1.1          180.0         2.0          Using default value 
CA-CA-CA-F          1.1          180.0         2.0          Using default value 
 
NONBON 
  N           1.8240  0.1700             same as n   
  H           0.6000  0.0157             same as hn  
  CT          1.9080  0.1094             same as c3  
  CA          1.9080  0.0860             same as ca  
  HA          1.4870  0.0157             same as hc  
  F           1.7500  0.0610             same as f   
  HC          1.4870  0.0157             same as hc  
  H1          1.4870  0.0157             same as hc  
  C           1.9080  0.0860             same as c   
  O           1.6612  0.2100             same as o   
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LIPIDS 
SDS 
.prepi file:  
    0    0    2 
This is a remark line 
sds.res 
SDS   INT  0 
CORRECT     OMIT DU   BEG 
  0.0000 
   1  DUMM  DU    M    0  -1  -2     0.000      .0        .0      .00000 
   2  DUMM  DU    M    1   0  -1     1.449      .0        .0      .00000 
   3  DUMM  DU    M    2   1   0     1.522   111.1        .0      .00000 
   4  O2    o     M    3   2   1     1.540   111.208  -180.000  -0.67456 
   5  S1    s6    M    4   3   2     1.438    19.047   132.668   1.29138 
   6  O3    o     E    5   4   3     1.447   115.333   102.604  -0.67456 
   7  O4    o     E    5   4   3     1.446   115.321  -122.068  -0.67456 
   8  O1    os    M    5   4   3     1.633   101.805    -9.671  -0.48958 
   9  C1    c3    M    8   5   4     1.406   116.952   176.279   0.21893 
  10  H1    h1    E    9   8   5     1.088   106.699   136.387   0.01297 
  11  H2    h1    E    9   8   5     1.081   110.255    19.894   0.01297 
  12  C2    c3    M    9   8   5     1.524   110.389  -104.017  -0.07803 
  13  H3    hc    E   12   9   8     1.083   108.194    61.303   0.04669 
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  14  H4    hc    E   12   9   8     1.087   107.771   -54.024   0.04669 
  15  C3    c3    M   12   9   8     1.534   114.031  -175.268  -0.04926 
  16  H5    hc    E   15  12   9     1.089   108.534   170.556  -0.00858 
  17  H6    hc    E   15  12   9     1.091   109.647    55.328  -0.00858 
  18  C4    c3    M   15  12   9     1.532   114.631   -67.980   0.02383 
  19  H7    hc    E   18  15  12     1.087   109.980    62.375   0.02701 
  20  H8    hc    E   18  15  12     1.087   109.091   -53.556   0.02701 
  21  C5    c3    M   18  15  12     1.530   112.973  -175.607  -0.04733 
  22  H9    hc    E   21  18  15     1.090   109.344    58.805   0.01570 
  23  H10   hc    E   21  18  15     1.088   109.010   -56.948   0.01570 
  24  C6    c3    M   21  18  15     1.532   112.921  -179.544  -0.06946 
  25  H11   hc    E   24  21  18     1.089   109.288    61.243   0.01568 
  26  H12   hc    E   24  21  18     1.088   108.585   -53.969   0.01568 
  27  C7    c3    M   24  21  18     1.533   114.996  -175.511   0.02242 
  28  H13   hc    E   27  24  21     1.089   108.580   172.050  -0.00530 
  29  H14   hc    E   27  24  21     1.089   109.234    56.778  -0.00530 
  30  C8    c3    M   27  24  21     1.531   114.871   -66.275   0.05251 
  31  H15   hc    E   30  27  24     1.087   110.009    61.960  -0.00785 
  32  H16   hc    E   30  27  24     1.090   109.149   -54.263  -0.00785 
  33  C9    c3    M   30  27  24     1.530   112.992  -176.037  -0.06972 
  34  H17   hc    E   33  30  27     1.089   109.301    58.076   0.00147 
  35  H18   hc    E   33  30  27     1.089   109.279   -57.738   0.00147 
  36  C10   c3    M   33  30  27     1.530   113.347  -179.826   0.03431 
  37  H19   hc    E   36  33  30     1.089   109.290    58.034  -0.00750 
  38  H20   hc    E   36  33  30     1.089   109.326   -57.806  -0.00750 
  39  C11   c3    M   36  33  30     1.530   113.373  -179.881   0.14924 
  40  H21   hc    E   39  36  33     1.088   109.309    58.010  -0.02747 
  41  H22   hc    E   39  36  33     1.088   109.351   -57.957  -0.02747 
  42  C12   c3    M   39  36  33     1.528   113.057  -179.996  -0.24073 
  43  H23   hc    E   42  39  36     1.086   111.185   -59.899   0.04985 
  44  H24   hc    E   42  39  36     1.087   111.385   179.975   0.04985 
  45  H25   hc    E   42  39  36     1.087   111.144    59.958   0.04985 
LOOP 
IMPROPER 
DONE 
STOP  
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POPC 
 
.mol2 file: 
@<TRIPOS>MOLECULE 
POC 
  134   133     1     0     0 
SMALL 
resp 
@<TRIPOS>ATOM 
      1 C1         -4.4310   -2.8040    0.7390 C         1 POC       0.8311 
      2 C2         -3.1620   -3.4380    1.3030 CT        1 POC      -0.3652 
      3 C3         -1.9420   -3.1170    0.3910 CT        1 POC       0.1019 
      4 C4         -0.6050   -3.7060    0.9010 CT        1 POC      -0.0136 
      5 C5          0.5790   -3.3450   -0.0280 CT        1 POC      -0.0809 
      6 C6          1.9660   -3.8310    0.4560 CT        1 POC       0.0519 
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      7 C7          3.1040   -3.4010   -0.5000 CT        1 POC       0.0239 
      8 C8          4.5320   -3.7740   -0.0360 CT        1 POC      -0.0183 
      9 C9          5.6200   -3.2680   -1.0150 CT        1 POC       0.0599 
     10 C10         7.0780   -3.5320   -0.5690 CT        1 POC      -0.0053 
     11 C11         8.1180   -2.9390   -1.5500 CT        1 POC      -0.0029 
     12 C12         9.5920   -3.1180   -1.1190 CT        1 POC       0.0694 
     13 C13        10.5930   -2.4330   -2.0810 CT        1 POC      -0.0269 
     14 C14        12.0740   -2.5510   -1.6520 CT        1 POC      -0.0261 
     15 C15        13.0520   -1.8180   -2.6020 CT        1 POC       0.1280 
     16 C16        14.5320   -1.9180   -2.1680 CT        1 POC      -0.2429 
     17 O1         -5.1580   -3.3190   -0.1040 O         1 POC      -0.5977 
     18 O2         -4.6240   -1.5470    1.2600 OS        1 POC      -0.4534 
     19 C17        -5.7430   -0.7750    0.6930 CT        1 POC      -0.0010 
     20 C18        -5.9400    0.4770    1.5490 CT        1 POC       0.3483 
     21 C19        -7.2010    1.2800    1.1530 CT        1 POC       0.1009 
     22 O3         -4.7330    1.3380    1.6200 OS        1 POC      -0.6032 
     23 C20        -4.2420    1.9610    0.4990 C         1 POC       0.8540 
     24 C21        -3.0020    2.7810    0.8650 CT        1 POC      -0.2087 
     25 O4         -4.7340    1.8860   -0.6220 O         1 POC      -0.6060 
     26 C22        -1.9910    2.9400   -0.2940 CT        1 POC       0.0724 
     27 C23        -0.7370    3.7420    0.1280 CT        1 POC       0.0171 
     28 C24         0.3370    3.8610   -0.9800 CT        1 POC       0.0221 
     29 C25         1.6290    4.5640   -0.5010 CT        1 POC      -0.0242 
     30 C26         2.7470    4.6390   -1.5680 CT        1 POC       0.0170 
     31 C27         4.0760    5.2260   -1.0090 CT        1 POC       0.1055 
     32 C28         5.1910    5.3120   -2.0330 CM        1 POC      -0.2879 
     33 C29         6.2650    4.5020   -2.1530 CM        1 POC      -0.3128 
     34 C30         6.6150    3.2940   -1.3080 CT        1 POC       0.1620 
     35 C31         7.9030    3.4660   -0.4530 CT        1 POC      -0.0279 
     36 C32         8.2340    2.2100    0.3860 CT        1 POC      -0.0455 
     37 C33         9.4930    2.3470    1.2750 CT        1 POC       0.0548 
     38 C34         9.7810    1.0840    2.1220 CT        1 POC      -0.0161 
     39 C35        11.0360    1.1930    3.0200 CT        1 POC      -0.0253 
     40 C36        11.3090   -0.0780    3.8590 CT        1 POC       0.1697 
     41 C37        12.5650    0.0240    4.7520 CT        1 POC      -0.2488 
     42 O5         -8.3400    0.5530    1.6930 OS        1 POC      -0.5218 
     43 P1         -9.7590    0.5410    0.8620 P         1 POC       1.2943 
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     44 O6        -10.8030   -0.1130    1.7400 O2        1 POC      -0.7816 
     45 O7        -10.0250    1.8320    0.1210 O2        1 POC      -0.7816 
     46 O8         -9.2960   -0.6210   -0.3210 OS        1 POC      -0.4951 
     47 C38       -10.1980   -0.7820   -1.4100 CT        1 POC       0.3475 
     48 C39       -11.5030   -1.5170   -0.9630 CT        1 POC      -0.0757 
     49 N1        -12.8580   -0.7730   -1.2030 N3        1 POC       0.1545 
     50 C40       -12.9240    0.5730   -0.4680 CT        1 POC      -0.4259 
     51 H1        -11.4440   -1.6720    0.1190 HP        1 POC       0.0991 
     52 H2          5.0970    6.1300   -2.7560 HA        1 POC       0.1490 
     53 H3         -2.9780   -3.0650    2.3200 HC        1 POC       0.0949 
     54 H4         -3.3230   -4.5230    1.3450 HC        1 POC       0.0949 
     55 H5         -2.1500   -3.4980   -0.6210 HC        1 POC       0.0149 
     56 H6         -1.8440   -2.0240    0.3040 HC        1 POC       0.0149 
     57 H7         -0.4030   -3.3280    1.9170 HC        1 POC       0.0203 
     58 H8         -0.6910   -4.8020    0.9860 HC        1 POC       0.0203 
     59 H9          0.3840   -3.7530   -1.0340 HC        1 POC       0.0142 
     60 H10         0.6130   -2.2480   -0.1460 HC        1 POC       0.0142 
     61 H11         2.1620   -3.4270    1.4640 HC        1 POC      -0.0134 
     62 H12         1.9600   -4.9300    0.5580 HC        1 POC      -0.0134 
     63 H13         2.9230   -3.8380   -1.4960 HC        1 POC      -0.0035 
     64 H14         3.0540   -2.3070   -0.6360 HC        1 POC      -0.0035 
     65 H15         4.7140   -3.3440    0.9640 HC        1 POC      -0.0010 
     66 H16         4.6140   -4.8680    0.0790 HC        1 POC      -0.0010 
     67 H17         5.4570   -3.7260   -2.0050 HC        1 POC      -0.0213 
     68 H18         5.4870   -2.1820   -1.1570 HC        1 POC      -0.0213 
     69 H19         7.2360   -3.0960    0.4320 HC        1 POC      -0.0072 
     70 H20         7.2440   -4.6180   -0.4620 HC        1 POC      -0.0072 
     71 H21         7.9750   -3.3900   -2.5470 HC        1 POC      -0.0039 
     72 H22         7.9120   -1.8620   -1.6720 HC        1 POC      -0.0039 
     73 H23         9.7260   -2.7040   -0.1050 HC        1 POC      -0.0197 
     74 H24         9.8280   -4.1930   -1.0450 HC        1 POC      -0.0197 
     75 H25        10.4730   -2.8570   -3.0930 HC        1 POC      -0.0007 
     76 H26        10.3290   -1.3640   -2.1660 HC        1 POC      -0.0007 
     77 H27        12.1910   -2.1450   -0.6330 HC        1 POC       0.0098 
     78 H28        12.3550   -3.6160   -1.5910 HC        1 POC       0.0098 
     79 H29        12.9440   -2.2260   -3.6210 HC        1 POC      -0.0165 
     80 H30        12.7640   -0.7550   -2.6660 HC        1 POC      -0.0165 
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     81 H31        15.1890   -1.3820   -2.8700 HC        1 POC       0.0552 
     82 H32        14.8670   -2.9660   -2.1280 HC        1 POC       0.0552 
     83 H33        14.6850   -1.4820   -1.1680 HC        1 POC       0.0552 
     84 H34        -5.5130   -0.5320   -0.3480 H1        1 POC       0.0865 
     85 H35        -6.6590   -1.3750    0.7260 H1        1 POC       0.0865 
     86 H36        -6.0540    0.1730    2.5960 H1        1 POC       0.0907 
     87 H37        -7.1570    2.2730    1.6210 H1        1 POC       0.0740 
     88 H38        -7.2860    1.4040    0.0700 H1        1 POC       0.0740 
     89 H39        -3.3640    3.7710    1.1880 HC        1 POC       0.0646 
     90 H40        -2.5270    2.3270    1.7450 HC        1 POC       0.0646 
     91 H41        -1.6840    1.9400   -0.6410 HC        1 POC      -0.0073 
     92 H42        -2.4870    3.4240   -1.1470 HC        1 POC      -0.0073 
     93 H43        -1.0390    4.7520    0.4540 HC        1 POC       0.0001 
     94 H44        -0.2840    3.2590    1.0110 HC        1 POC       0.0001 
     95 H45         0.5930    2.8510   -1.3440 HC        1 POC      -0.0068 
     96 H46        -0.0830    4.4030   -1.8450 HC        1 POC      -0.0068 
     97 H47         1.3870    5.5830   -0.1540 HC        1 POC      -0.0063 
     98 H48         2.0160    4.0260    0.3820 HC        1 POC      -0.0063 
     99 H49         2.9490    3.6310   -1.9650 HC        1 POC       0.0044 
    100 H50         2.4060    5.2460   -2.4230 HC        1 POC       0.0044 
    101 H51         3.8760    6.2390   -0.6190 HC        1 POC       0.0171 
    102 H52         4.3900    4.6230   -0.1450 HC        1 POC       0.0171 
    103 H53         6.9770    4.7260   -2.9560 HA        1 POC       0.1468 
    104 H54         5.7800    3.0310   -0.6430 HC        1 POC       0.0077 
    105 H55         6.7560    2.4280   -1.9790 HC        1 POC       0.0077 
    106 H56         8.7530    3.7050   -1.1140 HC        1 POC       0.0148 
    107 H57         7.7750    4.3350    0.2120 HC        1 POC       0.0148 
    108 H58         7.3680    1.9700    1.0280 HC        1 POC       0.0067 
    109 H59         8.3600    1.3480   -0.2900 HC        1 POC       0.0067 
    110 H60        10.3680    2.5680    0.6410 HC        1 POC      -0.0122 
    111 H61         9.3710    3.2150    1.9460 HC        1 POC      -0.0122 
    112 H62         9.8930    0.2170    1.4490 HC        1 POC       0.0021 
    113 H63         8.9040    0.8670    2.7560 HC        1 POC       0.0021 
    114 H64        11.9170    1.4070    2.3900 HC        1 POC       0.0029 
    115 H65        10.9250    2.0570    3.6970 HC        1 POC       0.0029 
    116 H66        10.4300   -0.2890    4.4910 HC        1 POC      -0.0308 
    117 H67        11.4140   -0.9420    3.1820 HC        1 POC      -0.0308 
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    118 H68        12.7210   -0.9010    5.3270 HC        1 POC       0.0545 
    119 H69        12.4780    0.8540    5.4710 HC        1 POC       0.0545 
    120 H70        13.4700    0.2000    4.1500 HC        1 POC       0.0545 
    121 H71       -10.4140    0.1900   -1.8820 H1        1 POC      -0.0146 
    122 H72        -9.6820   -1.4090   -2.1510 H1        1 POC      -0.0146 
    123 H73       -11.6250   -2.4740   -1.4840 HP        1 POC       0.0991 
    124 C41       -13.0800   -0.5540   -2.6900 CT        1 POC      -0.4259 
    125 C42       -13.9640   -1.6660   -0.6580 CT        1 POC      -0.4259 
    126 H74       -13.9170    0.9980   -0.6480 HP        1 POC       0.1928 
    127 H75       -12.1330    1.2330   -0.8330 HP        1 POC       0.1928 
    128 H76       -12.7300    0.3920    0.5930 HP        1 POC       0.1928 
    129 H77       -14.0590   -0.0890   -2.8370 HP        1 POC       0.1928 
    130 H78       -13.0410   -1.5200   -3.2040 HP        1 POC       0.1928 
    131 H79       -12.2980    0.1060   -3.0720 HP        1 POC       0.1928 
    132 H80       -14.9280   -1.1740   -0.8200 HP        1 POC       0.1928 
    133 H81       -13.7910   -1.8110    0.4110 HP        1 POC       0.1928 
    134 H82       -13.9400   -2.6280   -1.1790 HP        1 POC       0.1928 
@<TRIPOS>BOND 
     1    1    2 1    
     2    1   17 2    
     3    1   18 1    
     4    2    3 1    
     5    2   53 1    
     6    2   54 1    
     7    3    4 1    
     8    3   55 1    
     9    3   56 1    
    10    4    5 1    
    11    4   57 1    
    12    4   58 1    
    13    5    6 1    
    14    5   59 1    
    15    5   60 1    
    16    6    7 1    
    17    6   61 1    
    18    6   62 1    
    19    7    8 1    
    20    7   63 1    
    21    7   64 1    
    22    8    9 1    
    23    8   65 1    
    24    8   66 1    
    25    9   10 1    
    26    9   67 1    
    27    9   68 1    
    28   10   11 1    
    29   10   69 1    
    30   10   70 1    
    31   11   12 1    
    32   11   71 1    
    33   11   72 1    
    34   12   13 1    
    35   12   73 1    
    36   12   74 1    
    37   13   14 1    
    38   13   75 1    
    39   13   76 1    
    40   14   15 1    
    41   14   77 1    
    42   14   78 1    
    43   15   16 1    
    44   15   79 1    
    45   15   80 1    
    46   16   81 1    
    47   16   82 1    
    48   16   83 1    
    49   18   19 1    
    50   19   20 1    
    51   19   84 1    
    52   19   85 1    
    53   20   21 1    
    54   20   22 1    
    55   20   86 1    
    56   21   42 1    
    57   21   87 1    
    58   21   88 1    
    59   22   23 1    
    60   23   24 1    
    61   23   25 2    
    62   24   26 1    
    63   24   89 1    
    64   24   90 1    
    65   26   27 1    
    66   26   91 1    
    67   26   92 1    
    68   27   28 1    
    69   27   93 1    
    70   27   94 1    
    71   28   29 1    
    72   28   95 1    
    73   28   96 1    
    74   29   30 1    
    75   29   97 1    
    76   29   98 1    
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    77   30   31 1    
    78   30   99 1    
    79   30  100 1    
    80   31   32 1    
    81   31  101 1    
    82   31  102 1    
    83   32   33 2    
    84   32   52 1    
    85   33   34 1    
    86   33  103 1    
    87   34   35 1    
    88   34  104 1    
    89   34  105 1    
    90   35   36 1    
    91   35  106 1    
    92   35  107 1    
    93   36   37 1    
    94   36  108 1    
    95   36  109 1    
    96   37   38 1    
    97   37  110 1    
    98   37  111 1    
    99   38   39 1    
   100   38  112 1    
   101   38  113 1    
   102   39   40 1    
   103   39  114 1    
   104   39  115 1    
   105   40   41 1    
   106   40  116 1    
   107   40  117 1    
   108   41  118 1    
   109   41  119 1    
   110   41  120 1    
   111   42   43 1    
   112   43   44 1    
   113   43   45 1    
   114   43   46 1    
   115   46   47 1    
   116   47   48 1    
   117   47  121 1    
   118   47  122 1    
   119   48   49 1    
   120   48   51 1    
   121   48  123 1    
   122   49   50 1    
   123   49  124 1    
   124   49  125 1    
   125   50  126 1    
   126   50  127 1    
   127   50  128 1    
   128  124  129 1    
   129  124  130 1    
   130  124  131 1    
   131  125  132 1    
   132  125  133 1    
   133  125  134 1    
@<TRIPOS>SUBSTRUCTURE 
     1 POC         1 TEMP              0 ****  ****    0 ROOT 
.frcmod file: 
remark goes here 
MASS 
C  12.010        0.616               same as c   
CT 12.010        0.878               same as c3  
O  16.000        0.434               same as o   
OS 16.000        0.465               same as os  
CM 12.010        0.360               same as c2  
P  30.970        1.538               same as p4  
O2 16.000        0.434               same as o   
N3 14.010        0.530               same as n4  
HP 1.008         0.135               same as hc  
HA 1.008         0.135               same as hc  
HC 1.008         0.135               same as hc  
H1 1.008         0.135               same as hc  
 
BOND 
C -CT  328.30   1.508       same as c -c3 
C -O   648.00   1.214       same as c -o  
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C -OS  411.30   1.343       same as c -os 
CT-CT  303.10   1.535       same as c3-c3 
CT-HC  337.30   1.092       same as c3-hc 
OS-CT  301.50   1.439       same as c3-os 
CT-H1  337.30   1.092       same as c3-hc 
CT-CM  328.30   1.508       same as c2-c3 
CM-CM  418.30   1.429       same as cc-cc 
CM-HA  344.30   1.087       same as c2-hc 
OS-P   311.60   1.636       same as os-p4 
P -O2  456.40   1.503       same as o -p4 
CT-N3  293.60   1.499       same as c3-n4 
CT-HP  337.30   1.092       same as c3-hc 
 
ANGLE 
C -CT-CT   63.800     110.530   same as c -c3-c3 
C -CT-HC   47.200     109.680   same as c -c3-hc 
C -OS-CT   63.600     115.140   same as c -os-c3 
CT-C -O    68.000     123.110   same as c3-c -o  
CT-C -OS   69.300     111.960   same as c3-c -os 
CT-CT-CT   63.200     110.630   same as c3-c3-c3 
CT-CT-HC   46.400     110.050   same as c3-c3-hc 
O -C -OS   76.200     122.430   same as o -c -os 
OS-CT-CT   67.800     108.420   same as c3-c3-os 
OS-CT-H1   50.900     108.700   same as hc-c3-os 
CT-CT-H1   46.400     110.050   same as c3-c3-hc 
CT-OS-P    77.600     117.480   same as c3-os-p4 
CT-CT-CM   63.700     110.960   same as c2-c3-c3 
CT-CM-CM   64.300     123.420   same as c2-c2-c3 
CT-CM-HA   45.100     120.000   same as c3-c2-hc 
CM-CT-HC   47.000     110.490   same as c2-c3-hc 
CM-CM-HA   50.300     119.700   same as c2-c2-hc 
OS-P -O2   43.100     116.670   same as o -p4-os 
OS-P -OS   44.700     100.340   same as os-p4-os 
O2-P -O2   45.100     117.220   same as o -p4-o  
CT-CT-N3   66.000     108.930   same as c3-c3-n4 
CT-CT-HP   46.400     110.050   same as c3-c3-hc 
CT-N3-CT   62.800     110.640   same as c3-n4-c3 
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N3-CT-HP   49.000     107.900   same as hc-c3-n4 
HP-CT-HP   39.400     108.350   same as hc-c3-hc 
HC-CT-HC   39.400     108.350   same as hc-c3-hc 
H1-CT-H1   39.400     108.350   same as hc-c3-hc 
 
DIHE 
C -CT-CT-CT   1    0.156         0.000           3.000      same as X -c3-c3-X  
C -CT-CT-HC   1    0.156         0.000           3.000      same as X -c3-c3-X  
C -OS-CT-CT   1    0.383         0.000           3.000      same as X -c3-os-X  
C -OS-CT-H1   1    0.383         0.000           3.000      same as X -c3-os-X  
CT-C -OS-CT   1    2.700       180.000           2.000      same as X -c -os-X  
CT-CT-CT-CT   1    0.156         0.000           3.000      same as X -c3-c3-X  
CT-CT-CT-HC   1    0.156         0.000           3.000      same as X -c3-c3-X  
CT-CT-C -O    1    0.000       180.000           2.000      same as X -c -c3-X  
CT-CT-C -OS   1    0.000       180.000           2.000      same as X -c -c3-X  
O -C -CT-HC   1    0.000       180.000           2.000      same as X -c -c3-X  
O -C -OS-CT   1    2.700       180.000           2.000      same as X -c -os-X  
OS-C -CT-HC   1    0.000       180.000           2.000      same as X -c -c3-X  
OS-CT-CT-CT   1    0.156         0.000           3.000      same as X -c3-c3-X  
OS-CT-CT-OS   1    0.156         0.000           3.000      same as X -c3-c3-X  
OS-CT-CT-H1   1    0.156         0.000           3.000      same as X -c3-c3-X  
CT-CT-CT-H1   1    0.156         0.000           3.000      same as X -c3-c3-X  
CT-CT-OS-P    1    0.383         0.000           3.000      same as X -c3-os-X  
CT-OS-P -O2   1    1.050       180.000           2.000      same as X -os-p4-X  
CT-OS-P -OS   1    1.050       180.000           2.000      same as X -os-p4-X  
CT-CT-CT-CM   1    0.156         0.000           3.000      same as X -c3-c3-X  
CT-CT-CM-CM   1    0.000         0.000           2.000      same as X -c2-c3-X  
CT-CT-CM-HA   1    0.000         0.000           2.000      same as X -c2-c3-X  
CT-CM-CM-CT   1    6.650       180.000           2.000      same as X -c2-c2-X  
CT-CM-CM-HA   1    6.650       180.000           2.000      same as X -c2-c2-X  
CM-CT-CT-HC   1    0.156         0.000           3.000      same as X -c3-c3-X  
CM-CM-CT-HC   1    0.000         0.000           2.000      same as X -c2-c3-X  
P -OS-CT-H1   1    0.383         0.000           3.000      same as X -c3-os-X  
OS-CT-CT-N3   1    0.156         0.000           3.000      same as X -c3-c3-X  
OS-CT-CT-HP   1    0.156         0.000           3.000      same as X -c3-c3-X  
CT-CT-N3-CT   1    0.156         0.000           3.000      same as X -c3-n4-X  
CT-N3-CT-HP   1    0.156         0.000           3.000      same as X -c3-n4-X  
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N3-CT-CT-H1   1    0.156         0.000           3.000      same as X -c3-c3-X  
HP-CT-CT-H1   1    0.156         0.000           3.000      same as X -c3-c3-X  
HA-CM-CT-HC   1    0.000         0.000           2.000      same as X -c2-c3-X  
HA-CM-CM-HA   1    6.650       180.000           2.000      same as X -c2-c2-X  
HC-CT-CT-HC   1    0.156         0.000           3.000      same as X -c3-c3-X  
H1-CT-CT-H1   1    0.156         0.000           3.000      same as X -c3-c3-X  
 
IMPROPER 
CT-O -C -OS         1.1          180.0         2.0          Using default value 
CM-CT-CM-HA         1.1          180.0         2.0          Using default value 
 
NONBON 
  C           1.9080  0.0860             same as c   
  CT          1.9080  0.1094             same as c3  
  O           1.6612  0.2100             same as o   
  OS          1.6837  0.1700             same as os  
  CM          1.9080  0.0860             same as cc  
  P           2.1000  0.2000             same as p4  
  O2          1.6612  0.2100             same as o   
  N3          1.8240  0.1700             same as n4  
  HP          1.4870  0.0157             same as hc  
  HA          1.4870  0.0157             same as hc  
  HC          1.4870  0.0157             same as hc  
  H1          1.4870  0.0157             same as hc  
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POPG 
 
.mol2 file:  
@<TRIPOS>MOLECULE 
POG 
  127   126     1     0     0 
SMALL 
resp 
@<TRIPOS>ATOM 
      1 C1          4.5080    3.4210    0.9000 C         1 POG       0.8405 
      2 C2          3.1430    3.7480    1.5140 CT        1 POG      -0.4121 
      3 C3          2.0230    3.5210    0.4600 CT        1 POG       0.0549 
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      4 C4          0.5880    3.7820    0.9770 CT        1 POG      -0.0511 
      5 C5         -0.4760    3.5290   -0.1200 CT        1 POG      -0.0190 
      6 C6         -1.9480    3.6370    0.3480 CT        1 POG      -0.0574 
      7 C7         -2.9540    3.2990   -0.7810 CT        1 POG       0.1014 
      8 C8         -4.4420    3.2870   -0.3540 CT        1 POG      -0.0547 
      9 C9         -5.3880    2.8220   -1.4880 CT        1 POG       0.0496 
     10 C10        -6.8750    2.6920   -1.0790 CT        1 POG       0.0042 
     11 C11        -7.7570    2.0510   -2.1800 CT        1 POG      -0.0262 
     12 C12        -9.2090    1.7500   -1.7350 CT        1 POG       0.1264 
     13 C13       -10.0210    0.9280   -2.7660 CT        1 POG      -0.0691 
     14 C14       -11.4110    0.4790   -2.2540 CT        1 POG       0.0010 
     15 C15       -12.1940   -0.4050   -3.2540 CT        1 POG       0.1184 
     16 C16       -13.5480   -0.9100   -2.7050 CT        1 POG      -0.2710 
     17 O1          5.0860    4.1480    0.0990 O         1 POG      -0.6061 
     18 O2          4.9560    2.1990    1.3180 OS        1 POG      -0.4641 
     19 C17         6.1670    1.6590    0.6510 CT        1 POG       0.0155 
     20 C18         6.6040    0.4190    1.4280 CT        1 POG       0.2668 
     21 C19         7.8240   -0.3090    0.8040 CT        1 POG       0.0580 
     22 O3          5.4940   -0.5740    1.3840 OS        1 POG      -0.5269 
     23 C20         4.9890   -1.0650    2.5540 C         1 POG       0.7444 
     24 C21         3.8790   -2.0810    2.2620 CT        1 POG      -0.2676 
     25 O4          5.3620   -0.7530    3.6820 O         1 POG      -0.5884 
     26 C22         2.6350   -1.4470    1.5860 CT        1 POG       0.0447 
     27 C23         1.5450   -2.4790    1.2130 CT        1 POG      -0.0388 
     28 C24         0.3410   -1.8390    0.4820 CT        1 POG       0.0075 
     29 C25        -0.7330   -2.8500    0.0170 CT        1 POG      -0.0396 
     30 C26        -1.8870   -2.1870   -0.7720 CT        1 POG       0.0440 
     31 C27        -2.9500   -3.1920   -1.3000 CT        1 POG       0.0760 
     32 C28        -4.0000   -2.5240   -2.1630 CM        1 POG      -0.2495 
     33 C29        -5.3360   -2.4570   -1.9790 CM        1 POG      -0.2929 
     34 C30        -6.1790   -3.0520   -0.8690 CT        1 POG       0.0552 
     35 C31        -6.9920   -1.9820   -0.0850 CT        1 POG       0.0249 
     36 C32        -8.1240   -2.5680    0.7910 CT        1 POG      -0.1027 
     37 C33        -8.9360   -1.4890    1.5500 CT        1 POG       0.1728 
     38 C34       -10.2050   -2.0280    2.2520 CT        1 POG      -0.0701 
     39 C35       -11.0660   -0.9240    2.9110 CT        1 POG       0.0314 
     40 C36       -12.3730   -1.4480    3.5520 CT        1 POG       0.1143 
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     41 C37       -13.2570   -0.3340    4.1550 CT        1 POG      -0.2351 
     42 O5          9.0030    0.5060    0.8360 OS        1 POG      -0.5591 
     43 P1          9.6820    0.9650   -0.6610 P         1 POG       1.2657 
     44 O6          8.5640    1.3180   -1.6070 O2        1 POG      -0.7815 
     45 O7         10.8550    1.8360   -0.2980 O2        1 POG      -0.7815 
     46 O8         10.2430   -0.5380   -1.2190 OS        1 POG      -0.5584 
     47 C38        11.4590   -1.0710   -0.6690 CT        1 POG       0.2972 
     48 C39        12.1520   -1.9070   -1.7640 CT        1 POG       0.1672 
     49 C40        11.4450   -3.2240   -2.1290 CT        1 POG       0.1872 
     50 O9         11.4830   -4.2040   -1.0620 OH        1 POG      -0.6631 
     51 O10        13.5130   -2.2860   -1.3510 OH        1 POG      -0.6877 
     52 H1         -3.5980   -2.0260   -3.0530 HA        1 POG       0.1314 
     53 H2          2.9670    3.1290    2.4040 HC        1 POG       0.1140 
     54 H3          3.1600    4.8050    1.8160 HC        1 POG       0.1140 
     55 H4          2.2260    4.1710   -0.4040 HC        1 POG       0.0269 
     56 H5          2.0870    2.4840    0.0940 HC        1 POG       0.0269 
     57 H6          0.3840    3.1300    1.8440 HC        1 POG       0.0287 
     58 H7          0.5080    4.8200    1.3420 HC        1 POG       0.0287 
     59 H8         -0.3090    4.2330   -0.9520 HC        1 POG       0.0081 
     60 H9         -0.3160    2.5210   -0.5390 HC        1 POG       0.0081 
     61 H10        -2.1110    2.9470    1.1940 HC        1 POG       0.0083 
     62 H11        -2.1460    4.6510    0.7350 HC        1 POG       0.0083 
     63 H12        -2.8190    4.0100   -1.6140 HC        1 POG      -0.0223 
     64 H13        -2.7000    2.3050   -1.1860 HC        1 POG      -0.0223 
     65 H14        -4.5600    2.6060    0.5070 HC        1 POG       0.0083 
     66 H15        -4.7410    4.2870    0.0030 HC        1 POG       0.0083 
     67 H16        -5.2970    3.5060   -2.3490 HC        1 POG      -0.0157 
     68 H17        -5.0390    1.8380   -1.8450 HC        1 POG      -0.0157 
     69 H18        -6.9370    2.0640   -0.1740 HC        1 POG      -0.0112 
     70 H19        -7.2780    3.6790   -0.7970 HC        1 POG      -0.0112 
     71 H20        -7.7640    2.6910   -3.0780 HC        1 POG      -0.0007 
     72 H21        -7.2840    1.1030   -2.4870 HC        1 POG      -0.0007 
     73 H22        -9.1720    1.1840   -0.7900 HC        1 POG      -0.0350 
     74 H23        -9.7370    2.6910   -1.5050 HC        1 POG      -0.0350 
     75 H24       -10.1380    1.5060   -3.6980 HC        1 POG       0.0034 
     76 H25        -9.4400    0.0300   -3.0370 HC        1 POG       0.0034 
     77 H26       -11.2790   -0.0820   -1.3130 HC        1 POG       0.0060 
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     78 H27       -12.0160    1.3660   -1.9990 HC        1 POG       0.0060 
     79 H28       -12.3650    0.1580   -4.1860 HC        1 POG      -0.0117 
     80 H29       -11.5720   -1.2730   -3.5310 HC        1 POG      -0.0117 
     81 H30       -14.0790   -1.5200   -3.4520 HC        1 POG       0.0627 
     82 H31       -14.2050   -0.0710   -2.4280 HC        1 POG       0.0627 
     83 H32       -13.4060   -1.5320   -1.8070 HC        1 POG       0.0627 
     84 H33         5.9210    1.4310   -0.3920 H1        1 POG       0.1386 
     85 H34         6.9670    2.4040    0.6550 H1        1 POG       0.1386 
     86 H35         6.7930    0.6680    2.4770 H1        1 POG       0.0878 
     87 H36         8.0060   -1.2150    1.4060 H1        1 POG       0.0894 
     88 H37         7.5720   -0.6140   -0.2210 H1        1 POG       0.0894 
     89 H38         4.2950   -2.8570    1.6010 HC        1 POG       0.0797 
     90 H39         3.6080   -2.5510    3.2160 HC        1 POG       0.0797 
     91 H40         2.2090   -0.6850    2.2590 HC        1 POG       0.0320 
     92 H41         2.9590   -0.9210    0.6780 HC        1 POG       0.0320 
     93 H42         1.9910   -3.2520    0.5640 HC        1 POG       0.0215 
     94 H43         1.1950   -3.0010    2.1200 HC        1 POG       0.0215 
     95 H44        -0.1250   -1.0840    1.1380 HC        1 POG      -0.0010 
     96 H45         0.7150   -1.2900   -0.3980 HC        1 POG      -0.0010 
     97 H46        -0.2570   -3.6170   -0.6170 HC        1 POG      -0.0027 
     98 H47        -1.1430   -3.3840    0.8920 HC        1 POG      -0.0027 
     99 H48        -2.3870   -1.4350   -0.1400 HC        1 POG       0.0083 
    100 H49        -1.4640   -1.6350   -1.6280 HC        1 POG       0.0083 
    101 H50        -2.4300   -3.9530   -1.9090 HC        1 POG       0.0192 
    102 H51        -3.4060   -3.7290   -0.4560 HC        1 POG       0.0192 
    103 H52        -5.9090   -1.9040   -2.7320 HA        1 POG       0.1476 
    104 H53        -6.8880   -3.7710   -1.3180 HC        1 POG       0.0279 
    105 H54        -5.5600   -3.6290   -0.1670 HC        1 POG       0.0279 
    106 H55        -6.2970   -1.3990    0.5410 HC        1 POG       0.0201 
    107 H56        -7.4290   -1.2680   -0.8010 HC        1 POG       0.0201 
    108 H57        -8.8080   -3.1470    0.1460 HC        1 POG       0.0091 
    109 H58        -7.7020   -3.2870    1.5140 HC        1 POG       0.0091 
    110 H59        -8.2860   -0.9930    2.2900 HC        1 POG      -0.0410 
    111 H60        -9.2380   -0.7050    0.8360 HC        1 POG      -0.0410 
    112 H61       -10.8190   -2.5680    1.5110 HC        1 POG       0.0047 
    113 H62        -9.9190   -2.7740    3.0140 HC        1 POG       0.0047 
    114 H63       -10.4680   -0.4030    3.6780 HC        1 POG      -0.0118 
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    115 H64       -11.3210   -0.1640    2.1520 HC        1 POG      -0.0118 
    116 H65       -12.9520   -1.9970    2.7900 HC        1 POG      -0.0171 
    117 H66       -12.1260   -2.1830    4.3360 HC        1 POG      -0.0171 
    118 H67       -14.1740   -0.7500    4.6010 HC        1 POG       0.0535 
    119 H68       -13.5600    0.3940    3.3870 HC        1 POG       0.0535 
    120 H69       -12.7220    0.2180    4.9440 HC        1 POG       0.0535 
    121 H70        12.1240   -0.2420   -0.3730 H1        1 POG       0.0074 
    122 H71        11.2490   -1.6900    0.2190 H1        1 POG       0.0074 
    123 H72        12.2070   -1.2890   -2.6760 H1        1 POG       0.0340 
    124 H73        10.3890   -3.0160   -2.3380 H1        1 POG       0.0373 
    125 H74        11.9130   -3.6420   -3.0390 H1        1 POG       0.0373 
    126 H75        12.3940   -4.1550   -0.7100 HO        1 POG       0.3996 
    127 H76        13.8780   -1.5260   -0.8600 HO        1 POG       0.3985 
@<TRIPOS>BOND 
     1    1    2 1    
     2    1   17 2    
     3    1   18 1    
     4    2    3 1    
     5    2   53 1    
     6    2   54 1    
     7    3    4 1    
     8    3   55 1    
     9    3   56 1    
    10    4    5 1    
    11    4   57 1    
    12    4   58 1    
    13    5    6 1    
    14    5   59 1    
    15    5   60 1    
    16    6    7 1    
    17    6   61 1    
    18    6   62 1    
    19    7    8 1    
    20    7   63 1    
    21    7   64 1    
    22    8    9 1    
    23    8   65 1    
    24    8   66 1    
    25    9   10 1    
    26    9   67 1    
    27    9   68 1    
    28   10   11 1    
    29   10   69 1    
    30   10   70 1    
    31   11   12 1    
    32   11   71 1    
    33   11   72 1    
    34   12   13 1    
    35   12   73 1    
    36   12   74 1    
    37   13   14 1    
    38   13   75 1    
    39   13   76 1    
    40   14   15 1    
    41   14   77 1    
    42   14   78 1    
    43   15   16 1    
    44   15   79 1    
    45   15   80 1    
    46   16   81 1    
    47   16   82 1    
    48   16   83 1    
    49   18   19 1    
    50   19   20 1    
    51   19   84 1    
    52   19   85 1    
    53   20   21 1    
    54   20   22 1    
    55   20   86 1    
    56   21   42 1    
    57   21   87 1    
    58   21   88 1    
    59   22   23 1    
    60   23   24 1    
    61   23   25 2    
    62   24   26 1    
    63   24   89 1    
    64   24   90 1    
    65   26   27 1    
    66   26   91 1    
    67   26   92 1    
    68   27   28 1    
    69   27   93 1    
    70   27   94 1    
    71   28   29 1    
    72   28   95 1    
    73   28   96 1    
    74   29   30 1    
    75   29   97 1    
    76   29   98 1    
    77   30   31 1    
    78   30   99 1    
    79   30  100 1    
    80   31   32 1    
    81   31  101 1    
    82   31  102 1    
    83   32   33 2    
    84   32   52 1    
    85   33   34 1    
    86   33  103 1    
    87   34   35 1    
    88   34  104 1    
    89   34  105 1    
    90   35   36 1    
    91   35  106 1    
    92   35  107 1    
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    93   36   37 1    
    94   36  108 1    
    95   36  109 1    
    96   37   38 1    
    97   37  110 1    
    98   37  111 1    
    99   38   39 1    
   100   38  112 1    
   101   38  113 1    
   102   39   40 1    
   103   39  114 1    
   104   39  115 1    
   105   40   41 1    
   106   40  116 1    
   107   40  117 1    
   108   41  118 1    
   109   41  119 1    
   110   41  120 1    
   111   42   43 1    
   112   43   44 1    
   113   43   45 1    
   114   43   46 1    
   115   46   47 1    
   116   47   48 1    
   117   47  121 1    
   118   47  122 1    
   119   48   49 1    
   120   48   51 1    
   121   48  123 1    
   122   49   50 1    
   123   49  124 1    
   124   49  125 1    
   125   50  126 1    
   126   51  127 1    
@<TRIPOS>SUBSTRUCTURE 
     1 POG         1 TEMP              0 ****  ****    0 ROOT 
 
.frcmod file: 
remark goes here 
MASS 
C  12.010        0.616               same as c   
CT 12.010        0.878               same as c3  
O  16.000        0.434               same as o   
OS 16.000        0.465               same as os  
CM 12.010        0.360               same as c2  
P  30.970        1.538               same as p4  
O2 16.000        0.434               same as o   
OH 16.000        0.465               same as oh  
HA 1.008         0.135               same as hc  
HC 1.008         0.135               same as hc  
H1 1.008         0.135               same as hc  
HO 1.008         0.135               same as ho  
 
BOND 
C -CT  328.30   1.508       same as c -c3 
C -O   648.00   1.214       same as c -o  
C -OS  411.30   1.343       same as c -os 
CT-CT  303.10   1.535       same as c3-c3 
CT-HC  337.30   1.092       same as c3-hc 
OS-CT  301.50   1.439       same as c3-os 
CT-H1  337.30   1.092       same as c3-hc 
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CT-CM  328.30   1.508       same as c2-c3 
CM-CM  418.30   1.429       same as cc-cc 
CM-HA  344.30   1.087       same as c2-hc 
OS-P   311.60   1.636       same as os-p4 
P -O2  456.40   1.503       same as o -p4 
CT-OH  314.10   1.426       same as c3-oh 
OH-HO  369.60   0.974       same as ho-oh 
 
ANGLE 
C -CT-CT   63.800     110.530   same as c -c3-c3 
C -CT-HC   47.200     109.680   same as c -c3-hc 
C -OS-CT   63.600     115.140   same as c -os-c3 
CT-C -O    68.000     123.110   same as c3-c -o  
CT-C -OS   69.300     111.960   same as c3-c -os 
CT-CT-CT   63.200     110.630   same as c3-c3-c3 
CT-CT-HC   46.400     110.050   same as c3-c3-hc 
O -C -OS   76.200     122.430   same as o -c -os 
OS-CT-CT   67.800     108.420   same as c3-c3-os 
OS-CT-H1   50.900     108.700   same as hc-c3-os 
CT-CT-H1   46.400     110.050   same as c3-c3-hc 
CT-OS-P    77.600     117.480   same as c3-os-p4 
CT-CT-CM   63.700     110.960   same as c2-c3-c3 
CT-CM-CM   64.300     123.420   same as c2-c2-c3 
CT-CM-HA   45.100     120.000   same as c3-c2-hc 
CM-CT-HC   47.000     110.490   same as c2-c3-hc 
CM-CM-HA   50.300     119.700   same as c2-c2-hc 
OS-P -O2   43.100     116.670   same as o -p4-os 
OS-P -OS   44.700     100.340   same as os-p4-os 
O2-P -O2   45.100     117.220   same as o -p4-o  
CT-CT-OH   67.700     109.430   same as c3-c3-oh 
CT-OH-HO   47.100     108.160   same as c3-oh-ho 
OH-CT-H1   51.100     109.500   same as hc-c3-oh 
HC-CT-HC   39.400     108.350   same as hc-c3-hc 
H1-CT-H1   39.400     108.350   same as hc-c3-hc 
 
DIHE 
C -CT-CT-CT   1    0.156         0.000           3.000      same as X -c3-c3-X  
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C -CT-CT-HC   1    0.156         0.000           3.000      same as X -c3-c3-X  
C -OS-CT-CT   1    0.383         0.000           3.000      same as X -c3-os-X  
C -OS-CT-H1   1    0.383         0.000           3.000      same as X -c3-os-X  
CT-C -OS-CT   1    2.700       180.000           2.000      same as X -c -os-X  
CT-CT-CT-CT   1    0.156         0.000           3.000      same as X -c3-c3-X  
CT-CT-CT-HC   1    0.156         0.000           3.000      same as X -c3-c3-X  
CT-CT-C -O    1    0.000       180.000           2.000      same as X -c -c3-X  
CT-CT-C -OS   1    0.000       180.000           2.000      same as X -c -c3-X  
O -C -CT-HC   1    0.000       180.000           2.000      same as X -c -c3-X  
O -C -OS-CT   1    2.700       180.000           2.000      same as X -c -os-X  
OS-C -CT-HC   1    0.000       180.000           2.000      same as X -c -c3-X  
OS-CT-CT-CT   1    0.156         0.000           3.000      same as X -c3-c3-X  
OS-CT-CT-OS   1    0.156         0.000           3.000      same as X -c3-c3-X  
OS-CT-CT-H1   1    0.156         0.000           3.000      same as X -c3-c3-X  
CT-CT-CT-H1   1    0.156         0.000           3.000      same as X -c3-c3-X  
CT-CT-OS-P    1    0.383         0.000           3.000      same as X -c3-os-X  
CT-OS-P -O2   1    1.050       180.000           2.000      same as X -os-p4-X  
CT-OS-P -OS   1    1.050       180.000           2.000      same as X -os-p4-X  
CT-CT-CT-CM   1    0.156         0.000           3.000      same as X -c3-c3-X  
CT-CT-CM-CM   1    0.000         0.000           2.000      same as X -c2-c3-X  
CT-CT-CM-HA   1    0.000         0.000           2.000      same as X -c2-c3-X  
CT-CM-CM-CT   1    6.650       180.000           2.000      same as X -c2-c2-X  
CT-CM-CM-HA   1    6.650       180.000           2.000      same as X -c2-c2-X  
CM-CT-CT-HC   1    0.156         0.000           3.000      same as X -c3-c3-X  
CM-CM-CT-HC   1    0.000         0.000           2.000      same as X -c2-c3-X  
P -OS-CT-H1   1    0.383         0.000           3.000      same as X -c3-os-X  
OS-CT-CT-OH   1    0.156         0.000           3.000      same as X -c3-c3-X  
CT-CT-CT-OH   1    0.156         0.000           3.000      same as X -c3-c3-X  
CT-CT-OH-HO   1    0.167         0.000           3.000      same as X -c3-oh-X  
OH-CT-CT-OH   1    0.156         0.000           3.000      same as X -c3-c3-X  
OH-CT-CT-H1   1    0.156         0.000           3.000      same as X -c3-c3-X  
HA-CM-CT-HC   1    0.000         0.000           2.000      same as X -c2-c3-X  
HA-CM-CM-HA   1    6.650       180.000           2.000      same as X -c2-c2-X  
HC-CT-CT-HC   1    0.156         0.000           3.000      same as X -c3-c3-X  
H1-CT-CT-H1   1    0.156         0.000           3.000      same as X -c3-c3-X  
H1-CT-OH-HO   1    0.167         0.000           3.000      same as X -c3-oh-X  
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IMPROPER 
CT-O -C -OS         1.1          180.0         2.0          Using default value 
CM-CT-CM-HA         1.1          180.0         2.0          Using default value 
 
NONBON 
  C           1.9080  0.0860             same as c   
  CT          1.9080  0.1094             same as c3  
  O           1.6612  0.2100             same as o   
  OS          1.6837  0.1700             same as os  
  CM          1.9080  0.0860             same as cc  
  P           2.1000  0.2000             same as p4  
  O2          1.6612  0.2100             same as o   
  OH          1.7210  0.2104             same as oh  
  HA          1.4870  0.0157             same as hc  
  HC          1.4870  0.0157             same as hc  
  H1          1.4870  0.0157             same as hc  
  HO          0.0000  0.0000             same as ho  
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POPG2 
 
.mol2 file: 
PG2 
  127   126     1     0     0 
SMALL 
resp 
 
@<TRIPOS>ATOM 
      1 C1          4.6850   -3.2340   -2.1100 C         1 PG2       0.5134 
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      2 C2          3.3330   -2.5780   -2.4540 CT        1 PG2      -0.0300 
      3 C3          2.2460   -2.8670   -1.3990 CT        1 PG2       0.0266 
      4 C4          0.8740   -2.3210   -1.8330 CT        1 PG2      -0.1017 
      5 C5         -0.2780   -2.7510   -0.9110 CT        1 PG2       0.0344 
      6 C6         -1.6410   -2.3010   -1.4590 CT        1 PG2       0.0179 
      7 C7         -2.8310   -2.7670   -0.6070 CT        1 PG2       0.0765 
      8 C8         -4.1730   -2.3300   -1.2180 CT        1 PG2      -0.0897 
      9 C9         -5.3930   -2.7730   -0.3950 CT        1 PG2       0.0479 
     10 C10        -6.7070   -2.2280   -0.9780 CT        1 PG2      -0.0310 
     11 C11        -7.9140   -2.4500   -0.0540 CT        1 PG2       0.0828 
     12 C12        -9.1930   -1.7990   -0.6010 CT        1 PG2       0.0934 
     13 C13       -10.3480   -1.8290    0.4100 CT        1 PG2      -0.0295 
     14 C14       -11.6130   -1.1360   -0.1200 CT        1 PG2       0.0346 
     15 C15       -12.7490   -1.1150    0.9140 CT        1 PG2       0.1847 
     16 C16       -14.0020   -0.4010    0.3940 CT        1 PG2      -0.2761 
     17 O1          4.5300   -4.6260   -1.9900 O         1 PG2      -0.5306 
     18 O2          5.1820   -2.6970   -0.9300 OS        1 PG2      -0.3606 
     19 C17         6.0190   -1.5540   -1.1130 CT        1 PG2       0.0697 
     20 C18         6.5790   -1.1060    0.2440 CT        1 PG2       0.1684 
     21 C19         7.8460   -0.2390    0.1260 CT        1 PG2       0.1898 
     22 O3          5.5780   -0.3650    0.9350 OS        1 PG2      -0.2960 
     23 C20         5.2460   -0.8520    2.1910 C         1 PG2       0.5494 
     24 C21         4.0910    0.0080    2.7220 CT        1 PG2      -0.1930 
     25 O4          6.3350   -0.7610    3.0840 O         1 PG2      -0.5451 
     26 C22         2.7770   -0.3190    1.9930 CT        1 PG2      -0.0446 
     27 C23         1.6040    0.4980    2.5590 CT        1 PG2       0.0052 
     28 C24         0.2210   -0.0190    2.1310 CT        1 PG2       0.0535 
     29 C25        -0.9120    0.7400    2.8410 CT        1 PG2      -0.0997 
     30 C26        -2.2920    0.0860    2.6710 CT        1 PG2       0.0389 
     31 C27        -3.3640    0.7700    3.5370 CT        1 PG2       0.1552 
     32 C28        -4.6850   -0.0160    3.6320 CM        1 PG2      -0.3724 
     33 C29        -5.5330   -0.0160    2.3500 CM        1 PG2      -0.0937 
     34 C30        -6.2380    1.3220    2.0700 CT        1 PG2      -0.3867 
     35 C31        -7.2050    1.2190    0.8840 CT        1 PG2       0.0095 
     36 C32        -7.9460    2.5300    0.5940 CT        1 PG2      -0.0534 
     37 C33        -8.9330    2.3810   -0.5730 CT        1 PG2       0.1961 
     38 C34        -9.6890    3.6800   -0.8870 CT        1 PG2      -0.0575 
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     39 C35       -10.6630    3.5170   -2.0620 CT        1 PG2       0.0115 
     40 C36       -11.4220    4.8120   -2.3820 CT        1 PG2       0.1702 
     41 C37       -12.3820    4.6510   -3.5670 CT        1 PG2      -0.2476 
     42 O5          7.6310    0.8500   -0.7510 OS        1 PG2      -0.4956 
     43 P1          8.9160    1.6660   -1.4710 P         1 PG2       1.1120 
     44 O6          9.8240    0.6540   -2.4440 O2        1 PG2      -0.7838 
     45 O7          8.2800    2.8470   -2.4660 O2        1 PG2      -0.7838 
     46 O8          9.8770    2.4930   -0.3610 OS        1 PG2      -0.5449 
     47 C38        10.8390    1.8070    0.4170 CT        1 PG2       0.3690 
     48 C39        12.2110    2.0780   -0.2250 CT        1 PG2       0.0480 
     49 C40        13.3910    1.5450    0.6090 CT        1 PG2       0.0598 
     50 O9         13.4950    2.2260    1.8410 OH        1 PG2      -0.6693 
     51 O10        12.2520    1.4250   -1.4780 OH        1 PG2      -0.5620 
     52 H1         -5.2810    0.3820    4.4540 HA        1 PG2       0.1832 
     53 H2          3.4760   -1.5030   -2.5690 HC        1 PG2       0.0216 
     54 H3          3.0200   -2.9610   -3.4250 HC        1 PG2       0.0216 
     55 H4          2.1620   -3.9430   -1.2450 HC        1 PG2       0.0492 
     56 H5          2.5350   -2.4410   -0.4390 HC        1 PG2       0.0492 
     57 H6          0.9160   -1.2330   -1.8870 HC        1 PG2       0.0329 
     58 H7          0.6620   -2.6710   -2.8420 HC        1 PG2       0.0329 
     59 H8         -0.2730   -3.8380   -0.8080 HC        1 PG2      -0.0171 
     60 H9         -0.1240   -2.3450    0.0890 HC        1 PG2      -0.0171 
     61 H10        -1.6550   -1.2120   -1.5390 HC        1 PG2      -0.0095 
     62 H11        -1.7610   -2.6820   -2.4740 HC        1 PG2      -0.0095 
     63 H12        -2.8120   -3.8530   -0.5120 HC        1 PG2      -0.0203 
     64 H13        -2.7380   -2.3640    0.4020 HC        1 PG2      -0.0203 
     65 H14        -4.1800   -1.2430   -1.3140 HC        1 PG2       0.0167 
     66 H15        -4.2590   -2.7270   -2.2310 HC        1 PG2       0.0167 
     67 H16        -5.4340   -3.8610   -0.3460 HC        1 PG2      -0.0146 
     68 H17        -5.2750   -2.4270    0.6310 HC        1 PG2      -0.0146 
     69 H18        -6.5970   -1.1600   -1.1640 HC        1 PG2      -0.0009 
     70 H19        -6.8950   -2.6880   -1.9490 HC        1 PG2      -0.0009 
     71 H20        -8.0760   -3.5170    0.0970 HC        1 PG2      -0.0346 
     72 H21        -7.6900   -2.0320    0.9280 HC        1 PG2      -0.0346 
     73 H22        -8.9860   -0.7620   -0.8700 HC        1 PG2      -0.0407 
     74 H23        -9.4940   -2.2990   -1.5220 HC        1 PG2      -0.0407 
     75 H24       -10.5790   -2.8620    0.6730 HC        1 PG2      -0.0130 
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     76 H25       -10.0330   -1.3390    1.3320 HC        1 PG2      -0.0130 
     77 H26       -11.3740   -0.1130   -0.4110 HC        1 PG2      -0.0143 
     78 H27       -11.9530   -1.6410   -1.0250 HC        1 PG2      -0.0143 
     79 H28       -13.0070   -2.1360    1.1980 HC        1 PG2      -0.0355 
     80 H29       -12.4070   -0.6200    1.8240 HC        1 PG2      -0.0355 
     81 H30       -14.7900   -0.4010    1.1490 HC        1 PG2       0.0592 
     82 H31       -14.3970   -0.8920   -0.4960 HC        1 PG2       0.0592 
     83 H32       -13.7890    0.6370    0.1390 HC        1 PG2       0.0592 
     84 H33         6.8540   -1.8260   -1.7610 H1        1 PG2       0.0843 
     85 H34         5.4810   -0.7380   -1.5990 H1        1 PG2       0.0843 
     86 H35         6.8580   -2.0050    0.7970 H1        1 PG2       0.0374 
     87 H36         8.1510    0.1290    1.1050 H1        1 PG2       0.0458 
     88 H37         8.6650   -0.8490   -0.2580 H1        1 PG2       0.0458 
     89 H38         3.9710   -0.1830    3.7880 HC        1 PG2       0.1118 
     90 H39         4.3560    1.0590    2.6030 HC        1 PG2       0.1118 
     91 H40         2.8810   -0.1320    0.9220 HC        1 PG2       0.0129 
     92 H41         2.5630   -1.3840    2.0970 HC        1 PG2       0.0129 
     93 H42         1.6560    0.4740    3.6490 HC        1 PG2       0.0099 
     94 H43         1.7160    1.5450    2.2750 HC        1 PG2       0.0099 
     95 H44         0.1060    0.0580    1.0490 HC        1 PG2       0.0024 
     96 H45         0.1500   -1.0800    2.3740 HC        1 PG2       0.0024 
     97 H46        -0.6850    0.7900    3.9070 HC        1 PG2       0.0083 
     98 H47        -0.9450    1.7710    2.4860 HC        1 PG2       0.0083 
     99 H48        -2.5840    0.1000    1.6200 HC        1 PG2       0.0101 
    100 H49        -2.2220   -0.9670    2.9530 HC        1 PG2       0.0101 
    101 H50        -2.9740    0.8770    4.5500 HC        1 PG2      -0.0093 
    102 H51        -3.5470    1.7840    3.1820 HC        1 PG2      -0.0093 
    103 H52        -6.2920   -0.7940    2.4490 HA        1 PG2       0.1242 
    104 H53        -6.7870    1.6400    2.9550 HC        1 PG2       0.1653 
    105 H54        -5.4970    2.0960    1.8740 HC        1 PG2       0.1653 
    106 H55        -6.6500    0.9130   -0.0050 HC        1 PG2       0.0533 
    107 H56        -7.9350    0.4330    1.0830 HC        1 PG2       0.0533 
    108 H57        -8.4850    2.8480    1.4870 HC        1 PG2      -0.0001 
    109 H58        -7.2250    3.3170    0.3690 HC        1 PG2      -0.0001 
    110 H59        -8.3950    2.0490   -1.4610 HC        1 PG2      -0.0541 
    111 H60        -9.6520    1.5950   -0.3370 HC        1 PG2      -0.0541 
    112 H61       -10.2370    4.0050   -0.0000 HC        1 PG2      -0.0021 
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    113 H62        -8.9720    4.4700   -1.1150 HC        1 PG2      -0.0021 
    114 H63       -10.1130    3.1910   -2.9470 HC        1 PG2      -0.0075 
    115 H64       -11.3770    2.7230   -1.8360 HC        1 PG2      -0.0075 
    116 H65       -11.9850    5.1330   -1.5050 HC        1 PG2      -0.0302 
    117 H66       -10.7120    5.6100   -2.6000 HC        1 PG2      -0.0302 
    118 H67       -12.9090    5.5840   -3.7700 HC        1 PG2       0.0522 
    119 H68       -13.1310    3.8840   -3.3670 HC        1 PG2       0.0522 
    120 H69       -11.8460    4.3690   -4.4730 HC        1 PG2       0.0522 
    121 H70        10.7980    2.1760    1.4420 H1        1 PG2       0.0176 
    122 H71        10.6230    0.7380    0.4580 H1        1 PG2       0.0176 
    123 H72        12.3300    3.1520   -0.3860 H1        1 PG2       0.0756 
    124 H73        13.2720    0.4760    0.7960 H1        1 PG2       0.0630 
    125 H74        14.3290    1.6710    0.0650 H1        1 PG2       0.0630 
    126 H75        13.7010    3.1360    1.6830 HO        1 PG2       0.4116 
    127 H76        13.0430    1.6980   -1.9250 HO        1 PG2       0.3918 
@<TRIPOS>BOND 
     1    1    2 1    
     2    1   17 2    
     3    1   18 1    
     4    2    3 1    
     5    2   53 1    
     6    2   54 1    
     7    3    4 1    
     8    3   55 1    
     9    3   56 1    
    10    4    5 1    
    11    4   57 1    
    12    4   58 1    
    13    5    6 1    
    14    5   59 1    
    15    5   60 1    
    16    6    7 1    
    17    6   61 1    
    18    6   62 1    
    19    7    8 1    
    20    7   63 1    
    21    7   64 1    
    22    8    9 1    
    23    8   65 1    
    24    8   66 1    
    25    9   10 1    
    26    9   67 1    
    27    9   68 1    
    28   10   11 1    
    29   10   69 1    
    30   10   70 1    
    31   11   12 1    
    32   11   71 1    
    33   11   72 1    
    34   12   13 1    
    35   12   73 1    
    36   12   74 1    
    37   13   14 1    
    38   13   75 1    
    39   13   76 1    
    40   14   15 1    
    41   14   77 1    
    42   14   78 1    
    43   15   16 1    
    44   15   79 1    
    45   15   80 1    
    46   16   81 1    
    47   16   82 1    
    48   16   83 1    
    49   18   19 1    
    50   19   20 1    
    51   19   84 1    
    52   19   85 1    
    53   20   21 1    
    54   20   22 1    
    55   20   86 1    
    56   21   42 1    
    57   21   87 1    
    58   21   88 1    
    59   22   23 1    
    60   23   24 1    
    61   23   25 2    
    62   24   26 1    
    63   24   89 1    
    64   24   90 1    
    65   26   27 1    
    66   26   91 1    
    67   26   92 1    
    68   27   28 1    
    69   27   93 1    
    70   27   94 1    
    71   28   29 1    
    72   28   95 1    
    73   28   96 1    
    74   29   30 1    
    75   29   97 1    
    76   29   98 1    
    77   30   31 1    
    78   30   99 1    
    79   30  100 1    
    80   31   32 1    
    81   31  101 1    
    82   31  102 1    
    83   32   33 2    
    84   32   52 1    
    85   33   34 1    
    86   33  103 1    
    87   34   35 1    
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    88   34  104 1    
    89   34  105 1    
    90   35   36 1    
    91   35  106 1    
    92   35  107 1    
    93   36   37 1    
    94   36  108 1    
    95   36  109 1    
    96   37   38 1    
    97   37  110 1    
    98   37  111 1    
    99   38   39 1    
   100   38  112 1    
   101   38  113 1    
   102   39   40 1    
   103   39  114 1    
   104   39  115 1    
   105   40   41 1    
   106   40  116 1    
   107   40  117 1    
   108   41  118 1    
   109   41  119 1    
   110   41  120 1    
   111   42   43 1    
   112   43   44 1    
   113   43   45 1    
   114   43   46 1    
   115   46   47 1    
   116   47   48 1    
   117   47  121 1    
   118   47  122 1    
   119   48   49 1    
   120   48   51 1    
   121   48  123 1    
   122   49   50 1    
   123   49  124 1    
   124   49  125 1    
   125   50  126 1    
   126   51  127 1    
 270 
 
.frcmod file: 
PG2 .frcmod input 
MASS 
C  12.010        0.616               same as c   
CT 12.010        0.878               same as c3  
O  16.000        0.434               same as o   
OS 16.000        0.465               same as os  
CM 12.010        0.360               same as c2  
P  30.970        1.538               same as p4  
O2 16.000        0.434               same as o   
OH 16.000        0.465               same as oh  
HA 1.008         0.135               same as hc  
HC 1.008         0.135               same as hc  
H1 1.008         0.135               same as hc  
HO 1.008         0.135               same as ho  
 
BOND 
C -CT  328.30   1.508       same as c -c3 
C -O   648.00   1.214       same as c -o  
C -OS  411.30   1.343       same as c -os 
CT-CT  303.10   1.535       same as c3-c3 
CT-HC  337.30   1.092       same as c3-hc 
OS-CT  301.50   1.439       same as c3-os 
CT-H1  337.30   1.092       same as c3-hc 
CT-CM  328.30   1.508       same as c2-c3 
CM-CM  418.30   1.429       same as cc-cc 
CM-HA  344.30   1.087       same as c2-hc 
OS-P   311.60   1.636       same as os-p4 
P -O2  456.40   1.503       same as o -p4 
CT-OH  314.10   1.426       same as c3-oh 
OH-HO  369.60   0.974       same as ho-oh 
 
ANGLE 
C -CT-CT   63.800     110.530   same as c -c3-c3 
C -CT-HC   47.200     109.680   same as c -c3-hc 
C -OS-CT   63.600     115.140   same as c -os-c3 
CT-C -O    68.000     123.110   same as c3-c -o  
CT-C -OS   69.300     111.960   same as c3-c -os 
CT-CT-CT   63.200     110.630   same as c3-c3-c3 
CT-CT-HC   46.400     110.050   same as c3-c3-hc 
O -C -OS   76.200     122.430   same as o -c -os 
OS-CT-CT   67.800     108.420   same as c3-c3-os 
OS-CT-H1   50.900     108.700   same as hc-c3-os 
CT-CT-H1   46.400     110.050   same as c3-c3-hc 
CT-OS-P    77.600     117.480   same as c3-os-p4 
CT-CT-CM   63.700     110.960   same as c2-c3-c3 
CT-CM-CM   64.300     123.420   same as c2-c2-c3 
CT-CM-HA   45.100     120.000   same as c3-c2-hc 
CM-CT-HC   47.000     110.490   same as c2-c3-hc 
CM-CM-HA   50.300     119.700   same as c2-c2-hc 
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OS-P -O2   43.100     116.670   same as o -p4-os 
OS-P -OS   44.700     100.340   same as os-p4-os 
O2-P -O2   45.100     117.220   same as o -p4-o  
CT-CT-OH   67.700     109.430   same as c3-c3-oh 
CT-OH-HO   47.100     108.160   same as c3-oh-ho 
OH-CT-H1   51.100     109.500   same as hc-c3-oh 
HC-CT-HC   39.400     108.350   same as hc-c3-hc 
H1-CT-H1   39.400     108.350   same as hc-c3-hc 
 
DIHE 
C -CT-CT-CT   1    0.156         0.000           3.000      same as X -c3-c3-X  
C -CT-CT-HC   1    0.156         0.000           3.000      same as X -c3-c3-X  
C -OS-CT-CT   1    0.383         0.000           3.000      same as X -c3-os-X  
C -OS-CT-H1   1    0.383         0.000           3.000      same as X -c3-os-X  
CT-C -OS-CT   1    2.700       180.000           2.000      same as X -c -os-X  
CT-CT-CT-CT   1    0.156         0.000           3.000      same as X -c3-c3-X  
CT-CT-CT-HC   1    0.156         0.000           3.000      same as X -c3-c3-X  
CT-CT-C -O    1    0.000       180.000           2.000      same as X -c -c3-X  
CT-CT-C -OS   1    0.000       180.000           2.000      same as X -c -c3-X  
O -C -CT-HC   1    0.000       180.000           2.000      same as X -c -c3-X  
O -C -OS-CT   1    2.700       180.000           2.000      same as X -c -os-X  
OS-C -CT-HC   1    0.000       180.000           2.000      same as X -c -c3-X  
OS-CT-CT-CT   1    0.156         0.000           3.000      same as X -c3-c3-X  
OS-CT-CT-OS   1    0.156         0.000           3.000      same as X -c3-c3-X  
OS-CT-CT-H1   1    0.156         0.000           3.000      same as X -c3-c3-X  
CT-CT-CT-H1   1    0.156         0.000           3.000      same as X -c3-c3-X  
CT-CT-OS-P    1    0.383         0.000           3.000      same as X -c3-os-X  
CT-OS-P -O2   1    1.050       180.000           2.000      same as X -os-p4-X  
CT-OS-P -OS   1    1.050       180.000           2.000      same as X -os-p4-X  
CT-CT-CT-CM   1    0.156         0.000           3.000      same as X -c3-c3-X  
CT-CT-CM-CM   1    0.000         0.000           2.000      same as X -c2-c3-X  
CT-CT-CM-HA   1    0.000         0.000           2.000      same as X -c2-c3-X  
CT-CM-CM-CT   1    6.650       180.000           2.000      same as X -c2-c2-X  
CT-CM-CM-HA   1    6.650       180.000           2.000      same as X -c2-c2-X  
CM-CT-CT-HC   1    0.156         0.000           3.000      same as X -c3-c3-X  
CM-CM-CT-HC   1    0.000         0.000           2.000      same as X -c2-c3-X  
P -OS-CT-H1   1    0.383         0.000           3.000      same as X -c3-os-X  
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OS-CT-CT-OH   1    0.156         0.000           3.000      same as X -c3-c3-X  
CT-CT-CT-OH   1    0.156         0.000           3.000      same as X -c3-c3-X  
CT-CT-OH-HO   1    0.167         0.000           3.000      same as X -c3-oh-X  
OH-CT-CT-OH   1    0.156         0.000           3.000      same as X -c3-c3-X  
OH-CT-CT-H1   1    0.156         0.000           3.000      same as X -c3-c3-X  
HA-CM-CT-HC   1    0.000         0.000           2.000      same as X -c2-c3-X  
HA-CM-CM-HA   1    6.650       180.000           2.000      same as X -c2-c2-X  
HC-CT-CT-HC   1    0.156         0.000           3.000      same as X -c3-c3-X  
H1-CT-CT-H1   1    0.156         0.000           3.000      same as X -c3-c3-X  
H1-CT-OH-HO   1    0.167         0.000           3.000      same as X -c3-oh-X  
 
IMPROPER 
CT-O -C -OS         1.1          180.0         2.0          Using default value 
CM-CT-CM-HA         1.1          180.0         2.0          Using default value 
 
NONBON 
  C           1.9080  0.0860             same as c   
  CT          1.9080  0.1094             same as c3  
  O           1.6612  0.2100             same as o   
  OS          1.6837  0.1700             same as os  
  CM          1.9080  0.0860             same as cc  
  P           2.1000  0.2000             same as p4  
  O2          1.6612  0.2100             same as o   
  OH          1.7210  0.2104             same as oh  
  HA          1.4870  0.0157             same as hc  
  HC          1.4870  0.0157             same as hc  
  H1          1.4870  0.0157             same as hc  
  HO          0.0000  0.0000             same as ho
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Minimization MIN0: 
 &cntrl 
   imin=1,         
   maxcyc=5000,   
   ntmin=1, ncyc=500, 
   dielc=1.0, cut=10.0, nsnb=5,   
   scee=1.2,    
   ntpr=25, 
   ntt=2, 
   ntb=1, ntp=0, 
   iwrap=1, 
   nmropt=0, 
   ntr=1, 
   restraint_wt= 15.0  
   restraintmask=':241-261',  
 &end 
END 
 
Minimization MIN: 
 &cntrl 
   imin=1,         
   maxcyc=3000,   
   ntmin=1, ncyc=2500, 
   dielc=1.0, cut=10.0, nsnb=5,   
   scee=1.2,    
   ntpr=50, 
   ntt=2, 
   ntb=1 ntp=0, 
   nmropt=0, 
   iwrap=1, 
 &end 
 
 
Equilibration (initial) Warming Step: 
 &cntrl 
   nstlim=21000, 
   ntpr=500, ntwx=000, ntwv=000, ntwe=000, 
   cut=10.0, nsnb=5, 
   dt=0.0020, temp0=5.0, 
   ntt=2, 
   ntb=1, ntp=0, 
   ntc=2, ntf=2, 
   iwrap=1, 
   nmropt=0, 
 &end 
 &wt type='TEMP0', istep1=0001,  istep2=1000,  value1=0.05, 
value2=0.05, &end 
 &wt type='TEMP0', istep1=1001,  istep2=3000,  value1=0.05, 
value2=50.,  &end 
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 &wt type='TEMP0', istep1=3001,  istep2=5000,  value1=50.,  
value2=100., &end 
 &wt type='TEMP0', istep1=5001,  istep2=7000,  value1=100., 
value2=150., &end 
 &wt type='TEMP0', istep1=7001,  istep2=9000,  value1=150., 
value2=200., &end 
 &wt type='TEMP0', istep1=9001,  istep2=11000, value1=200., 
value2=250., &end 
 &wt type='TEMP0', istep1=11001, istep2=16000, value1=250., 
value2=300., &end 
 &wt type='TEMP0', istep1=16001, istep2=21000, value1=300., 
value2=310., &end 
 &wt type='END'  &end 
END 
 
 
 
 
Md_npt: 
Molecular dynamics 
 &cntrl 
   nstlim=5000000, 
   irest=0, ntx=1, 
   ntpr=500, ntwx=500, ntwv=0, ntwe=0, 
   cut=10.0, nsnb=25, 
   dt=0.0015, temp0=310.00, tempi=310.0, 
   ntc=2, ntf=2, 
   ntt=3, gamma_ln=1.0, 
   ntb=2, ntp=2, 
   pres0=1.0, 
   taup=3.0, 
   iwrap=1, 
 &end 
 
 
MD_nvt: 
Molecular dynamics 
 &cntrl 
   nstlim=5000000, 
   irest=1, ntx=5, 
   ntpr=100, ntwx=1000, ntwv=0, ntwe=0, 
   cut=10.0, nsnb=25, 
   dt=0.0015, temp0=310.00, tempi=310.0, 
   ntc=2, ntf=2, 
   ntt=2,  
   ntb=1, ntp=0, 
   iwrap=1, 
 &end 
 
 
  
APPENDIX C 
PHI/PSI/OMEGA 
CALCULATION SCRIPTS
277 
 
THIS SCRIPT IS USED TO CALL THE SECOND SCRIPT- THE COMMAND LINE INPUT IS AS 
FOLLOWS: 
./Script Name  /directory path of pdb files /directory path of file with atom numbers.txt /Output 
directory and file name 
#! /bin/sh 
#tells you what the current directory is the directory from which the 
script is started 
currentdir=`pwd` 
 
#this is where the pdb files are located it is the second entry of the 
cmd. line 
pdbdirectory=$1 
 
#this is where the file with the atom numbers is located the third 
entry of the cmd. line 
coordinatefile=$2 
 
#this is where the output will be located, the fourth entry of the 
cmd. line 
outputfile=$3 
cd $currentdir 
 
#print to the output file the following statement 
echo "snapshot,phi,psi, omega1, omega2" >$outputfile 
for lines in  `ls $pdbdirectory/*.pdb.*`;  
 
#for lines in `ls /cygdrive/d/Scripts/prist/*.pdb.*`; 
do 
# echo $coordinatefile 
# echo $lines  
# echo $currentdir 
# echo $pdbdirectory 
# echo $lines 
 echo $lines" "$coordinatefile" "$currentdir" /asst" 
#This tells you the number of the pdb it is taking the data from  
 number=`echo $lines | awk -F '/' '{print $NF}' | awk -F '.' 
'{print $NF}'` 
#This is what you have to enter on the cmd line to get things started 
 /usr/bin/python /cygdrive/d/Scripts/MagicScript $lines 
$coordinatefile $currentdir/asst$number  
$coordinatefile $currentdir/asst$number 
#The value that is calculated is temporarily placed here 
 value=`cat $currentdir/asst$number` 
 echo $number","$value >> $outputfile 
 
#This removes the temporary file 
 rm $currentdir/asst$number    
done    
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MAGICSCRIPT 
 
import string 
import math 
import os 
import sys 
 
#The following lines have been included for debugging  
#infile = "D:/Scripts/pro/noW.pdb.1" 
#infile1 = "D:/Scripts/pro.txt" 
#outfile = "D:/Scripts/pro/Angles.csv" 
#will allow the submission of file names as arguments to read in a 
sequence of files 
# system argument (take something from the cmd. line for this could be 
file name or variable # 
infile=sys.argv[1] 
# two input files 
infile1=sys.argv[2] 
 
#this is the file that will be read in 
input = open(infile, 'r') 
#this is the actual reading of the data from the file 
#the whole pdb file is read in 
text = input.read() 
#splits at the end of the line and creates a list     
line = text.split('\n') 
 
input1 = open(infile1, 'r') 
text1 = input1.read() 
#split by the line 
line1 = text1.split('\n') 
 
outfile=sys.argv[3] 
output = open(outfile, 'w') 
 
# A function to remove duplicate bonds, angles and dihedrals  
 
def duplicates(array): 
    duplicate1 = 1 
    while duplicate1 < len(array): 
        duplicate2 = 0 
        duplicate3 = (len(array[duplicate1]) - 1) 
        duplicate4 = [] 
        while duplicate3 >= 0: 
            duplicate4.append(array[duplicate1][duplicate3]) 
            duplicate3 = duplicate3 -1 
        while duplicate2 < duplicate1: 
            if duplicate4 == array[duplicate2]: 
                del array[duplicate1] 
                duplicate1 = duplicate1 -1 
                break 
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            else: 
                duplicate2 = duplicate2 + 1 
        duplicate1 = duplicate1 + 1 
    return array 
 
#A function to calculate the difference between two vectors 
 
def vectordiff(vector1,vector2): 
    vectorpoint1 = 0 
    vector3 = [] 
    while vectorpoint1 < 3: 
        vector3.append(((vector1[vectorpoint1]) - 
(vector2[vectorpoint1]))) 
        vectorpoint1 = vectorpoint1 + 1 
    return vector3 
 
#A function to calculate the cross product of two vectors 
 
def crossproduct(vector4,vector5): 
    vector6 = [] 
    vector6.append((vector4[1] * vector5[2]) - (vector5[1] * 
vector4[2])) 
    vector6.append(-((vector4[0] * vector5[2]) - (vector5[0] * 
vector4[2]))) 
    vector6.append((vector4[0] * vector5[1]) - (vector5[0] * 
vector4[1])) 
    return vector6 
 
#A function to calculate the angle between two vectors, the dihedral 
angle 
 
def costheta(vector7,vector8): 
    costheta = ((vector7[0] * vector8[0]) + (vector7[1] * vector8[1]) 
+ (vector7[2] * vector8[2]))/((math.sqrt( pow(vector7[0],2) + 
pow(vector7[1],2) + pow(vector7[2],2))) * (math.sqrt( 
pow(vector8[0],2) + pow(vector8[1],2) + pow(vector8[2],2)))) 
    return costheta 
 
#the split function is split by whatever you put in the ()  ex. , or a 
space or a tab(5spaces) 
intarray=line1[0].split() 
phiarray=[] 
phiarray.append(int(intarray[1])) 
phiarray.append(int(intarray[2])) 
phiarray.append(int(intarray[3])) 
phiarray.append(int(intarray[4])) 
 
intarray=line1[2].split() 
psiarray=[] 
psiarray.append(int(intarray[1])) 
psiarray.append(int(intarray[2])) 
psiarray.append(int(intarray[3])) 
280 
 
psiarray.append(int(intarray[4])) 
psiarray.append(int(intarray[4])) 
 
#print phiarray 
#print psiarray 
#print omega1array 
 
intarray=line1[4].split() 
omega1array=[] 
omega1array.append(int(intarray[1])) 
omega1array.append(int(intarray[2])) 
omega1array.append(int(intarray[3])) 
omega1array.append(int(intarray[4])) 
 
intarray=line1[6].split() 
#creates array 
omega2array=[] 
#appends data to array 
omega2array.append(int(intarray[1])) 
omega2array.append(int(intarray[2])) 
omega2array.append(int(intarray[3])) 
omega2array.append(int(intarray[4])) 
 
#print phiarray 
#print psiarray 
#print omega1array 
##print omega2array 
 
#calculate the Phi Angle  
c=1 
coord=[] 
while c < len(line)-1: 
#while c < 5: 
        coord1=[] 
        coord2=[] 
        coord1=line[c].rsplit() 
        coord2.append(eval(coord1[5])) 
        coord2.append(eval(coord1[6])) 
        coord2.append(eval(coord1[7])) 
        coord2.append(int(coord1[1])) 
        coord.append(coord2) 
        c = c + 1 
#a=[40,46,48,50] 
#phiarray= 
#a=[15, 17, 27, 29] 
 
d=0 
vectorreference1=[] 
while d< len(coord): 
    coord4=[] 
    e=0 
    while e < len(phiarray): 
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        if phiarray[e] == coord[d][3]: 
            coord5=[] 
            coord5.append(coord[d][0]) 
            coord5.append(coord[d][1]) 
            coord5.append(coord[d][2]) 
            vectorreference1.append(coord5) 
        e=e+1 
    d=d+1 
 
    
vectorij = vectordiff(vectorreference1[0],vectorreference1[1]) 
vectorjk = vectordiff(vectorreference1[1],vectorreference1[2]) 
vectorkl = vectordiff(vectorreference1[2],vectorreference1[3]) 
vectorm = crossproduct(vectorij,vectorjk) 
vectorn = crossproduct(vectorjk,vectorkl) 
phi = math.acos(costheta(vectorn,vectorm))* 180 * 7/22 
sign = vectorm[0]*vectorkl[0] + vectorm[1]*vectorkl[1] + 
vectorm[2]*vectorkl[2]   
if sign > 0: 
    phi = -1 *phi 
#print phi 
 
  
 
#calculate the Psi Angle  
#a=[40,46,48,50] 
#psiarray b=[17, 27, 29, 31] 
d=0 
vectorreference1=[] 
while d< len(coord): 
    coord4=[] 
    e=0 
    while e < len(psiarray): 
        if psiarray[e] == coord[d][3]: 
            coord5=[] 
            coord5.append(coord[d][0]) 
            coord5.append(coord[d][1]) 
            coord5.append(coord[d][2]) 
            vectorreference1.append(coord5) 
        e=e+1 
    d=d+1 
 
    
vectorij = vectordiff(vectorreference1[0],vectorreference1[1]) 
vectorjk = vectordiff(vectorreference1[1],vectorreference1[2]) 
vectorkl = vectordiff(vectorreference1[2],vectorreference1[3]) 
vectorm = crossproduct(vectorij,vectorjk) 
vectorn = crossproduct(vectorjk,vectorkl) 
Psi = math.acos(costheta(vectorn,vectorm))* 180 * 7/22 
sign = vectorm[0]*vectorkl[0] + vectorm[1]*vectorkl[1] + 
vectorm[2]*vectorkl[2]   
if sign > 0: 
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    Psi = -1 *Psi 
#print Psi 
 
#calculate the OMEGA 1 Angle  
#a=[9, 15, 17, 27] 
#omega1array 
d=0 
vectorreference1=[] 
while d< len(coord): 
    coord4=[] 
    e=0 
    while e < len(omega1array): 
        if omega1array[e] == coord[d][3]: 
            coord5=[] 
            coord5.append(coord[d][0]) 
            coord5.append(coord[d][1]) 
            coord5.append(coord[d][2]) 
            vectorreference1.append(coord5) 
        e=e+1 
    d=d+1 
 
    
vectorij = vectordiff(vectorreference1[0],vectorreference1[1]) 
vectorjk = vectordiff(vectorreference1[1],vectorreference1[2]) 
vectorkl = vectordiff(vectorreference1[2],vectorreference1[3]) 
vectorm = crossproduct(vectorij,vectorjk) 
vectorn = crossproduct(vectorjk,vectorkl) 
omega1 = math.acos(costheta(vectorn,vectorm))* 180 * 7/22 
sign = vectorm[0]*vectorkl[0] + vectorm[1]*vectorkl[1] + 
vectorm[2]*vectorkl[2]   
if sign > 0: 
    omega1 = -1 *omega1 
#print omega1 
 
 
#calculate the OMEGA 2 Angle  
#a=[40,46,48,50] 
a=[27, 29, 31,33] 
#omega2array 
d=0 
vectorreference1=[] 
while d< len(coord): 
    coord4=[] 
    e=0 
    while e < len(omega2array): 
        if omega2array[e] == coord[d][3]: 
            coord5=[] 
            coord5.append(coord[d][0]) 
            coord5.append(coord[d][1]) 
            coord5.append(coord[d][2]) 
            vectorreference1.append(coord5) 
        e=e+1 
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    d=d+1 
 
    
vectorij = vectordiff(vectorreference1[0],vectorreference1[1]) 
vectorjk = vectordiff(vectorreference1[1],vectorreference1[2]) 
vectorkl = vectordiff(vectorreference1[2],vectorreference1[3]) 
vectorm = crossproduct(vectorij,vectorjk) 
vectorn = crossproduct(vectorjk,vectorkl) 
omega2 = math.acos(costheta(vectorn,vectorm))* 180 * 7/22 
sign = vectorm[0]*vectorkl[0] + vectorm[1]*vectorkl[1] + 
vectorm[2]*vectorkl[2]   
if sign > 0: 
    omega2= -1 *omega2 
#print omega2 
 
output.write("%f,%f,%f,%f\n" %(phi,Psi,omega1,omega2)) 
input.close() 
input1.close() 
output.close() 
 
                  
 
 
 
 
 
 
  
 
APPENDIX D  
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INTRODUCTION 
Peptide 23 was inserted into both the mixed and control bilayers.  Two simulations with 
the mixed bilayer were conducted.  The first had the N terminus inserted into the bilayer and the 
second had the C terminus inserted into the hydrophobic region of the bilayer.    The following 
provides a brief perspective of the behavior of the peptide when placed in varying membrane 
environments. 
CONTROL BILAYER PEPTIDE 23 INSERTED 
 
 Figures D.1 A, D.2 A & B, and D.3 show the starting orientation of peptide 23 when 
inserted into the control bilayer.  The control bilayer was taken from the previous MD simulation 
of peptide 23 with the control bilayer (see Chapter 5) after 90 ns of the production simulation.   
Figure D.1 B shows the position of peptide trajectory of the mixed bilayer simulation 
with peptide 23.  In the short 14 ns trajectory the system does not equilibrate.  The interesting 
notation occurs in the conformation of the peptide relative to the bilayer.  The polar C-terminus 
which had been placed at the bilayer surface moves away from the membrane surface allowing 
the more hydrophobic trajectory of the mixed bilayer simulation with peptide 23.  In the short 14 
ns trajectory the system does not equilibrate.  The interesting notation occurs in the conformation 
of the peptide relative to the bilayer.  The polar C-terminus which had been placed at the bilayer 
surface moves away from the membrane surface allowing the more hydrophobic at the end of the 
simulation.  Figure D.4 shows the trajectory of the control bilayer simulation with peptide 23 
inserted into the membrane surface.  In the short 14 ns trajectory the system did not equilibrate as 
evidenced by the average slope of the RMSD plot, Figure D.4.  The interesting notation occurs in 
the conformation of the peptide relative to the bilayer surface.  The polar C-terminus which had 
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Figure D.1 A) Peptide 23 inserted into the control bilayer at the beginning of the simulation B) peptide 
23 in the control bilayer at the end of the 14 ns trajectory 
A) 
B) 
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Figure D.2 Peptide 23 inserted into the control bilayer at the beginning of the simulation 
Figure D.3 Peptide 23 inserted into the control bilayer at the beginning of the simulation 
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been placed at the bilayer surface moves away from the membrane surface allowing the more 
hydrophobic rings near the N terminus to move out of the hydrophobic region of the bilayer D.5. 
The short trajectory and lack of structure stabilization prevent conclusions from being 
drawn from the structures however it provides insight into how the peptide’s residues behave 
when in a hydrophobic environment. 
  
Figure D.4 Trajectory of peptide 23 inserted into the control bilayer 
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PEPTIDE 23 N TERMINUS INSERTED INTO MIXED BILAYER  
 
Figure D.6 A and B show the starting orientation of peptide 23 when inserted into the 
mixed bilayer with the N terminus in the hydrophobic region of the bilayer.  The mixed bilayer 
was taken from the previous MD simulation of peptide 23 with the mixed bilayer (see Chapter 5) 
after 105 ns of the production simulation.  The simulation was continued for an additional ~ 30 
ns without trajectory stabilization.  The peptide was observed to move from the starting position 
relative to the bilayer surface. 
Figure D.7 shows the trajectory of the mixed bilayer simulation with peptide 23 inserted 
into the hydrophobic region of the bilayer.  In the 30 ns trajectory from the production simulation 
was sufficient for peptide 23 to equilibrate as evidenced by the average slope near 0.  The short 
simulation time was not sufficient for the bilayer to equilibrate which is not surprising given the 
Figure D.1 Atoms involved in the Omega 1 angle, outlined in blue.  The Omega 2 angle is outlined in 
green.  Phi angle, outlined in magenta and psi angle, outlined in yellow. 
Figure D.5 Peptide 23 at the end of the ~14 ns MD trajectory 
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previous long trajectory attained without having the system equilibrate (Figure D.7).   
The interesting observations are made with the peptide relative to both the starting 
position and the bilayer surface.  At the beginning of the trajectory the N terminus was inserted 
into the bilayer with the C terminus, with the four polar lysine residues residing at the bilayer 
surface (Figure 5.6 A & B).  The final orientation relative to the starting position shows the 
peptide is moving the peptide out of the hydrophobic region of the bilayer pushing all of the 
polar lysine residues to the bilayer surface (Figure D.8).  It should be noted that the thinning of 
the membrane is a result of the previous simulation with peptide 23 at the surface (Chapter 5) 
and not a result of the peptide inserted into the bilayer.  The N terminal hydrophobic rings of the 
Tic, Oic, and Phe residues are still partially buried at the within the hydrophobic region of the 
bilayer at the end of 30 ns (Figure D.8).  The lysine residue closest to the N terminus have 
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Figure D.6 Mixed Bilayer Peptide 23 inserted N terminus into the hydrophobic region of the bilayer. 
A) 
B) 
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moved to positions allowing interaction with the polar lipid head groups (Figure D.8).  The 
position of the peptide should not be construed as the preferred orientation; the trajectory has not 
yet attained sufficient data to draw conclusions (Figure D.9).   
  
Figure D.7 Trajectory of peptide 23 inserted into the mixed bilayer 
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Figure D.9 Mixed bilayer with peptide 23 N terminus of the peptide inserted into the bilayer after 30 ns 
of MD simulation. 
Figure D.8 Mixed bilayer with peptide 23 N terminus of the peptide inserted into the bilayer after 30 ns 
of MD simulation. 
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PEPTIDE 23 C TERMINUS INSERTED INTO MIXED BILAYER 
Figure D.10 A and B show the starting orientation of peptide 23 inserted into the mixed 
bilayer with the C terminus inserted into the hydrophobic region of the bilayer.  The mixed 
bilayer was taken from the previous MD simulation of peptide 23 with the mixed bilayer (see 
Chapter 5) after 105 ns of the production simulation.  In Figure D.11 the starting position of the 
peptide relative to the two lipid types is depicted.  The anionic POPG lipids are noted in lavender 
and the zwitterionic POPC lipids are noted in green.  The peptide was placed near two anionic 
POPC lipids at the start of the simulation.   
Figure D.12 shows the trajectory of the mixed bilayer simulation with peptide 23 inserted 
into the bilayer with the C terminus buried in the hydrophobic region of the bilayer.  The bilayer 
appears to be stabilizing in the short 20 ns trajectory shown in Figure D.12.  A longer simulation 
is necessary to draw any conclusions from the trajectory.  The peptide inserted with the polar C 
terminus in the hydrophobic region of the bilayer underwent several conformational changes as 
evidenced by the slope of the RMSD plot in Figure D.12.   
The interesting notation occurs in the conformation of the peptide relative to the bilayer 
(Figure D.13 and D.14).  The less polar N terminus which had been placed at the bilayer surface 
moves away from the original position in the membrane surface allowing the polar lysine 
residues to move toward the polar head groups of the lipids forming hydrogen bonds, see figure 
D.14.  Each of the lysine residues in peptide 23 has moved into reasonable proximity to form 
intermolecular hydrogen bonds with the surrounding lipids.  There does not appear to be a 
preference for the charge associated with the lipid in the formation of these intermolecular 
interactions. 
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Figure D.10 Mixed bilayer with peptide 23 C terminus of the peptide inserted into the hydrophobic 
region of the bilayer. 
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Figure D.12 Trajectory of peptide 23 with the C terminus inserted into the hydrophobic region of the 
mixed bilayer.  Deviation is noted from the minimum energy structure at the beginning of the 
production run. 
Figure D.11 Starting position of peptide 23 inserted with the C terminus in the hydrophobic region of 
the bilayer.  Position of the peptide relative to the anionic POPG lipidsis noted in lavender and the 
zwitterionic POPG lipidsare noted in green. 
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Figure D.14 Mixed bilayer with peptide 23 inserted with the C terminus inserted into the hydrophobic 
region of the bilayer.  Structure was taken from  the end of 20 ns of production simulation.   
Figure D.13 Peptide 23 inserted with the C terminus in the hydrophobic region of the bilayer.  
Structure is from the end of a 20 ns production run.    
  
 
 
